TempI

33042442 2020. Transcription factor-mediated signaling pathways' contribution to the pathology of acute lung injury and acute respiratory distress syndrome.
33034338 2020. Computer-aided prediction and design of IL-6 inducing peptides: IL-6 plays a crucial role in COVID-19.
33126244 2020. Compositional diversity and evolutionary pattern of coronavirus accessory proteins.
33110251 2020. SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response.
33060840 2020. Unique immunological profile in patients with COVID-19.
33139905 2020. Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods.
33037400 2020. A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract.
33139926 2020. The SARS-CoV-2 spike protein: balancing stability and infectivity.
33077165 2020. Editorial overview: Membrane traffic in the time of COVID-19.
33071044 2020. Type I IFN-dependent antibody response at the basis of sex dimorphism in the outcome of COVID-19.
33029657 2020. Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study.
33023827 2020. Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis.
33158808 2020. Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology.
33038769 2020. The role for the metagenome in the pathogenesis of COVID-19.
33050983 2020. Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection.
33083436 2020. Does inflammation help during COVID-19?
33107217 2020. Delayed acute myocarditis and COVID-19-related multisystem inflammatory syndrome.
33162632 2020. Are dopamine and serotonin involved in COVID-19 pathophysiology?
33149541 2020. New Pathways of Mutational Change in SARS-CoV-2 Proteomes Involve Regions of Intrinsic Disorder Important for Virus Replication and Release.
33171276 2020. Age-related mitochondrial dysfunction as a key factor in COVID-19 disease.
33118022 2020. Molecular diversity of coronavirus host cell entry receptors.
33038530 2020. The potential link between inherited G6PD deficiency, oxidative stress, and vitamin D deficiency and the racial inequities in mortality associated with COVID-19.
33194826 2020. miR-1207-5p Can Contribute to Dysregulation of Inflammatory Response in COVID-19 via Targeting SARS-CoV-2 RNA.
33123498 2020. Within-Host Diversity of SARS-CoV-2 in COVID-19 Patients With Variable Disease Severities.
33072624 2020. The Possible Dual Role of the ACE2 Receptor in Asthma and Coronavirus (SARS-CoV2) Infection.
33178720 2020. Frequencies of CD33+CD11b+HLA-DR-CD14-CD66b+ and CD33+CD11b+HLA-DR-CD14+CD66b- Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19.
33178021 2020. Tempering Macrophage Plasticity for Controlling SARS-CoV-2 Infection for Managing COVID-19 Disease.
32974267 2020. An Overview of the Temporal Shedding of SARS-CoV-2 RNA in Clinical Specimens.
33085541 2020. Mutation profile of over 4500 SARS-CoV-2 isolations reveals prevalent cytosine-to-uridine deamination on viral RNAs.
33163695 2020. Genomic exploration light on multiple origin with potential parsimony-informative sites of the severe acute respiratory syndrome coronavirus 2 in Bangladesh.
33173592 2020. A Hydrophobic-Interaction-Based Mechanism Triggers Docking between the SARS-CoV-2 Spike and Angiotensin-Converting Enzyme 2.
33135055 2020. Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2.
33139855 2020. The pivotal role of the angiotensin-II-NF-kappaB axis in the development of COVID-19 pathophysiology.
33163360 2020. A fatal course of multiple inflammatory syndrome in children coinfection with dengue. A case report from Indonesia.
33040752 2020. Whither immunity? The search for effective, durable immunity to coronavirus disease 2019 (COVID-19).
33039603 2020. Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex.
33035643 2020. Emergence and molecular mechanisms of SARS-CoV-2 and HIV to target host cells and potential therapeutics.
32937193 2020. Quasi-species nature and differential gene expression of severe acute respiratory syndrome coronavirus 2 and phylogenetic analysis of a novel Iranian strain.
33079210 2020. Inflammasome formation in the lungs of patients with fatal COVID-19.
33029758 2020. Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications.
33159646 2020. The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients.
33131215 2020. What is the long-term clinical significance of anti-SARS-CoV-2-specific IgG?
33039966 2020. Continuous tracking of COVID-19 patients' immune status.
33039965 2020. Decreased complement C3 levels are associated with poor prognosis in patients with COVID-19: A retrospective cohort study.
33068863 2020. Nucleic acid and antibody assay results in Chinese patients with coronavirus disease 2019 (COVID-19).
33068865 2020. Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics.
33058970 2020. Papain-like cysteine proteinase zone (PCP-zone) and PCP structural catalytic core (PCP-SCC) of enzymes with cysteine proteinase fold.
33061814 2020. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients.
33076729 2020. Immune system changes during COVID-19 recovery play key role in determining disease severity.
33115680 2020. Serological cross-reaction and coinfection of dengue and COVID-19 in Asia: Experience from Indonesia.
33075532 2020. Higher binding affinity of Furin to SARS-CoV-2 spike (S) protein D614G could be associated with higher SARS-CoV-2 infectivity.
33176202 2020. High prevalence of pre-existing serological cross-reactivity against SARS-CoV-2 in sub-Sahara Africa.
33160066 2020. Viral Kinetics of SARS-CoV-2 over the preclinical, clinical, and postclinical period.
33057783 2020. Paediatric Inflammatory Multisystem Syndrome Temporally-Associated with SARS-CoV-2 Infection: An Overview.
33099545 2020. Understanding Severe Acute Respiratory Syndrome Coronavirus 2 Replication to Design Efficient Drug Combination Therapies.
33043283 2020. SARS-CoV-2 Infection Dysregulates the Metabolomic and Lipidomic Profiles of Serum.
33134888 2020. SARS-CoV-2 Targets by the pscRNA Profiling of ACE2, TMPRSS2 and Furin Proteases.
33122196 2020. High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity.
33060199 2020. Unusual zwitterionic catalytic site of SARS-CoV-2 main protease revealed by neutron crystallography.
33051211 2020. Coronavirus infection and PARP expression dysregulate the NAD Metabolome: an actionable component of innate immunity.
33154165 2020. Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment.
33161818 2020. The Circadian Clock and Viral Infections.
33145472 2020. SARS-CoV-2 (COVID-19) and the Endocrine System.
32910820 2020. Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies.
33128369 2020. Analysis of humoral immune responses in SARS-CoV-2 infected patients.
33122141 2020. Dynamics of Blood Viral Load Is Strongly Associated with Clinical Outcomes in Coronavirus Disease 2019 (COVID-19) Patients: A Prospective Cohort Study.
33099199 2021. Exploring the intrinsic dynamics of SARS-CoV-2, SARS-CoV and MERS-CoV spike glycoprotein through normal mode analysis using anisotropic network model.
33135884 2020. Structure of the SARS-CoV-2 Nsp1/5'-Untranslated Region Complex and Implications for Potential Therapeutic Targets, a Vaccine, and Virulence.
33103907 2020. Evidence of Structural Protein Damage and Membrane Lipid Remodeling in Red Blood Cells from COVID-19 Patients.
33103435 2020. Computational Identification of Human Biological Processes and Protein Sequence Motifs Putatively Targeted by SARS-CoV-2 Proteins Using Protein-Protein Interaction Networks.
32946692 2020. Structural Insights into the Binding Modes of Viral RNA-Dependent RNA Polymerases Using a Function-Site Interaction Fingerprint Method for RNA Virus Drug Discovery.
33169633 2020. Angiotensin II, III, and IV may be important in the progression of COVID-19.
33035201 2020. Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers, and convalescent plasma donors.
33129392 2020. Host or pathogen-related factors in COVID-19 severity? - Authors' reply.
33129391 2020. Host or pathogen-related factors in COVID-19 severity?
33129826 2020. Immunity after COVID-19: Protection or sensitization?
33049594 2020. Viral replication of SARS-CoV-2 could be self-limitative - The role of the renin-angiotensin system on COVID-19 pathophysiology.
33112981 2020. Interdisziplinares COVID-Board bei SARS-CoV-2-getriggerter hyperferritinamischer Inflammation.
33083157 2020. Mutations of SARS-CoV-2 nsp14 exhibit strong association with increased genome-wide mutation load.
32983652 2020. Potential role of cellular miRNAs in coronavirus-host interplay.
33065209 2020. The role of kallikrein-kinin and renin-angiotensin systems in COVID-19 infection.
33137344 2020. Human coronavirus spike protein-host receptor recognition.
33106987 2020. Role of Oxidative Stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) Infection: A Review.
33098476 2020. An Overview of the Crystallized Structures of the SARS-CoV-2.
33181413 2020. High-density lipoprotein cholesterol as a factor affecting virus clearance in covid-19 patients.
33058760 2020. The Architecture of Inactivated SARS-CoV-2 with Postfusion Spikes Revealed by Cryo-EM and Cryo-ET.
33189428 2020. Duration of anti-SARS-CoV-2 antibodies much shorter in India.
33164796 2020. Identification of a dominant CD8(+) CTL epitope in the SARS-associated coronavirus 2 spike protein.
33050053 2020. Evolutionary Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reveals Genomic Divergence with Implications for Universal Vaccine Efficacy.
33036202 2020. Host Receptors of Influenza Viruses and Coronaviruses-Molecular Mechanisms of Recognition.
33041736 2020. Glicosilacion, sitios de union de ligandos y variaciones antigenicas entre la glicoproteina de membrana del COVID-19 y los coronavirus asociados.
33121513 2020. Prediction and evolution of B cell epitopes of surface protein in SARS-CoV-2.
33059711 2020. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.
33164536 2020. Is mitochondrial bioenergetics and coenzyme Q10 the target of a virus causing COVID-19?
33108121 2020. Lecons biochimiques et statistiques de l'evolution du virus SARS-CoV-2 : nouveaux chemins pour combattre les virus.
33064620 2020. The role of the thymus in COVID-19 disease severity: implications for antibody treatment and immunization.
33166547 2020. A fluorescence-based high throughput-screening assay for the SARS-CoV RNA synthesis complex.
33176080 2020. Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host.
33077916 2020. Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor.
33077915 2020. Tissue-specific and interferon-inducible expression of nonfunctional ACE2 through endogenous retroelement co-option.
33169014 2020. Proinflammatory IgG Fc structures in patients with severe COVID-19.
33139917 2020. Overlapping B cell pathways in severe COVID-19 and lupus.
33028979 2020. Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19.
32855347 2020. Atrioventricular Block in Children With Multisystem Inflammatory Syndrome.
33115920 2020. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months.
33093098 2020. The engines of SARS-CoV-2 spread.
33060197 2020. Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.
33159009 2020. Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.
33082295 2020. Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate.
33082294 2020. Neuropilin-1 is a host factor for SARS-CoV-2 infection.
33082293 2020. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.
33147933 2020. [Progress in research on cytokine storm].

33140034 2020. Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein.
33166035 2020. The role of senescent T cells in immunopathology.
33041634 2020. Characterization of SARS-CoV-2 Dynamics in the Host.
33178900 2020. SARS-CoV-2 cell receptor gene ACE2 -mediated immunomodulation in breast cancer subtypes.
33072893 2020. Identification of novel mutations in the methyltransferase complex (Nsp10-Nsp16) of SARS-CoV-2.
33039147 2020. High-resolution structure and biophysical characterization of the nucleocapsid phosphoprotein dimerization domain from the Covid-19 severe acute respiratory syndrome coronavirus 2.
33097184 2020. Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19.
33069360 2020. Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies.
33138856 2020. Serological determinants of COVID-19.
33153065 2020. Anti-SARS-Cov-2 IgA Response in Tears of COVID-19 Patients.
33120236 2020. Innate and adaptive immune responses against coronavirus.
33102591 2020. Sequence Analysis and Structure Prediction of SARS-CoV-2 Accessory Proteins 9b and ORF14: Evolutionary Analysis Indicates Close Relatedness to Bat Coronavirus.
33143053 2020. miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19.
33159807 2020. (1)H, (13)C, and (15)N backbone chemical shift assignments of coronavirus-2 non-structural protein Nsp10.
33142431 2020. A perspective on potential target proteins of COVID-19: Comparison with SARS-CoV for designing new small molecules.
33035469 2020. COVID-19 in children: a case report of Multisystem Inflammatory Syndrome (MIS-C) in Sao Paulo, Brazil.
33038939 2020. Cytokine Storms in Cancer and COVID-19.
33101705 2020. The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing.
33031765 2020. Mining the Antibody Repertoire for Solutions to SARS-CoV-2.
33096026 2020. Large-Scale Multi-omic Analysis of COVID-19 Severity.
33138195 2020. Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19.
33086697 2020. Effects of Coronavirus Persistence on the Genome Structure and Subsequent Gene Expression, Pathogenicity and Adaptation Capability.
33171736 2020. Cell Biology of Viral Infections.
33087172 2020. The epigenetic implication in coronavirus infection and therapy.
33069853 2020. Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children.
33147319 2020. Lack of antibodies to SARS-CoV-2 in a large cohort of previously infected persons.
33123353 2020. Complement and protection from tissue injury in COVID-19.
33049415 2020. Cardiovascular magnetic resonance imaging in children with pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 and heart dysfunction.
33144203 2020. Intra-host non-synonymous diversity at a neutralizing antibody epitope of SARS-CoV-2 spike protein N-terminal domain.
33055229 2020. Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis.
33072323 2020. Kinetics and isotype assessment of antibodies targeting the spike protein receptor-binding domain of severe acute respiratory syndrome-coronavirus-2 in COVID-19 patients as a function of age, biological sex and disease severity.
33135345 2020. The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID-19.
32965311 2020. Hemophagocytic syndrome: a potential COVID-19 complication.
33066459 2020. Presentation, Treatment Response and Short-Term Outcomes in Paediatric Multisystem Inflammatory Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS).
33147321 2020. An unconventional view of COVID-19 T cell immunity.
32999425 2020. Response to "the role of the exposome in promoting resilience or susceptibility after SARS-CoV-2 infection".
33031080 2020. Could "trained immunity" be induced by live attenuated vaccines protect against COVID-19? Review of available evidence.
33140086 2020. Longitudinal analysis of serology and neutralizing antibody levels in COVID19 convalescents.
33116747 2020. Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy.
33046418 2020. Antibody response to SARS-CoV-2 in people living with HIV.
33082599 2020. Chloroquine and hydroxychloroquine inhibitors for COVID-19 sialic acid cellular receptor: Structure, hirshfeld atomic charge analysis and solvent effect.
33157499 2020. Detailed immune monitoring of a pregnant woman with critical Covid-19.
33130538 2020. Can immunity during pregnancy influence SARS-CoV-2 infection? - A systematic review.
33158944 2020. The SARS-CoV-2 conserved macrodomain is a mono-ADP-ribosylhydrolase.
33144321 2020. Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies.
33170317 2020. ACE2: The Major Cell Entry Receptor for SARS-CoV-2.
33163958 2020. Comparative analysis of nanomechanical features of coronavirus spike proteins and correlation with lethality and infection rate.
33127861 2020. Pervasive RNA Secondary Structure in the Genomes of SARS-CoV-2 and Other Coronaviruses.
33067385 2020. Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals.
33067384 2020. SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans.
33184103 2020. Defensive Properties of Mucin Glycoproteins during Respiratory Infections-Relevance for SARS-CoV-2.
33146390 2020. Characterizing transcriptional regulatory sequences in coronaviruses and their role in recombination.
33047062 2020. Designing of cytotoxic and helper T cell epitope map provides insights into the highly contagious nature of the pandemic novel coronavirus SARS-CoV-2.
33163105 2020. Analyses genomiques et phylodynamiques du Sars-CoV-2.
33113222 2020. T cell immunobiology and cytokine storm of COVID-19.
33187979 2020. Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm.
33106497 2020. Title: Cytokine release syndrome is not usually caused by secondary hemophagocytic lymphohistiocytosis in a cohort of 19 critically ill COVID-19 patients.
33082451 2020. Point mutation bias in SARS-CoV-2 variants results in increased ability to stimulate inflammatory responses.
33077873 2020. Reduced numbers of T cells and B cells correlates with persistent SARS-CoV-2 presence in non-severe COVID-19 patients.
33077837 2020. Finding disease modules for cancer and COVID-19 in gene co-expression networks with the Core&Peel method.
33067518 2020. Quantifying the adhesive strength between the SARS-CoV-2 S-proteins and human receptor and its effect in therapeutics.
33184506 2020. The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19).
33177594 2020. SARS-CoV-2 receptor is co-expressed with elements of the kinin-kallikrein, renin-angiotensin and coagulation systems in alveolar cells.
33173052 2020. Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy.
33037188 2020. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.
33037187 2020. Inhibition of translation and immune responses by the virulence factor Nsp1 of SARS-CoV-2.
33127889 2020. SARS-CoV-2 spike protein: flexibility as a new target for fighting infection.
33127886 2020. SARS-CoV-2 spike behavior in situ: a Cryo-EM images for a better understanding of the COVID-19 pandemic.
33043252 2020. Kawasaki Disease and Multisystem Inflammatory Syndrome in Children with COVID-19.
33106783 2020. Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2: a New Challenge amid the Pandemic.
33195997 2020. Applying Immune Instincts and Maternal Intelligence from Comparative Microbiology to COVID-19.
33041212 2020. Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions.
33153908 2020. Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines.
33132005 2020. Mechanisms of SARS-CoV-2 Transmission and Pathogenesis.
33190685 2020. The Mystery of MIS-C Post-SARS-CoV-2 Infection.
33077340 2020. Sex-biased Immune Responses Following SARS-CoV-2 Infection.
33051104 2020. A Cytokine Circus with a Viral Ringleader: SARS-CoV-2-Associated Cytokine Storm Syndromes.
33029383 2020. Intra-genome variability in the dinucleotide composition of SARS-CoV-2.
33050511 2020. Impact of Microbiota: A Paradigm for Evolving Herd Immunity against Viral Diseases.
33182268 2020. CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study.
33147840 2020. First Phylogenetic Analysis of Malian SARS-CoV-2 Sequences Provides Molecular Insights into the Genomic Diversity of the Sahel Region.
33187074 2020. Spike Glycoprotein-Mediated Entry of SARS Coronaviruses.
33067221 2020. Defining the Cytokine Storm Syndrome of COVID-19: Role of the Clinical Laboratory.
33023959 2020. Response to 'Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID19): a multicentre cohort by Mastrolia et al.
33086866 2020. ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Serine Protease 2) Expression and Localization of SARS-CoV-2 Infection in the Human Heart.
33181224 2020. Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein.
33105999 2020. Computer simulations of the interaction between SARS-CoV-2 spike glycoprotein and different surfaces.
33139323 2020. Covid-19: T cell response lasts for at least six months after infection, study shows.
33084150 2020. Why Does the Novel Coronavirus Spike Protein Interact so Strongly with the Human ACE2? A Thermodynamic Answer.
33174669 2020. Computational Hot-Spot Analysis of the SARS-CoV-2 Receptor Binding Domain / ACE2 Complex.
33081670 2020. Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology.
33164997 2020. Inflammatory endotypes of CRSwNP and responses to COVID-19.
33165008 2020. The single-cell landscape of immunological responses of CD4+ T cells in HIV versus severe acute respiratory syndrome coronavirus 2.
33145867 2020. Immunology of COVID-19.
33174592 2020. Composition of the immunoglobulin G glycome associates with the severity of COVID-19.
33155530 2020. SARS-CoV-2 mutations and where to find them: an in silico perspective of structural changes and antigenicity of the spike protein.
33162259 2020. Multisystem Inflammatory Syndrome in Children.
33086932 2020. The bumpy road to achieve herd immunity in COVID-19.
33148714 2020. SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19-Seropositive Individuals.
33083826 2020. Associations between genetically predicted protein levels and COVID-19 severity.
33038254 2020. Complement activation in the disease course of COVID-19 and its effects on clinical outcomes.
33135795 2020. Characterization of antibody responses to SARS-CoV-2 in convalescent COVID-19 patients.
33180935 2020. Immunological assessment of pediatric multisystem inflammatory syndrome related to COVID-19.
33175159 2020. Multisystem inflammatory syndrome in children associated with SARS-CoV-2 in an 8-week old infant.
33075008 2020. Private Tour Guide to Pediatric Coronavirus Disease of 2019 and Multisystem Inflammatory Syndrome in Children in 10 Minutes: What Thoracic Radiologists Need to Know.
33141192 2020. Newly Discovered Cellular Pathway Blocks Ebola, COVID-19 Viruses.
33074293 2020. Herd Immunity and Implications for SARS-CoV-2 Control.
33106674 2020. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans.
33177698 2020. Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers.
33106671 2020. Spike mutation D614G alters SARS-CoV-2 fitness.
33139913 2020. Interferon deficiency can lead to severe COVID.
33084624 2020. Immune Responses During Human Coronavirus Infection: Suggestions for Future Studies.

33108239 2020. Can secondary lymphoid organs exert a favorable effect on the mild course of COVID-19 in children?
33090696 2020. Sex differences in antiviral immunity in SARS-CoV-2 infection: Mitochondria and mitomiR come into view.
33065551 2020. CD45: a critical regulator in immune cells to predict severe and non-severe COVID-19 patients.
33049711 2020. Using the common cold virus as a naturally occurring vaccine to prevent COVID-19: Lessons from Edward Jenner.
33040337 2020. Antibody dynamics to SARS-CoV-2 in asymptomatic COVID-19 infections.
33131972 2020. Multisystem inflammatory syndrome in children associated with novel coronavirus SARS-CoV-2: Presentations to a pediatric emergency department in Michigan.
33151090 2020. Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of COVID-19 patients.
33146564 2020. High-dimensional single-cell analysis reveals the immune characteristics of COVID-19.
33174447 2020. In well-differentiated primary human bronchial epithelial cells, TGF-beta1 and TGF-beta2 induce expression of furin.
33132066 2020. Documento espanol de consenso sobre diagnostico, estabilizacion y tratamiento del sindrome inflamatorio multisistemico pediatrico vinculado a SARS-CoV-2 (SIM-PedS).
33134148 2020. Clinical Management of Il-6 Driven Cytokine Storm Related to COVID-19 in a Patient with Recent Spinal Cord Stimulator Implants: A Case Report.
33161155 2020. Potential Association of Mast Cells with COVID-19.
33025199 2020. Identification of novel mutations in SARS-COV-2 isolates from Turkey.
33130000 2020. SARS-CoV-2, the autoimmune virus.
33153403 2020. Highlights in the fight against COVID-19: does autophagy play a role in SARS-CoV-2 infection?
33152343 2020. Detection of Viral Infections by Innate Immunity.
33161004 2020. Special section involvement of lipids in the occurrence of COVID-19.
33159981 2020. Bis(monoacylglycero)phosphate, an important actor in the host endocytic machinery hijacked by SARS-CoV-2 and related viruses.
33115667 2020. Membrane heist: Coronavirus host membrane remodeling during replication.
33075136 2020. Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19.
33146371 2020. ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV.
33090599 2020. Immunology of COVID-19 and disease-modifying therapies: the good, the bad and the unknown.
33088822 2020. SARS-CoV-2 Bound Human Serum Albumin and Systemic Septic Shock.
33072741 2020. How to Understand "Herd Immunity" in COVID-19 Pandemic.
33042994 2020. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System.
33195336 2020. Centrality of G6PD in COVID-19: The Biochemical Rationale and Clinical Implications.
33195331 2020. The Pursuit of COVID-19 Biomarkers: Putting the Spotlight on ACE2 and TMPRSS2 Regulatory Sequences.
33195321 2020. Coagulopathy as a Prodrome of Cytokine Storm in COVID-19-Infected Patients.
33042039 2020. Flexible, Functional, and Familiar: Characteristics of SARS-CoV-2 Spike Protein Evolution.
33195436 2020. ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives.
33195427 2020. Investigation of the Effect of Temperature on the Structure of SARS-CoV-2 Spike Protein by Molecular Dynamics Simulations.
33195415 2020. Systematic Analysis of Coronavirus Disease 2019 (COVID-19) Receptor ACE2 in Malignant Tumors: Pan-Cancer Analysis.
33195414 2020. Identifying Pathways and Networks Associated With the SARS-CoV-2 Cell Receptor ACE2 Based on Gene Expression Profiles in Normal and SARS-CoV-2-Infected Human Tissues.
33195401 2020. SARS-CoV-2 Virion Stabilization by Zn Binding.
33195400 2020. COVID-19: Targeting Proteases in Viral Invasion and Host Immune Response.
33173781 2020. Computational Study of the Ion and Water Permeation and Transport Mechanisms of the SARS-CoV-2 Pentameric E Protein Channel.
33134318 2020. ssRNA Virus and Host Lipid Rearrangements: Is There a Role for Lipid Droplets in SARS-CoV-2 Infection?
33088807 2020. Prognostic and Immunological Value of Angiotensin-Converting Enzyme 2 in Pan-Cancer.
33034002 2020. Cardiac Affection in a Young Girl with Post Covid-19 Kawasaki Like Syndrome.
33090321 2020. A Pediatric COVID19 Case with Suspected Acute Abdomen, Hyperferritinemic Sepsis and Developing MIS-C and Pancreatitis.
33078283 2020. Neurological Manifestations in Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS).
33149633 2020. Exploring Diversity of COVID19 Based on Substitution Distance.
33036230 2020. Crystal Structure of Non-Structural Protein 10 from Severe Acute Respiratory Syndrome Coronavirus-2.
33063791 2020. Continuous flexibility analysis of SARS-CoV-2 spike prefusion structures.
33063790 2020. Room-temperature X-ray crystallography reveals the oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL M(pro): insights into enzyme mechanism and drug design.
33145962 2020. Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19.
33119547 2020. Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection.
33104057 2020. Prolonged adaptive immune activation in COVID-19: implications for maintenance of long-term immunity?
33116752 2020. Cytokine Response in SARS-CoV-2 Infection in the Elderly.
33054818 2020. Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report.
33112147 2020. Critical Sequence Hotspots for Binding of Novel Coronavirus to Angiotensin Converter Enzyme as Evaluated by Molecular Simulations.
33085491 2020. Thermodynamics of the Interaction between the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus-2 and the Receptor of Human Angiotensin-Converting Enzyme 2. Effects of Possible Ligands.
33134610 2020. In the Age of COVID: Genomic Changes Over the Lifespan Help Explain Severe SARS-CoV-2 Disease.
33073064 2020. Cardiorenal Tissues Express SARS-CoV-2 Entry Genes and Basigin (BSG/CD147) Increases With Age in Endothelial Cells.
32984657 2020. Multiorgan Damage in Patients With COVID-19: Is the TGF-beta/BMP Pathway the Missing Link?
32950081 2020. A history of herd immunity.
33072868 2020. Cross-reactions between rheumatoid factor and IgM SARS-CoV-2.
33103107 2020. Protein-driven mechanism of multiorgan damage in COVID-19.
33110678 2020. Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor.
33061829 2020. Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals.
33028028 2020. Positive Anti-SSA/Ro Antibody in a Woman with SARS-CoV-2 Infection Using Immunophenotyping: A Case Report.
33196005 2020. COVID-19: An Archetype Innate Immunity Reaction and Modes of Treatment.
33196004 2020. Kawasaki Disease and COVID-19.
33157216 2020. Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection.
33049387 2020. Non-synonymous mutations of SARS-CoV-2 leads epitope loss and segregates its variants.
33093050 2020. Coding-Complete Genome Sequences of 23 SARS-CoV-2 Samples from the Philippines.
33066057 2020. Kinetics of Nucleo- and Spike Protein-Specific Immunoglobulin G and of Virus-Neutralizing Antibodies after SARS-CoV-2 Infection.
33147871 2020. New Insights in Laboratory Testing for COVID-19 Patients: Looking for the Role and Predictive Value of Human epididymis secretory protein 4 (HE4) and the Innate Immunity of the Oral Cavity and Respiratory Tract.
33077685 2020. Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins.
33040198 2020. SARS-CoV-2 has the advantage of competing the iMet-tRNAs with human hosts to allow efficient translation.
33167852 2020. SARS-CoV-2 and interferon blockade.
33053318 2020. The Road Less Traveled: SARS-CoV-2 and Cell-Mediated Immunity.
33186542 2020. COVID-19-Induced ARDS Is Associated with Decreased Frequency of Activated Memory/Effector T Cells Expressing CD11a(+).
33038327 2020. Tackling COVID19 by Exploiting Pre-existing Cross-Reacting Spike-Specific Immunity.
33033248 2020. Two distinct immunopathological profiles in autopsy lungs of COVID-19.
33028810 2020. Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease.
33116139 2020. ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs.
33110068 2020. Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation.
33046696 2020. Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium.
33139888 2020. Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models.
33051610 2020. IL-18-dependent MAIT cell activation in COVID-19.
33073555 2020. SARS-CoV-2-related lung pathology: macroscopic and histologic features and their clinical implications.
33154981 2020. The Structure of the Membrane Protein of SARS-CoV-2 Resembles the Sugar Transporter SemiSWEET.
33036180 2020. Tissue Proteases and Immune Responses: Influencing Factors of COVID-19 Severity and Mortality.
33114356 2020. New Insights on the Mobility of Viral and Host Non-Coding RNAs Reveal Extracellular Vesicles as Intriguing Candidate Antiviral Targets.
33099164 2020. Atypical lymphocytes in bronchoalveolar lavage fluid from patients with COVID-19 ARDS.
33194341 2020. Excessive G-U transversions in novel allele variants in SARS-CoV-2 genomes.
33088633 2020. Positive selection within the genomes of SARS-CoV-2 and other Coronaviruses independent of impact on protein function.
32898168 2020. In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age.
33170902 2020. Large scale genomic analysis of 3067 SARS-CoV-2 genomes reveals a clonal geo-distribution and a rich genetic variations of hotspots mutations.
33091042 2020. Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays.
33085715 2020. Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders.
33079950 2020. Proteins associated with neutrophil degranulation are upregulated in nasopharyngeal swabs from SARS-CoV-2 patients.
33034798 2020. Whole genome sequencing and phylogenetic classification of Tunisian SARS-CoV-2 strains from patients of the Military Hospital in Tunis.
33166565 2021. Deletion in the C-terminal region of the envelope glycoprotein in some of the Indian SARS-CoV-2 genome.
33069815 2020. The role of dysregulated immune responses in COVID-19 pathogenesis.
33180463 2020. COVID-19 in the Developing World: Is the Immune Response to alpha-Gal an Overlooked Factor Mitigating the Severity of Infection?
33073197 2020. Can SARS-CoV-2 Accumulate Mutations in the S-Protein to Increase Pathogenicity?
33112638 2020. Literature review on Virus and Host Response Proteins in COVID-19: Pathobiology, Management, Diagnosis and Treatment.
33112637 2020. Mechanisms and potential therapeutic targets of hyperinflammatory responses in SARS-CoV2.
33128792 2020. Immunological imprint of COVID-19 on human peripheral blood leukocyte populations.
33105230 2020. Characteristics of Pediatric Inflammatory Multisystem Syndrome Associated with COVID-19.
33064955 2020. Will Research on COVID-19 Stimulate the Identification of Immunological Mechanisms Underlying Some Protective Effects?
33140827 2020. ACE2 and gut amino acid transport.
33044282 2020. Acute Kidney Injury in Pediatric Inflammatory Multisystem Syndrome Temporally Associated With Severe Acute Respiratory Syndrome Coronavirus-2 Pandemic: Experience From PICUs Across United Kingdom.
33176273 2020. Detection of viruses by inflammasomes.
33023438 2020. miRNAs in SARS-CoV 2: A Spoke in the Wheel of Pathogenesis.
33084029 2020. Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset.
33080068 2020. Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients.
33073359 2020. Divergent SARS-CoV-2-specific T- and B-cell responses in severe but not mild COVID-19 patients.
33152254 2020. The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection.
33113212 2020. COVID-19, varying genetic resistance to viral disease and immune tolerance checkpoints.

33096082 2020. Structure-Altering Mutations of the SARS-CoV-2 Frameshifting RNA Element.
33100352 2020. Change of Antigenic Determinants of SARS-CoV-2 Virus S-Protein as a Possible Cause of Antibody-Dependent Enhancement of Virus Infection and Cytokine Storm.
33171100 2020. Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19.
33157038 2020. beta-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway.
33147445 2020. Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells.
33147444 2020. Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection.
33096020 2020. Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4(+) T Cells in COVID-19.
33080218 2020. SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses.
33037393 2020. An aberrant STAT pathway is central to COVID-19.
33110074 2020. Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome.
33072409 2020. The role of death domain proteins in host response upon SARS-CoV-2 infection: modulation of programmed cell death and translational applications.
33024578 2020. Benchmarking evolutionary tinkering underlying human-viral molecular mimicry shows multiple host pulmonary-arterial peptides mimicked by SARS-CoV-2.
33158455 2020. Weak anti-SARS-CoV-2 antibody response is associated with mortality in a Swedish cohort of COVID-19 patients in critical care.
33138839 2020. CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS.
33131507 2020. The double edged interferon riddle in COVID-19 pathogenesis.
33063036 2020. Delayed Development of Coronary Artery Dilitation in Suspected Severe Acute Respiratory Syndrome Coronavirus 2 Multisystem Inflammatory Syndrome: More Research Needed.
33145128 2020. A Case of Multisystem Inflammatory Syndrome in Children Mimicking Acute Appendicitis in a COVID-19 Pandemic Area.
33133836 2020. Atypical Case of COVID-19 Associated Kawasaki Disease in an Eight-Year-Old Pakistani Boy.
33110725 2020. Multisystem Inflammatory Syndrome in Children Temporally Related to COVID-19: A Case Report From Saudi Arabia.
33112236 2020. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
33103998 2020. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.
33164753 2020. Single-cell multiomic profiling of human lungs reveals cell-type-specific and age-dynamic control of SARS-CoV2 host genes.
33164751 2020. ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities.
33051876 2020. Syncytia formation by SARS-CoV-2-infected cells.
33078545 2020. Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia.
33112036 2020. SARS-CoV-2 evades immune detection in alveolar macrophages.
33058753 2020. Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2-Specific IgG.
33083367 2020. Kawasaki-like Syndrome as an Emerging Complication of SARS-CoV-2 Infection in Young Adults.
33058143 2020. Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis.
33038418 2020. Targeting pivotal inflammatory pathways in COVID-19: A mechanistic review.
33086029 2020. Renin-angiotensin system at the interface of COVID-19 infection.
33193414 2020. Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets.
33193390 2020. SOCS, Intrinsic Virulence Factors, and Treatment of COVID-19.
33193384 2020. Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness.
33193377 2020. I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People.
33193337 2020. COVID-19 as an Immune Complex Hypersensitivity in Antigen Excess Conditions: Theoretical Pathogenetic Process and Suggestions for Potential Therapeutic Interventions.
33193331 2020. A 21st Century Evil: Immunopathology and New Therapies of COVID-19.
33178221 2020. T-Cell Hyperactivation and Paralysis in Severe COVID-19 Infection Revealed by Single-Cell Analysis.
33178220 2020. Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines.
33178207 2020. A Longitudinal Study of Immune Cells in Severe COVID-19 Patients.
33178193 2020. Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis?
33163005 2020. The Neat Dance of COVID-19: NEAT1, DANCR, and Co-Modulated Cholinergic RNAs Link to Inflammation.
33154753 2020. Elevated Exhaustion Levels of NK and CD8(+) T Cells as Indicators for Progression and Prognosis of COVID-19 Disease.
33154751 2020. Coronavirus Proteins as Ion Channels: Current and Potential Research.
33149733 2020. The Inflammasome in Times of COVID-19.
33133104 2020. Lower Circulating Interferon-Gamma Is a Risk Factor for Lung Fibrosis in COVID-19 Patients.
33133098 2020. Virological and Serological Discordant Profiles in COVID-19 Pneumonia: Two Atypical Clinical Cases.
33133083 2020. Immune Correlates of COVID-19 Control.
33123167 2020. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
33123154 2020. Increased Plasma Heparanase Activity in COVID-19 Patients.
33123152 2020. Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19?
33123149 2020. A "Window of Therapeutic Opportunity" for Anti-Cytokine Therapy in Patients With Coronavirus Disease 2019.
33117408 2020. The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19.
33117402 2020. Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer.
33117392 2020. Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients.
33117379 2020. ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19.
33117378 2020. The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens.
33101320 2020. Is Herd Immunity Against SARS-CoV-2 a Silver Lining?
33101306 2020. Covid-19: Perspectives on Innate Immune Evasion.
33072103 2020. Immunopathogenesis of COVID-19: Summary and Possible Interventions.
33072099 2020. Increased Serum Levels of sCD14 and sCD163 Indicate a Preponderant Role for Monocytes in COVID-19 Immunopathology.
33072097 2020. COVID-19: In the Eye of the Cytokine Storm.
33042116 2020. COVID-19: Infection or Autoimmunity.
33098549 2020. Persistence of humoral and cellular immune response after SARS-CoV-2 infection: opportunities and challenges.
33086021 2020. Epigenetic regulation of ACE2, the receptor of the SARS-CoV-2 virus.
33125064 2020. A path towards SARS-CoV-2 attenuation: metabolic pressure on CTP synthesis rules the virus evolution.
33069829 2020. Clustering and classification of virus sequence through music communication protocol and wavelet transform.
33161087 2020. Trends of mutation accumulation across global SARS-CoV-2 genomes: Implications for the evolution of the novel coronavirus.
33124193 2020. Transcriptomic analysis reveals novel mechanisms of SARS-CoV-2 infection in human lung cells.
33163249 2020. The Progression of SARS Coronavirus 2 (SARS-CoV2): Mutation in the Receptor Binding Domain of Spike Gene.
33129373 2020. Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity.
33128877 2020. Unbiased Screens Show CD8(+) T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein.
33128875 2020. Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19.
33130519 2020. Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies.
33168413 2020. Associations of medications used during hospitalization and immunological changes in patients with COVID-19 during 3-month follow-up.
33035675 2020. First COVID-19 Case in Zambia - Comparative phylogenomic analyses of SARS-CoV-2 detected in African countries.
33031941 2020. Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh.
32920092 2020. Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19.
32896310 2020. The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection.
33075409 2020. COVID-19-associated multisystem inflammatory syndrome in children (MIS-C): A novel disease that mimics toxic shock syndrome-the superantigen hypothesis.
33064671 2020. SARS-CoV-2 specific antibody rearrangements in pre-pandemic immune repertoires of risk cohorts and COVID-19 patients.
33055417 2020. What are protective antibody responses to pandemic SARS-CoV-2?
33064340 2020. Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects.
33058235 2020. Background immunity: How important is it for SARS-CoV-2?
33090512 2020. Effects of SARS-CoV-2 mutations on protein structures and intraviral protein-protein interactions.
33090493 2020. Mutations in membrane-fusion subunit of spike glycoprotein play crucial role in the recent outbreak of COVID-19.
33049069 2020. Analysis of SARS-CoV-2 mutations in Mexico, Belize, and isolated regions of Guatemala and its implication in the diagnosis.
33075298 2020. Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes.
33073244 2020. Imperfect storm: is interleukin-33 the Achilles heel of COVID-19?
33051609 2020. Intestinal attenuation of COVID-19 inflammation.
33068416 2020. Structural analysis of SARS-CoV-2 genome and predictions of the human interactome.
33097660 2020. SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling.
33082228 2020. Transcriptional and proteomic insights into the host response in fatal COVID-19 cases.
33037310 2020. The sequence at Spike S1/S2 site enables cleavage by furin and phospho-regulation in SARS-CoV2 but not in SARS-CoV1 or MERS-CoV.
33033346 2020. The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism.
33033344 2020. Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method.
33122706 2020. Kinetics of SARS-CoV-2 positivity of infected and recovered patients from a single center.
33106569 2020. The global population of SARS-CoV-2 is composed of six major subtypes.
33060796 2020. Rapid genomic characterization of SARS-CoV-2 viruses from clinical specimens using nanopore sequencing.
33149224 2020. Epitope similarity cannot explain the pre-formed T cell immunity towards structural SARS-CoV-2 proteins.
33148089 2020. Shock and Myocardial Injury in Children With Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection: What We Know. Case Series and Review of the Literature.
33107601 2020. Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.
33095454 2020. Evolutionary dynamics of SARS-CoV-2 nucleocapsid protein and its consequences.
33085084 2020. SARS-CoV-2-specific virulence factors in COVID-19.
33087872 2020. The false promise of herd immunity for COVID-19.
33181794 2020. Pediatric Inflammatory Multisystem Syndrome Associated With SARS-CoV-2: A Case Series Quantitative Systematic Review.
33055501 2020. COVID-19 and Multisystem Inflammatory Syndrome in Latin American Children: A Multinational Study.
33181783 2020. Fatal SARS-CoV-2 Inflammatory Syndrome and Myocarditis in an Adolescent: A Case Report.
33177233 2020. In fatal COVID-19, the immune response can control the virus but kill the patient.
33033173 2020. Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients.
33033172 2020. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients.
33148390 2020. [Progress on role of cytokine storm in exacerbation of coronavirus disease 2019 (COVID-19): Review].

33029570 2020. Molecular docking between human TMPRSS2 and SARS-CoV-2 spike protein: conformation and intermolecular interactions.
33047493 2020. T cell and antibody responses to SARS-CoV-2: Experience from a French transplantation and hemodialysis center during the COVID-19 pandemic.
33064451 2020. Comprehensive Analysis of the Glycan Complement of SARS-CoV-2 Spike Proteins Using Signature Ions-Triggered Electron-Transfer/Higher-Energy Collisional Dissociation (EThcD) Mass Spectrometry.
33087299 2020. Understanding the role of neutrophils in acute respiratory distress syndrome.
33036956 2020. Machine learning techniques for sequence-based prediction of viral-host interactions between SARS-CoV-2 and human proteins.
33118327 2020. Biophysical analysis of SARS-CoV-2 transmission and theranostic development via N protein computational characterization.
33167900 2020. Kinetic changes in virology, specific antibody response and imaging during the clinical course of COVID-19: a descriptive study.
33167916 2020. Clinical characteristics of 10 children with a pediatric inflammatory multisystem syndrome associated with COVID-19 in Iran.
33142819 2020. COVID-19 and Parkinson's Disease: Shared Inflammatory Pathways Under Oxidative Stress.
33062362 2020. Discovering Associations: Kawasaki Disease and COVID-19.
33092458 2020. Similarities between the effect of SARS-CoV-2 and HCV on the cellular level, and the possible role of ion channels in COVID19 progression: a review of potential targets for diagnosis and treatment.
33115882 2020. The beneficial and pathogenic roles of complement in COVID-19.
33111059 2020. Histopathologic Findings of Coronavirus in Lung: A Mini-Review.
33091758 2020. The role of androgens in COVID-19.
33100263 2020. ORF3a mutation associated with higher mortality rate in SARS-CoV-2 infection.
33033152 2020. Cellular Senescence: Friend or Foe to Respiratory Viral Infections?
33060154 2020. mTORC1 Hyperactivation in LAM Leads to ACE2 Upregulation in Type II Pneumocytes: Implications for COVID-19.
33155247 2020. COVID-19 - gastrointestinal and gut microbiota-related aspects.
33193227 2020. Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals.
33193156 2020. G-Quadruplexes Are Present in Human Coronaviruses Including SARS-CoV-2.
33193132 2020. Positive Selection of ORF1ab, ORF3a, and ORF8 Genes Drives the Early Evolutionary Trends of SARS-CoV-2 During the 2020 COVID-19 Pandemic.
33178176 2020. Differential Expression of Viral Transcripts From Single-Cell RNA Sequencing of Moderate and Severe COVID-19 Patients and Its Implications for Case Severity.
33133055 2020. SARS-CoV-2 nsp1: Bioinformatics, Potential Structural and Functional Features, and Implications for Drug/Vaccine Designs.
33101264 2020. Genetic Spectrum and Distinct Evolution Patterns of SARS-CoV-2.
33101244 2020. Rapid Genomic Characterization of SARS-CoV-2 by Direct Amplicon-Based Sequencing Through Comparison of MinION and Illumina iSeq100(TM) System.
33072032 2020. Small Non-coding RNAs: Do They Encode Answers for Controlling SARS-CoV-2 in the Future?
33072018 2020. Translation-Associated Mutational U-Pressure in the First ORF of SARS-CoV-2 and Other Coronaviruses.
33071996 2020. Proteomics Insights Into the Molecular Basis of SARS-CoV-2 Infection: What We Can Learn From the Human Olfactory Axis.
33072695 2020. The CHIR Score for Evaluating the Hyperimmune Response in COVID-19: A Preliminary Concept.
33075345 2020. The SARS-CoV-2 attachment receptor ACE2 is decreased in Crohn's disease and regulated by microbial and inflammatory signaling.
33143811 2020. Clinical characteristics and persistence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG antibodies in 4,607 French healthcare workers: Comparison with European countries.
33092731 2020. Cardiac Dysfunction in Multisystem Inflammatory Syndrome in Children: A Call to Action.
33108354 2020. Inflammatory syndromes associated with SARS-CoV-2 infection: dysregulation of the immune response across the age spectrum.
33085654 2020. Age-related susceptibility to coronavirus infections: role of impaired and dysregulated host immunity.
33143379 2020. The Role of Molecular Chaperones in Virus Infection and Implications for Understanding and Treating COVID-19.
33126723 2020. Similar Clinical Course and Significance of Circulating Innate and Adaptive Immune Cell Counts in STEMI and COVID-19.
33105634 2020. Pediatric Inflammatory Multisystem Syndrome (PIMS) Did Occur in Poland during Months with Low COVID-19 Prevalence, Preliminary Results of a Nationwide Register.
33161369 2020. Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect.
33110452 2020. Case report: a fatal combination of hemophagocytic lymphohistiocytosis with extensive pulmonary microvascular damage in COVID-19 pneumonia.
33169560 2020. Multisystem Inflammatory Syndrome in Children Related to COVID-19: the First Case in Korea.
33038012 2020. Evaluation of alpha defensin, IL-1 receptor antagonist, and IL-18 levels in COVID-19 patients with macrophage activation syndrome and acute respiratory distress syndrome.
33065115 2020. Discriminating Multisystem Inflammatory Syndrome in Children Requiring Treatment from Common Febrile Conditions in Outpatient Settings.
33186512 2020. Multisystem inflammatory syndrome in children (MIS-C) during SARS-CoV-2 pandemic in Brazil: a multicenter, prospective cohort study.
33043289 2020. Structures and dynamics of the novel S1/S2 protease cleavage site loop of the SARS-CoV-2 spike glycoprotein.
32988176 2020. The first case of pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 infection (PIMS-TS) in Poland, complicated by giant coronary artery aneurysms.
33160625 2020. CD64, CD11a and CD18 leukocytes expression in children with SARS-CoV-2 multisystem inflammatory syndrome versus children with Kawasaki disease: Similar but not the same.
33107277 2020. An unusual inflammatory disease linked to SARS coronavirus-2 in children: are we prepared enough?
33107273 2020. Covid-19 and kawasaki disease: is there a need for revising treatment guidelines?
33031361 2020. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection - United Kingdom and United States, March-August 2020.
33177214 2020. Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.
33036934 2020. Multisystem inflammatory syndrome in SARS-CoV-2 infection mimicking acute appendicitis in children.
33170884 2020. Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of "Up" versus "Down" protomer states.
33152019 2020. Variant analysis of 1,040 SARS-CoV-2 genomes.
33112891 2020. Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2.
33181855 2020. Multisystem inflammatory syndrome with refractory cardiogenic shock due to acute myocarditis and mononeuritis multiplex after SARS-CoV-2 infection in an adult.
33186686 2020. Protective immunity against COVID-19: Unravelling the evidences for humoral vs. cellular components.
33086860 2020. COVID-19 and Endocan Levels.
33115730 2020. Covid-19: Antibody prevalence in England fell from 6.0% to 4.4% over three months, study finds.
33166189 2020. Acute Cardiovascular Manifestations in 286 Children with Multisystem Inflammatory Syndrome Associated with COVID-19 Infection in Europe.
33166178 2020. Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children.
33105391 2020. Eosinophilic esophagitis: is the Th2 inflammation protective against the severe form of COVID-19?
33124149 2020. The effects of aging on host resistance and disease tolerance to SARS-CoV-2 infection.
33098359 2020. Proteomic characteristics of bronchoalveolar lavage fluid in critical COVID-19 patients.
33077007 2020. Understanding viral shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Review of current literature.
33151142 2020. Lysine 164 is critical for SARS-CoV-2 Nsp1 inhibition of host gene expression.
33137315 2020. Coronavirus disease 2019, multisystem inflammatory syndrome in children, apolipoprotein E4, and race.
33093376 2020. COVID-19-associated Multisystem Inflammatory Syndrome in Children Presenting as Acute Pancreatitis.
33174576 2020. Context contribution to the intermolecular recognition of human ACE2-derived peptides by SARS-CoV-2 spike protein: implications for improving the peptide affinity but not altering the peptide specificity by optimizing indirect readout.
33070335 2020. The Human Coronavirus Receptor ANPEP (CD13) Is Overexpressed in Parkinson's Disease.
33167030 2020. Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy.
33166999 2020. Genome-wide mapping of SARS-CoV-2 RNA structures identifies therapeutically-relevant elements.
33147113 2020. Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I- and III Interferons.
33181057 2020. Type I IFNs: A Blessing in Disguise or Partner in Crime in MERS-CoV-, SARS-CoV-, and SARS-CoV-2-Induced Pathology and Potential Use of Type I IFNs in Synergism with IFN-gamma as a Novel Antiviral Approach Against COVID-19.

32918894 2020. Stability of severe acute respiratory syndrome coronavirus 2 RNA in placenta and fetal cells.
32866527 2020. Confirmatory evidence of the visualization of severe acute respiratory syndrome coronavirus 2 invading the human placenta using electron microscopy.
32858014 2020. Comparative nanostructure consideration on novel coronavirus and possibility of transplacental transmission.
32853537 2020. Expression of severe acute respiratory syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and transmembrane protease serine 2, in the placenta across gestation and at the maternal-fetal interface in pregnancies complicated by preterm birth or preeclampsia.
33020692 2020. In-host Mathematical Modelling of COVID-19 in Humans.
32904415 2020. A data-driven understanding of COVID-19 dynamics using sequential genetic algorithm based probabilistic cellular automata.
32901204 2020. Analyzing COVID-19 virus based on enhanced fragmented biological Local Aligner using improved Ions Motion Optimization algorithm.
32943188 2020. RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19.
32981683 2020. Machine learning methods accurately predict host specificity of coronaviruses based on spike sequences alone.
32931703 2020. Sequence Characterization and Molecular Modeling of Clinically Relevant Variants of the SARS-CoV-2 Main Protease.
32976572 2020. COVID-19 Knowledge Graph: a computable, multi-modal, cause-and-effect knowledge model of COVID-19 pathophysiology.
32994678 2020. Comparative molecular docking analysis of the SARS CoV-2 Spike glycoprotein with the human ACE-2 receptors and thrombin.
32994673 2020. CoViD-19 Susceptibility.
32923488 2020. Adaptive Evolution of Feline Coronavirus Genes Based on Selection Analysis.
32933047 2020. Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?
32895643 2020. Genomic characterization of SARS-CoV-2 identified in a reemerging COVID-19 outbreak in Beijing's Xinfadi market in 2020.
33008363 2020. Real-time audio and visual display of the Coronavirus genome.
32993540 2020. A young adult with COVID-19 and multisystem inflammatory syndrome in children (MIS-C)-like illness: a case report.
32892755 2020. Obesity, COVID-19 and innate immunometabolism.
32975865 2020. Expression of ACE2 in airways: Implication for COVID-19 risk and disease management in patients with chronic inflammatory respiratory diseases.
32978971 2020. Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage.
32864374 2020. Coronavirus epitope prediction from highly conserved region of spike protein.
32920210 2020. On the genetics and immunopathogenesis of COVID-19.
32866645 2020. Interferon gamma, TGF-beta1 and RANTES expression in upper airway samples from SARS-CoV-2 infected patients.
32898238 2020. Sustained responses of neutralizing antibodies against MERS-CoV in recovered patients and their therapeutic applicability.
32997739 2020. Severe COVID-19 is associated with elevated serum IgA and antiphospholipid IgA-antibodies.
32130405 2020. 2019 Novel Coronavirus Is Undergoing Active Recombination.
32797228 2020. Potential antigenic cross-reactivity between SARS-CoV-2 and Dengue viruses.
32898715 2020. The kinetics of viral load and antibodiesto SARS-CoV-2.
33005417 2020. Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
32989903 2020. COVID-19 and immunological dysregulation: can autoantibodies be useful?
32983400 2020. Computational biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity.
32983399 2020. An immersive journey to the molecular structure of SARS-CoV-2: Virtual reality in COVID-19.
32894160 2020. Assessment of pulmonary surfactant in COVID-19 patients.
32988728 2020. Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?
33017040 2020. Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection.
32979342 2020. Compartmental immunophenotyping in COVID-19 ARDS: a case series.
32895779 2020. Coronavirus: a shift in focus away from IFN response and towards other inflammatory targets.
32944935 2020. Single-cell RNA sequencing analysis of SARS-CoV-2 entry receptors in human organoids.
32897993 2020. Challenges in Diagnosing Multisystem Inflammatory Syndrome Related to SARS-CoV-2 in a Child With Severe Neurocognitive Impairment and Social Isolation.
32814701 2020. The Urgency of Conducting Serological Studies for COVID-19.
32788194 2020. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
33024281 2020. Cross-reactive memory T cells and herd immunity to SARS-CoV-2.
32943538 2020. Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients.
32989130 2020. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation.
32963094 2020. Transmission dynamics reveal the impracticality of COVID-19 herd immunity strategies.
32964627 2020. Immune response following infection with SARS-CoV-2 and other coronaviruses: A rapid review.
32946131 2020. Investigation of immune cells on elimination of pulmonary-Infected COVID-19 and important role of innate immunity, phagocytes.
32928234 2020. Characterization of codon usage pattern in SARS-CoV-2.
33011520 2020. Molecular and serological characterization of SARS-CoV-2 infection among COVID-19 patients.
32979477 2020. Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world.
32918944 2020. SARS-CoV-2 host tropism: An in silico analysis of the main cellular factors.
33003587 2020. Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins.
32992592 2020. Host Immune Response Driving SARS-CoV-2 Evolution.
32971895 2020. Identification of a Membrane Binding Peptide in the Envelope Protein of MHV Coronavirus.
32967229 2020. Immune Checkpoints in Viral Infections.
32961897 2020. Induction of the Antiviral Immune Response and Its Circumvention by Coronaviruses.
32937868 2020. Spatio-Temporal Mutational Profile Appearances of Swedish SARS-CoV-2 during the Early Pandemic.
32929876 2020. The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm.
32964796 2020. Coronavirus interactions with the cellular autophagy machinery.
32975439 2020. Cardiac Findings in Pediatric Patients With Multisystem Inflammatory Syndrome in Children Associated With COVID-19.
32912123 2020. Emerging Novel Coronavirus is a Global Threat: Insight in the Biology of COVID-19 and its Hijacking Process of Hosts' Cell.
33019935 2020. COVID-19: a Great Mime or a Trigger Event of Autoimmune Manifestations?
33016156 2020. Hypothesis: The electrical properties of coronavirus.
32914439 2020. Structures of the SARS-CoV-2 nucleocapsid and their perspectives for drug design.
32972235 2020. Secondary hemophagocytic lymphohistiocytosis versus cytokine release syndrome in severe COVID-19 patients.
32990479 2020. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
32986664 2020. COVID-19: Significance of antibodies.
32981399 2020. COVID-19 Infection: Concise Review Based on the Immunological Perspective.
33010854 2020. COVID-19-Related Multisystem Inflammatory Syndrome in Children Affects Left Ventricular Function and Global Strain Compared with Kawasaki Disease.
33023287 2020. COVID-19 and Multisystem Inflammatory Syndrome, or is it Mast Cell Activation Syndrome?
32945158 2020. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
33016027 2020. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
32948117 2020. Household pets and SARS-CoV2 transmissibility in the light of the ACE2 intrinsic disorder status.
32901940 2020. ACE2: Its potential role and regulation in severe acute respiratory syndrome and COVID-19.
32926425 2020. Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls.
33022076 2020. Immunobiology and immunotherapy of COVID-19: A clinically updated overview.
32962383 2020. Mathematical modeling and cellular automata simulation of infectious disease dynamics: Applications to the understanding of herd immunity.
32910875 2020. Is 'inflammaging' fuelling severe COVID-19 disease?
32817223 2020. Cryo-electron Microscopy Structure of the Swine Acute Diarrhea Syndrome Coronavirus Spike Glycoprotein Provides Insights into Evolution of Unique Coronavirus Spike Proteins.
32880615 2020. Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions.
32840583 2020. Difficult to Determine Herd Immunity Threshold for COVID-19.
32808969 2020. Neutralizing Antibodies Against SARS-CoV-2-Important Questions, Unclear Answers.
32795406 2020. Pseudotumor cerebri syndrome associated with MIS-C: a case report.
32960167 2020. Immunite adaptative contre le virus SARS-CoV-2.
32905684 2020. Trained Innate Immunity, Epigenetics, and Covid-19.
32966713 2020. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19. Reply.
32966712 2020. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
32966711 2020. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
32966710 2020. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
32999467 2020. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.
32788748 2020. Single-cell landscape of immunological responses in patients with COVID-19.
32855555 2020. The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge.
32895541 2020. T cells in COVID-19 - united in diversity.
32887977 2020. Broad and strong memory CD4(+) and CD8(+) T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.
32929268 2020. Seasonal coronavirus protective immunity is short-lasting.
32382153 2020. Protecting the population with immune individuals.
32812012 2020. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection.
32908214 2020. Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies.
32690955 2020. Inhibition of the integrated stress response by viral proteins that block p-eIF2-eIF2B association.
32788708 2020. The type I interferon response in COVID-19: implications for treatment.
32908316 2020. SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation.
32906143 2020. The coding capacity of SARS-CoV-2.
32942285 2020. Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion.
32901123 2020. The coronavirus is mutating - does it matter?
32895961 2020. Neuropathological findings in two patients with fatal COVID-19.
32935873 2020. Invited Review: The spectrum of neuropathology in COVID-19.
32981462 2020. The COVID-19 Effect on the Immune System and Mitochondrial Dynamics in Diabetes, Obesity, and Dementia.
32925824 2020. Bronchopulmonary MDR protein expression may protect against COVID-19 infection.
32932334 2020. Multisystem Inflammatory Syndrome Associated With COVID-19 With Neurologic Manifestations in a Child: A Brief Report.
33021596 2020. Serum Responses of Children With Kawasaki Disease Against Severe Acute Respiratory Syndrome Coronavirus 2 Proteins.
32994342 2020. Coronavirus hemagglutinin-esterase and spike proteins coevolve for functional balance and optimal virion avidity.

32997488 2020. Chemosensory Dysfunction in COVID-19: Integration of Genetic and Epidemiological Data Points to D614G Spike Protein Variant as a Contributing Factor.
32946224 2020. Structural, Biophysical, and Biochemical Elucidation of the SARS-CoV-2 Nonstructural Protein 3 Macro Domain.
32934769 2020. Striking Similarities between CDRs in Some mAbs That Neutralize COVID-19.
33006576 2020. Room-temperature neutron and X-ray data collection of 3CL M(pro) from SARS-CoV-2.
33020343 2020. The Management of Cytokine Storm in COVID-19.
32895623 2020. Crystal structure of SARS-CoV-2 papain-like protease.
32962761 2020. Severe COVID-19: what have we learned with the immunopathogenesis?
32991323 2020. SARS-CoV-2, immunosenescence and inflammaging: partners in the COVID-19 crime.
33006233 2020. COVID-19 is an emergent disease of aging.
32955770 2020. Cellular senescence as a potential mediator of COVID-19 severity in the elderly.
32956495 2020. Dexamethasone, pro-resolving lipid mediators and resolution of inflammation in COVID-19.
32965717 2020. SARS-CoV-2 infection in India bucks the trend: Trained innate immunity?
32978876 2020. Transmission-dynamics models for the SARS Coronavirus-2.
32838273 2020. Detection of severe acute respiratory syndrome coronavirus 2 in placentas with pathology and vertical transmission.
32996784 2020. Sex steroids skew ACE2 expression in human airway: a contributing factor to sex differences in COVID-19?
32851969 2020. Identification of Exertional Hypoxia and Its Implications in SARS-CoV-2 Pneumonia.
32925314 2020. Reduced Monocytic Human Leukocyte Antigen-DR Expression Indicates Immunosuppression in Critically Ill COVID-19 Patients.
32925313 2020. Human Leukocyte Antigen-DR Deficiency and Immunosuppression-Related End-Organ Failure in SARS-CoV2 Infection.
32968798 2020. Unveiling COVID-19-associated organ-specific cell types and cell-specific pathway cascade.
32914167 2020. Comparative host-pathogen protein-protein interaction analysis of recent coronavirus outbreaks and important host targets identification.
32966582 2020. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes.
32966547 2020. Hypertension and SARS-CoV-2 infection: is inflammation the missing link?
32966765 2020. The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19.
32841599 2020. Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding.
32946786 2020. Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.
32810439 2020. Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19.
32810438 2020. Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.
32783916 2020. Structural Basis for Helicase-Polymerase Coupling in the SARS-CoV-2 Replication-Transcription Complex.
33010815 2020. Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.
32991844 2020. Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.
32991843 2020. Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C).
32970989 2020. SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.
32991842 2020. Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant.
32979941 2020. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.
32979319 2020. Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study.
32976799 2020. COVID-19 Makes B Cells Forget, but T Cells Remember.
32877699 2020. Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19.
33020722 2020. Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2.
32983570 2020. Temporal antibody responses to SARS-CoV-2 in patients of coronavirus disease 2019.
32953130 2020. SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2.
32941787 2020. Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2.
32841605 2020. Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor.
32877692 2020. Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1alpha/Glycolysis-Dependent Axis.
32810597 2020. Identification of Transcription Factors Regulating SARS-CoV-2 Entry Genes in the Intestine.
32917983 2020. Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019.
32895485 2020. Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients.
32879471 2020. Expansion of atypical memory B cells is a prominent feature of COVID-19.
32963357 2020. Serum inflammatory factors are positively correlated with the production of specific antibodies in coronavirus disease 2019 patients.
32966801 2020. Activation of the SARS-CoV-2 Receptor Ace2 through JAK/STAT-Dependent Enhancers during Pregnancy.
32946807 2020. A Single-Cell RNA Expression Map of Human Coronavirus Entry Factors.
32941788 2020. SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant.
32979938 2020. Evasion of Type I Interferon by SARS-CoV-2.
32904468 2020. Robust T Cell Response Toward Spike, Membrane, and Nucleocapsid SARS-CoV-2 Proteins Is Not Associated with Recovery in Critical COVID-19 Patients.
32839763 2020. SARS-CoV-2-Specific T Cells Exhibit Phenotypic Features of Helper Function, Lack of Terminal Differentiation, and High Proliferation Potential.
33015650 2020. Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike.
32835306 2020. Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia.
32838342 2020. Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19.
32861744 2020. The multifaceted role of plasminogen in inflammation.
32916095 2020. Estimating the Binding of Sars-CoV-2 Peptides to HLA Class I in Human Subpopulations Using Artificial Neural Networks.
32911691 2020. Dendritic Cells and SARS-CoV-2 Infection: Still an Unclarified Connection.
33003471 2020. Disharmonic Inflammatory Signatures in COVID-19: Augmented Neutrophils' but Impaired Monocytes' and Dendritic Cells' Responsiveness.
32859121 2020. SARS-CoV-2 Spike 1 Protein Controls Natural Killer Cell Activation via the HLA-E/NKG2A Pathway.
32854433 2020. Coronaviruses: Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects.
32847031 2020. A New ERAP2/Iso3 Isoform Expression Is Triggered by Different Microbial Stimuli in Human Cells. Could It Play a Role in the Modulation of SARS-CoV-2 Infection?
32750325 2020. Chemical kinetics of the development of coronaviral infection in the human body: Critical conditions, toxicity mechanisms, "thermoheliox", and "thermovaccination".
32971122 2020. Deciphering the SSR incidences across viral members of Coronaviridae family.
32986926 2020. Binding of SARS-CoV-2 to cell receptors: a tale of molecular evolution.
32910974 2020. COVID-19 Acute Myocarditis and Multisystem Inflammatory Syndrome in Adult Intensive and Cardiac Care Units.
32931823 2020. Etoposide as Salvage Therapy for Cytokine Storm Due to COVID-19.
32221133 2020. Detection of serum immunoglobulin M and immunoglobulin G antibodies in 2019 novel coronavirus infected patients from different stages.
32938299 2020. Platelets Can Associate with SARS-Cov-2 RNA and Are Hyperactivated in COVID-19.
32897389 2020. Ultra-sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease.
32901577 2020. Ribonucleocapsid assembly/packaging signals in the genomes of the coronaviruses SARS-CoV and SARS-CoV-2: detection, comparison and implications for therapeutic targeting.
33000143 2020. Dynamics of neutralizing antibody titers in the months after SARS-CoV-2 infection.
32941618 2020. A Granulocytic Signature Identifies COVID-19 and Its Severity.
32986250 2020. A bioinformatic prediction of antigen presentation from SARS-CoV-2 spike protein revealed a theoretical correlation of HLA-DRB101 with COVID-19 fatality in Mexican population: An ecological approach.
32975856 2020. Evolution of SARS-CoV-2 genome from December 2019 to late March 2020: Emerged haplotypes and informative Tag nucleotide variations.
32970329 2020. Genomic and proteomic mutation landscapes of SARS-CoV-2.
32966656 2020. Biochemical rationale for hypoalbuminemia in COVID-19 patients.
32966646 2020. Phylogenetic analysis of SARS-CoV-2 in the first few months since its emergence.
32966614 2020. Clinical value anti-SARS-COV-2 serum IgA titration in patients with COVID-19.
33006900 2020. Molecular Simulations and Network Modeling Reveal an Allosteric Signaling in the SARS-CoV-2 Spike Proteins.
32786692 2020. Studying the Effects of ACE2 Mutations on the Stability, Dynamics, and Dissociation Process of SARS-CoV-2 S1/hACE2 Complexes.
32786691 2020. Serum Proteomics in COVID-19 Patients: Altered Coagulation and Complement Status as a Function of IL-6 Level.
32937590 2020. Acetylated K676 TGFBIp as a severity diagnostic blood biomarker for SARS-CoV-2 pneumonia.
32963239 2020. Consensus transcriptional regulatory networks of coronavirus-infected human cells.
32985562 2020. Immune dysfunction following COVID-19, especially in severe patients.
32929138 2020. Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition.
33020502 2020. SARS-CoV-2 spike protein predicted to form complexes with host receptor protein orthologues from a broad range of mammals.
32979900 2020. The assessment of the serum levels of TWEAK and prostaglandin F2? in COVID - 19.
32921745 2020. Novel Coronavirus (SARS-CoV-2) resistance in African populations: A cause worth exploring.
32921728 2020. The "perfect" storm: Current evidence on pediatric inflammatory multisystem disease during SARS-CoV-2 pandemic.
32921739 2020. Oncolytic effect of SARS-CoV2 in a patient with NK lymphoma.
32914749 2020. Revisiting Clinical Autopsies: Lessons to be Taken from the COVID-19 Pandemic.
32985209 2020. Genomic characterization and phylogenetic evolution of the SARS-CoV-2.
33010181 2020. Maximizing the value of human biospecimens: Lessons from coronavirus and the Seattle flu study.
32997945 2020. Biological Mechanisms of COVID-19 ARDS.
32997512 2020. Positive Bubble Study in Severe COVID-19 Indicates the Development of Anatomical Intra-pulmonary Shunts in Response to Microvascular Occlusion.
32997507 2020. Reply to: Positive Bubble Study in Severe COVID-19 Indicates the Development of Anatomical Intra-pulmonary Shunts in Response to Microvascular Occlusion.
32826529 2020. Comparison of RNA In Situ Hybridization and Immunohistochemistry Techniques for the Detection and Localization of SARS-CoV-2 in Human Tissues.
32996443 2020. Is Higher Viral Load in SARS-CoV-2 Associated with Death?
32897891 2020. Severe hyperphosphatasemia and severe acute respiratory syndrome coronavirus 2 infection in children.
33006605 2020. Systemic effects of missense mutations on SARS-CoV-2 spike glycoprotein stability and receptor-binding affinity.
32941261 2020. Myocarditis in Multisystem Inflammatory Syndrome in Children Associated With Coronavirus Disease 2019.
33020822 2020. Upper respiratory tract levels of SARS-CoV-2 RNA and duration of viral RNA shedding do not differ between patients with mild and severe/critical COVID-19.
32902889 2020. The emerging SARS-CoV-2 papain-like protease: Its relationship with recent coronavirus epidemics.
32897566 2020. Seroconversion against SARS-CoV-2 occurred after the recovery in patients with COVID-19.
32897544 2020. Immune response against SARS-CoV-2 in pediatric patients including young infants.
32910461 2020. The dynamics of immune response in COVID-19 patients with different illness severity.
32910458 2020. Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients: Clinical and laboratory characteristics.
33009829 2020. The antibody response to the glycan alpha-Gal correlates with COVID-19 disease symptoms.
32940328 2020. Seroprevalence of anti-SARS-CoV-2 antibodies in residents of Karachi-challenges in acquiring herd immunity for COVID 19.

32894217 2020. Quantifying antibody kinetics and RNA detection during early-phase SARS-CoV-2 infection by time since symptom onset.
32930052 2020. SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease.
33008679 2020. inverted question markInfeccion por SARS-CoV-2 como desencadenante de un sindrome inflamatorio sistemico?
32904601 2020. Mass Spectrometry Analysis of Newly Emerging Coronavirus HCoV-19 Spike Protein and Human ACE2 Reveals Camouflaging Glycans and Unique Post-Translational Modifications.
32959075 2020. Paediatric multisystem inflammatory syndrome associated with COVID-19: filling the gap between myocarditis and Kawasaki?
32949577 2020. Hypercytokinemia in COVID-19: Tear cytokine profile in hospitalized COVID-19 patients.
32974353 2020. SARS-CoV-2 Codon Usage Bias Downregulates Host Expressed Genes With Similar Codon Usage.
32850499 2020. Functional Pangenome Analysis Shows Key Features of E Protein Are Preserved in SARS and SARS-CoV-2.
33013929 2020. Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19.
32983176 2020. What's Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses.
32983174 2020. Re-analysis of Single Cell Transcriptome Reveals That the NR3C1-CXCL8-Neutrophil Axis Determines the Severity of COVID-19.
32983172 2020. Cytokine Storm in COVID-19: "When You Come Out of the Storm, You Won't Be the Same Person Who Walked in".
32983157 2020. The Metabolic Changes and Immune Profiles in Patients With COVID-19.
32983152 2020. The Immune Response and Immunopathology of COVID-19.
32983141 2020. Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection.
32983106 2020. Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute Plasmodium falciparum Malaria: LAG-3 and TIM-3 Correlate With T Cell Activation and Course of Disease.
32973803 2020. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
32922406 2020. The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections.
33013759 2020. Is There a Link Between the Pathogenic Human Coronavirus Envelope Protein and Immunopathology? A Review of the Literature.
32973730 2020. The Strengths of Scanning Electron Microscopy in Deciphering SARS-CoV-2 Infectious Cycle.
32974389 2020. SR/RS Motifs as Critical Determinants of Coronavirus Life Cycle.
33013423 2020. Age-Dependent Assessment of Genes Involved in Cellular Senescence, Telomere, and Mitochondrial Pathways in Human Lung Tissue of Smokers, COPD, and IPF: Associations With SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 Axis.
32982760 2020. Mitochondria Targeted Viral Replication and Survival Strategies-Prospective on SARS-CoV-2.
32922297 2020. COVID-19 Usurps Host Regulatory Networks.
32943587 2020. Impact of Circulating SARS-CoV-2 Mutant G614 on the COVID-19 Pandemic.
32895641 2020. Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis.
33015593 2020. Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity.
33015591 2020. PPARgamma Cistrome Repression during Activation of Lung Monocyte-Macrophages in Severe COVID-19.
32989429 2020. SARS-CoV-2 Infection Boosts MX1 Antiviral Effector in COVID-19 Patients.
32939273 2020. Crystal structures of SARS-CoV-2 ADP-ribose phosphatase: from the apo form to ligand complexes.
32916324 2020. IFN-gamma receptor 2 deficiency initial mimicry of multisystem inflammatory syndrome in children (MIS-C).
32990278 2020. Antibody responses in COVID-19 patients.
32975374 2020. Naturally activated adaptive immunity in COVID-19 patients.
32949179 2020. STAT3 isoforms differentially affect ACE2 expression: A potential target for COVID-19 therapy.
32924263 2020. Identification of Hub genes associated with infection of three lung cell lines by SARS-CoV-2 with integrated bioinformatics analysis.
32966269 2020. Healthy donor T-cell responses to common cold coronaviruses and SARS-CoV-2.
33021506 2020. COVID-19 and myeloid cells: complex interplay correlates with lung severity.
32976117 2020. Are T cells helpful for COVID-19: the relationship between response and risk.
32957548 2020. Complex Immunometabolic Profiling Reveals the Activation of Cellular Immunity and Biliary Lesions in Patients with Severe COVID-19.
32989935 2020. COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis.
32929291 2021. Structural dynamics of COVID-19 main protease.
32930936 2020. Infectivity of SARS-CoV-2: there Is Something More than D614G?
32885971 2020. The Answer Lies in the Energy: How Simple Atomistic Molecular Dynamics Simulations May Hold the Key to Epitope Prediction on the Fully Glycosylated SARS-CoV-2 Spike Protein.
32847856 2020. SARS-CoV-2 and Three Related Coronaviruses Utilize Multiple ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig.
33015645 2020. Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study.
33015644 2020. Defining the scourge of COVID-19 hyperinflammatory syndrome.
32978313 2020. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
32978311 2020. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit.
32948688 2020. Impaired Cytotoxic CD8(+) T Cell Response in Elderly COVID-19 Patients.
32913009 2020. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
32899009 2020. Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report.
32997001 2020. Genomic and phylogenetic characterisation of an imported case of SARS-CoV-2 in Amazonas State, Brazil.
32916246 2020. Immune response in COVID-19: What do we currently know?
32911086 2020. Viral load of SARS-CoV-2 across patients and compared to other respiratory viruses.
32891874 2020. Improved binding of SARS-CoV-2 Envelope protein to tight junction-associated PALS1 could play a key role in COVID-19 pathogenesis.
32972948 2020. Whole-Genome Sequence of SARS-CoV-2 Isolate Siena-1/2020.
32972934 2020. Coding-Complete Genome Sequences of Three SARS-CoV-2 Strains from Bangladesh.
33019592 2020. Gut Microbiota Dysbiosis-Immune Hyperresponse-Inflammation Triad in Coronavirus Disease 2019 (COVID-19): Impact of Pharmacological and Nutraceutical Approaches.
32895815 2020. COVID-19-Spatfolge bei Kindern: Multisystemische Entzundung : Coronavirus-Pandemie.
32790663 2020. COVID-19-Associated Multisystem Inflammatory Syndrome in Children - United States, March-July 2020.
32888056 2020. GC usage of SARS-CoV-2 genes might adapt to the environment of human lung expressed genes.
32993497 2020. The role of host defences in Covid 19 and treatments thereof.
32945643 2020. SeXX and COVID-19: tussle between the two.
32938700 2020. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
32871063 2020. Humoral Immune Response to SARS-CoV-2 in Iceland.
32948854 2020. Ultrasensitive high-resolution profiling of early seroconversion in patients with COVID-19.
32943637 2020. A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity.
32943630 2020. SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood.
32917884 2020. Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor.
32908300 2020. COVID-19 herd immunity: where are we?
33009506 2020. Fatty monocytes in COVID-19.
32895513 2020. Coordinated and sustained immune memory responses after mild COVID-19.
32895512 2020. SARS-CoV-2 ORF9c: a mysterious membrane-anchored protein that regulates immune evasion?
32895511 2020. Does a host restriction factor facilitate entry of SARS-CoV-2?
32995660 2020. Single cell sequencing unraveling genetic basis of shared immunologic switch between Severe COVID19 and Obesity.
32984641 2020. Gut microbiome dysbiosis and endotoxemia - Additional pathophysiological explanation for increased COVID-19 severity in obesity.
32939324 2020. Immune responses during COVID-19 infection.
32961074 2020. Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines.
32898469 2020. SARS-CoV-2 envelope protein topology in eukaryotic membranes.
32999893 2020. Fever Patterns, Cytokine Profiles, and Outcomes in COVID-19.
32989419 2020. The Antibody Response to SARS-CoV-2 Infection.
32792288 2020. Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19.
32891582 2020. Multi-system inflammatory syndrome in children & adolescents (MIS-C): A systematic review of clinical features and presentation.
32901164 2020. Apparent scaling of virus surface roughness-An example from the pandemic SARS-nCoV.
32911234 2020. A structured review of placental morphology and histopathological lesions associated with SARS-CoV-2 infection.
32997660 2020. IL6-mediated HCoV-host interactome regulatory network and GO/Pathway enrichment analysis.
32941419 2020. Genetic grouping of SARS-CoV-2 coronavirus sequences using informative subtype markers for pandemic spread visualization.
33006981 2020. Similarity between mutation spectra in hypermutated genomes of rubella virus and in SARS-CoV-2 genomes accumulated during the COVID-19 pandemic.
32976531 2020. The changes of the peripheral CD4+ lymphocytes and inflammatory cytokines in Patients with COVID-19.
32970753 2020. A web visualization tool using T cell subsets as the predictor to evaluate COVID-19 patient's severity.
32936826 2020. Isolation and characterization of severe acute respiratory syndrome coronavirus 2 in Turkey.
32903266 2020. Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma.
32913364 2020. A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients.
32894404 2020. The impact of aging and COVID-19 on our immune system: a high-resolution map from single cell analysis.
32965372 2020. Kawasaki and COVID-19 disease in children: a systematic review.
32936318 2020. Kawasaki-like disease in children with COVID-19.
32895366 2020. Storm of soluble immune checkpoints associated with disease severity of COVID-19.
32929061 2020. Type I IFN deficiency: an immunological characteristic of severe COVID-19 patients.
33024093 2020. SARS-CoV-2-specific T-cells in unexposed humans: presence of cross-reactive memory cells does not equal protective immunity.
33024073 2020. Main protease of SARS-CoV-2 serves as a bifunctional molecule in restricting type I interferon antiviral signaling.
32984664 2020. Identification of Geographic Specific SARS-Cov-2 Mutations by Random Forest Classification and Variable Selection Methods.
32920296 2020. Identification of the antithrombotic protein S as a potential target of the SARS-CoV-2 papain-like protease.
32815359 2020. Rettelse: Multiorgan inflammatorisk syndrom assosiert med sars-CoV-2 hos et barn.
32904637 2020. The role of carbon monoxide and heme oxygenase-1 in COVID-19.
32954666 2020. Comprehensive annotations of the mutational spectra of SARS-CoV-2 spike protein: a fast and accurate pipeline.
32953471 2020. Proprotein convertase furin in SARS-CoV-2 and non-small cell lung cancer.
32923679 2020. C-C chemokine receptor type 5 links COVID-19, rheumatoid arthritis, and Hydroxychloroquine: in silico analysis.
33024515 2020. Immunological aspects of COVID-19: What do we know?
32917722 2020. Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2.
32922564 2020. Coronavirus: a shift in focus away from IFN response and towards other inflammatory targets.
32796063 2020. Neuronal Ablation of Alpha/Beta Interferon (IFN-alpha/beta) Signaling Exacerbates Central Nervous System Viral Dissemination and Impairs IFN-gamma Responsiveness in Microglia/Macrophages.
32938761 2020. Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV.

32934770 2020. Structural Impact of Mutation D614G in SARS-CoV-2 Spike Protein: Enhanced Infectivity and Therapeutic Opportunity.
32952147 2020. Atypical Chest Computed Tomography Finding of Predominant Interstitial Thickening in a Patient with Coronavirus Disease 2019 (COVID-19) Pneumonia.
32919977 2020. Immunopathology of Hyperinflammation in COVID-19.
32876012 2020. Case Report: Adrenal Pathology Findings in Severe COVID-19: An Autopsy Study.
32950319 2020. Bell's palsy in a pediatric patient with hyper IgM syndrome and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
32992681 2020. Identification of Novel Hypothalamic MicroRNAs as Promising Therapeutics for SARS-CoV-2 by Regulating ACE2 and TMPRSS2 Expression: An In Silico Analysis.
32954242 2020. Host tolerance contributes to persistent viral shedding in COVID-19.
32923992 2020. Multisystem inflammatory syndrome in children: A systematic review.
32984786 2020. The spectrum of biochemical alterations associated with organ dysfunction and inflammatory status and their association with disease outcomes in severe COVID-19: A longitudinal cohort and time-series design study.
33001029 2020. Dynamically evolving novel overlapping gene as a factor in the SARS-CoV-2 pandemic.
32983015 2020. Picking up a Fight: Fine Tuning Mitochondrial Innate Immune Defenses Against RNA Viruses.
32984206 2020. Pediatric Inflammatory Multisystem Syndrome: Statement by the Pediatric Section of the European Society for Emergency Medicine and European Academy of Pediatrics.
32974046 2020. Toll-like receptors and COVID-19: a two-faced story with an exciting ending.
33005212 2020. In silico identification of conserved cis-acting RNA elements in the SARS-CoV-2 genome.
33015411 2020. Identification of twenty-five mutations in surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics.
32954047 2020. Genetic characterization of structural and open reading Fram-8 proteins of SARS-CoV-2 isolates from different countries.
33007398 2020. Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection.
32966857 2020. Mutations on COVID-19 diagnostic targets.
32927009 2020. Molecular phylogeny and missense mutations of envelope proteins across coronaviruses.
32920121 2020. SARS-CoV-2 transcriptome analysis and molecular cataloguing of immunodominant epitopes for multi-epitope based vaccine design.
33017875 2020. Confidence intervals for the COVID-19 neutralizing antibody retention rate in the Korean population.
33017874 2020. Computational analysis of SARS-CoV-2, SARS-CoV, and MERS-CoV genome using MEGA.
32902818 2020. A geroscience perspective on immune resilience and infectious diseases: a potential case for metformin.
32983837 2020. Evaluation of the SARS-CoV-2-IgG response in outpatients by five commercial immunoassays.
32984566 2020. Selective pressure on SARS-CoV-2 protein coding genes and glycosylation site prediction.
32904785 2020. Integrate structural analysis, isoform diversity, and interferon-inductive propensity of ACE2 to predict SARS-CoV2 susceptibility in vertebrates.
32984567 2020. A SARS-CoV-2 host infection model network based on genomic human Transcription Factors (TFs) depletion.
32904861 2020. Antibody response to SARS-Co-V-2, diagnostic and therapeutic implications.
32950268 2020. Characteristics of immune cells and cytokines in patients with coronavirus disease 2019 in Guangzhou, China.
32953455 2020. A challenging case of multisystem inflammatory syndrome in children related to coronavirus Disease-19 hospitalized under adult medical service.
33007369 2020. "Cytokine storm", not only in COVID-19 patients. Mini-review.
33007368 2020. How NETosis could drive "Post-COVID-19 syndrome" among survivors.
32989677 2020. Immune characteristics distinguish patients with severe disease associated with SARS-CoV-2.
32930973 2020. Multisystem Inflammatory Syndrome in Children Associated with COVID 19 Treated with Oral Steroid.
32950697 2020. Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in South America.
33014208 2020. How COVID-19 induces cytokine storm with high mortality.
33002623 2020. Patients with Covid-19 exhibit different immunological profiles according to their clinical presentation.
32920233 2020. Antibody-dependent enhancement of coronavirus.
32920235 2020. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome.
32945352 2020. Transcriptomic analysis of COVID19 lungs and bronchoalveolar lavage fluid samples reveals predominant B cell activation responses to infection.
32993015 2020. Role of SARS-CoV-2 in Altering the RNA-Binding Protein and miRNA-Directed Post-Transcriptional Regulatory Networks in Humans.
32933166 2020. Host Synthesized Carbohydrate Antigens on Viral Glycoproteins as "Achilles' Heel" of Viruses Contributing to Anti-Viral Immune Protection.
32917729 2020. Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 Patients.
32997749 2020. Paediatric Inflammatory Multisystem Syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in a patient receiving Infliximab therapy for Inflammatory Bowel Disease.
33011038 2020. Multisystem Inflammatory Syndrome in Children (MIS-C) in an Adolescent that Developed Coronary Aneurysms: A Case Report and Review of the Literature.
32954708 2020. Analysis of Host Cell Receptor GRP78 for Potential Natural Reservoirs of SARS-CoV-2.
32970885 2020. Comment on 'Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19': involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID-19.
32956726 2020. Kinetics of SARS-CoV-2 specific antibodies (IgM, IgA, IgG) in non-hospitalized patients four months following infection.
32920062 2020. A possible role for GRP78 in cross vaccination against COVID-19.
32853600 2020. Diagnostic significance of SARS-CoV-2 IgM positive/IgG negative antibody profile in symptomatic patients with suspected COVID-19 testing negative by RT-PCR.
32853599 2020. COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity.
32853597 2020. SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on.
32910175 2020. SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors.
32919931 2020. Syndrome resembling Kawasaki disease in COVID-19 asymptomatic children.
32982366 2020. Role of IFN and Complements System: Innate Immunity in SARS-CoV-2.
32991738 2020. Overexpression of the SARS-CoV-2 receptor ACE2 is induced by cigarette smoke in bronchial and alveolar epithelia.
32979386 2020. Use of tocilizumab in multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2.
32946801 2020. Multisystem inflammatory syndrome associated with COVID-19 from the pediatric emergency physician's point of view.
32945863 2020. Pediatric Inflammatory Multisystem Syndrome: Time to Collaborate.
32951037 2020. Defibrotide for the Treatment of Pediatric Inflammatory Multisystem Syndrome Temporally Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 2 Pediatric Patients.
32919067 2020. A graph-based approach identifies dynamic H-bond communication networks in spike protein S of SARS-CoV-2.
32967693 2020. A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual.
32938769 2020. The Enzymatic Activity of the nsp14 Exoribonuclease Is Critical for Replication of MERS-CoV and SARS-CoV-2.
32937615 2020. High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19.
32972123 2020. Dynamics of viral load and anti-SARS-CoV-2 antibodies in patients with positive RT-PCR results after recovery from COVID-19.
32956615 2020. A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process.
32835654 2020. Multisystem inflammatory syndrome in children in South Africa.
32979317 2020. The complexities of SARS-CoV-2 serology.
32987502 2020. The within-host viral kinetics of SARS-CoV-2.
32944295 2020. Impact of glycan cloud on the B-cell epitope prediction of SARS-CoV-2 Spike protein.
2972994 1988. Sequence specificity of streptozotocin-induced mutations.
32958678 2020. Low genetic diversity may be an Achilles heel of SARS-CoV-2.
32956843 2021. Angiotensin-converting enzyme 2 (ACE2): COVID 19 gate way to multiple organ failure syndromes.
32965173 2020. Secondary structure of the SARS-CoV-2 5'-UTR.
32991014 2020. The cytokine storm-An appropriate, over-reactive response to SARS-CoV-2 or the wrong immune pathway?
33024223 2020. Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir.
33024213 2020. SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients.
32963115 2020. Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection.
32972818 2020. COVID-19 and Metabolic Syndrome: NF-kappaB Activation. Crossroads.
32921279 2020. Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals.
32921711 2020. An Outbreak of Kawasaki-like Disease in children during SARS-CoV- 2 Epidemic: No Surprise?
32969849 2020. Atypical Endovascular Cells in SARS-CoV-2 Pneumonia.
32915505 2020. Structural Characterization of N-Linked Glycans in the Receptor Binding Domain of the SARS-CoV-2 Spike Protein and their Interactions with Human Lectins.
32907802 2020. Response to: 'Correspondence on 'Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences' by Ruscitti et al' by Chen et al.
32907800 2020. Correspondence on 'Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences' by Ruscitti et al.
32978236 2020. Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort' by Pouletty et al.
32958511 2020. Correspondence on 'Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: case-control study'.
32958508 2020. Correspondence to 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort'.
32933921 2020. Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): what does the future hold?
32943427 2020. Covid-19: Do many people have pre-existing immunity?
32920919 2020. Are SARS-CoV-2 IgA antibodies in paediatric patients with chilblain-like lesions indicative of COVID-19 asymptomatic or paucisymptomatic infection?
32902374 2020. Analysis of partial sequences of the RNA-dependent RNA polymerase gene as a tool for genus and subgenus classification of coronaviruses.
32902372 2020. Predicting the recombination potential of severe acute respiratory syndrome coronavirus 2 and Middle East respiratory syndrome coronavirus.
32985922 2020. Early Identification of IgA Anti-SARSCoV-2 in Milk of Mother With COVID-19 Infection.
32826281 2020. Neonatal and Children's Immune System and COVID-19: Biased Immune Tolerance versus Resistance Strategy.
32978281 2020. Discordance between Serum Neutralizing Antibody Titers and the Recovery from COVID-19.
32958687 2020. Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.
32930458 2020. Regulatory CD4(+) and CD8(+) T cells are negatively correlated with CD4(+) /CD8(+) T cell ratios in patients acutely infected with SARS-CoV-2.
32930456 2020. Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex.
32918747 2020. Ultrastructure of cell trafficking pathways and coronavirus: how to recognise the wolf amongst the sheep.
32969960 2020. Features of Intestinal Disease Associated with COVID-Related Multisystem Inflammatory Syndrome in Children.
32924059 2020. The Natural History of SARS-Cov-2 Related Multisystem Inflammatory Syndrome in Children (MIS-C): A Systematic Review.
31743644 2019. Membrane Cholesterol Modulates Oligomeric Status and Peptide-Membrane Interaction of Severe Acute Respiratory Syndrome Coronavirus Fusion Peptide.
32989174 2020. MAIT cell activation and dynamics associated with COVID-19 disease severity.
32943497 2020. Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19.
32994211 2020. High-resolution structures of the SARS-CoV-2 2'-O-methyltransferase reveal strategies for structure-based inhibitor design.
32958614 2020. Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients.
32994364 2020. Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity.
32958581 2020. Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years.
32972996 2020. Autoantibodies against type I IFNs in patients with life-threatening COVID-19.
32972995 2020. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.
32958580 2020. Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein.

32881367 2020. Global Initiative Seeks to Crack the COVID-19 Genetic Code.
32912866 2020. Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): the Evelina Experience.
32933913 2020. Paediatric case of prolonged COVID-19 manifesting as PMIS-TS and atypical Kawasaki.
32943758 2020. Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy.
32966752 2020. Cardiometabolic Traits, Sepsis, and Severe COVID-19: A Mendelian Randomization Investigation.
32935083 2020. Management of Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Survey from the International Kawasaki Disease Registry.
32967859 2020. The pulmonary pathology of COVID-19.
32948868 2020. SARS-CoV-2 spreads to lymph nodes and strongly expands CD4+ TEMRA cells in a patient with mild COVID-19.
32927483 2020. Kinetics of SARS-CoV-2 Antibody Avidity Maturation and Association with Disease Severity.
32907819 2020. Pediatric inflammatory multisystem syndrome temporally associated with COVID-19: a spectrum of diseases with many names.
33020707 2020. Structural insight into the recognition of S-adenosyl-L-homocysteine and sinefungin in SARS-CoV-2 Nsp16/Nsp10 RNA cap 2'-O-Methyltransferase.
32977223 2020. Immunological features of coronavirus disease 2019 in patients with cancer.
33022277 2020. ACE2-containing extracellular vesicles and exomeres bind the SARS-CoV-2 spike protein.
33025514 2020. Low-Dose Dexamethasone Following IVIG in Pediatric Inflammatory Multisystem Syndrome in Temporal Association with COVID-19 (PIMS-TC).
32986832 2020. Biased mutation and selection in RNA viruses.
32941612 2020. Potential pathogenicity determinants identified from structural proteomics of SARS-CoV and SARS-CoV-2.
33000221 2020. Neuropilin1 as a new potential SARSCoV2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID19.
32995557 2020. Integrated genomic view of SARS-CoV-2 in India.
32976188 2020. High level of defensin alpha 5 in intestine may explain the low incidence of diarrhoea in COVID-19 patients.
32910469 2020. Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia.
32935333 2020. T-cell responses and therapies against SARS-CoV-2 infection.
33001920 2020. Light and corona: guided-wave readout for coronavirus spike protein-host-receptor binding.
33009246 2020. SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia.
32979740 2020. Diffuse alveolar damage and thrombotic microangiopathy are the main histopathological findings in lung tissue biopsy samples of COVID-19 patients.
32897642 2020. The potential threat of multisystem inflammatory syndrome in children during the COVID-19 pandemic.
33003176 2020. Multisystem Inflammatory Syndrome in Children Associated With Coronavirus Disease 2019 in a Children's Hospital in New York City: Patient Characteristics and an Institutional Protocol for Evaluation, Management, and Follow-Up.
32970023 2020. Distinguishing Multisystem Inflammatory Syndrome in Children From Kawasaki Disease and Benign Inflammatory Illnesses in the SARS-CoV-2 Pandemic.
32925543 2020. Acute Appendicitis in Multisystem Inflammatory Syndrome in Children With COVID-19.
32947601 2020. Multisystem Inflammatory Syndrome (MIS-C) Surveillance and COVID-19 in Latin America.
32925547 2020. A Systematic Review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection.
32898090 2020. MIS-C After ARDS Associated With SARS-CoV-2.
32907921 2020. SARS-CoV-2 Polymorphisms and Multisystem Inflammatory Syndrome in Children.
32973121 2020. Multisystem Inflammatory Syndrome in Children and SARS-CoV-2 Serology.

32776378 2020. Beyond serosurveys: Human biology and the measurement of SARS-Cov-2 antibodies.
32459509 2020. Breaking Circular Thinking about the Value of Oxygenation.
32459507 2020. Reply to Modesto-Alapont et al.: Breaking Circular Thinking about the Value of Oxygenation.
32860089 2020. High density of IgG4-secreting plasma cells in the fibrotic tissue from a surgically resected tracheal ring impaired by complex subglottic stenosis post-tracheostomy as immune expression of a Th2 response due to severe COVID-19.
32745829 2020. Orientation of immobilized antigens on common surfaces by a simple computational model: Exposition of SARS-CoV-2 Spike protein RBD epitopes.
32721790 2020. Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics.
32818817 2020. Host-membrane interacting interface of the SARS coronavirus envelope protein: Immense functional potential of C-terminal domain.
32866437 2020. Immune response in SARS-CoV-2 infection: the role of interferons type I and type III.
32889638 2020. Coronaviruses and stress: from cellular to global.
32777699 2020. SARS-CoV-2 IgG antibody responses in New York City.
32799894 2020. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) - anatomic pathology perspective on current knowledge.
32752129 2020. Effect of Coronavirus Disease 2019 in Pulmonary Circulation. The Particular Scenario of Precapillary Pulmonary Hypertension.
32784826 2020. Preliminary Post-Mortem COVID-19 Evidence of Endothelial Injury and Factor VIII Hyperexpression.
32844713 2020. Functional mapping of B-cell linear epitopes of SARS-CoV-2 in COVID-19 convalescent population.
32882706 2020. COVID-19 is, in the end, an endothelial disease.
32882708 2020. How does COVID-19 kill at home and what should we do about it?
32887992 2020. Multisystem inflammatory syndrome in an adult with SARS-CoV-2 infection.
32859681 2020. Endothelial to mesenchymal transition (EndMT): a precursor to post-SARS-CoV-2 infection (COVID-19) interstitial pulmonary fibrosis and vascular obliteration?
32763951 2020. A Comprehensive, Flexible Collection of SARS-CoV-2 Coding Regions.
32881045 2020. COVID-19 related lung pathology: old patterns in new clothing?
32888767 2020. Conserved HLA binding peptides from five non-structural proteins of SARS-CoV-2-An in silico glance.
32773417 2020. Quasispecies analysis of the SARS-CoV-2 from representative clinical samples: A preliminary analysis.
32837525 2020. Role of Damage-Associated Molecular Patterns in Light of Modern Environmental Research: A Tautological Approach.
32767018 2020. Complete post-mortem data in a fatal case of COVID-19: clinical, radiological and pathological correlations.
32851474 2020. Postmortem examination of three SARS-CoV-2-positive autopsies including histopathologic and immunohistochemical analysis.
32861838 2020. Peripheral blood CD4+ cell counts but not CD3+ and CD8+ cell counts are reduced in SARS-CoV-2 infection.
32853638 2020. Immune dysregulation and multisystem inflammatory syndrome in children (MIS-C) in individuals with haploinsufficiency of SOCS1.
32864865 2020. The phenotypic changes of gammadelta T cells in COVID-19 patients.
32786709 2020. Computational Prediction of Mutational Effects on SARS-CoV-2 Binding by Relative Free Energy Calculations.
32827284 2020. Unraveling the Immune Response in Severe COVID-19.
32829467 2020. Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome.
32870815 2020. Immune pathogenesis of COVID-19-related Multisystem Inflammatory Syndrome in Children (MIS-C).
32730233 2020. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2.
32730226 2020. Is multisystem inflammatory syndrome in children on the Kawasaki syndrome spectrum?
32764200 2020. Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population.
32759504 2020. Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis.
32841212 2020. Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals.
32833687 2020. SARS-CoV-2 specific T-cell responses and correlations with COVID-19 patient predisposition.
32784290 2020. COVID-19 severity associates with pulmonary redistribution of CD1c+ DC and inflammatory transitional and nonclassical monocytes.
32531971 2020. Evaluation of Innate Immune Mediators Related to Respiratory Viruses in the Lung of Stable COPD Patients.
32826322 2020. Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with high attack rate.
32763812 2020. The D614G substitution in the S gene and clinical information for patients with COVID-19 detected in Hong Kong.
32818852 2020. SARS-CoV-2 exhibits intra-host genomic plasticity and low-frequency polymorphic quasispecies.
32850082 2020. COVID-19 infection and its deadly cytokine storm in a young obese adult.
32779780 2020. Atomistic simulation reveals structural mechanisms underlying D614G spike glycoprotein-enhanced fitness in SARS-COV-2.
32773261 2020. SARS-CoV 2 and the pathobiology of the respiratory control mechanisms in the brainstem.
32887634 2020. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19.
32243948 2020. Respiratory mucus and persistence of virus on surfaces.
32727811 2020. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
32726448 2020. Interferon-Induced Transmembrane Protein 3 Related to Coronavirus Disease 2019.
32726417 2020. Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
31621854 2020. Immune Predictors of Mortality After Ribonucleic Acid Virus Infection.
32726446 2020. Plasmodium falciparum infection may protect a population from SARS-CoV-2 infection.
32745172 2020. Transient lymphopenia and interstitial pneumonia with endotheliitis in SARS-CoV-2-infected macaques.
32812049 2020. Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19.
32785649 2020. COVID 19 Vaccines: Should we fear ADE?
32738141 2020. Immunoserologic detection and diagnostic relevance of cross-reactive auto-antibodies in COVID-19 patients.
31610541 2020. Innate Immune Evasion by Human Respiratory RNA Viruses.
32736274 2020. Structural stability of the SARS-CoV-2 main protease: Can metal ions affect function?
32794348 2020. Mismatch between circulating cytokines and spontaneous cytokine production by leukocytes in hyperinflammatory COVID-19.
32779742 2020. A child with a severe multisystem inflammatory syndrome following an asymptomatic COVID-19 infection: A novel management for a new disease?
32761905 2020. Comment on Hu et al: The cytokine storm and COVID-19.
32779784 2020. Mutational spectra of SARS-CoV-2 orf1ab polyprotein and signature mutations in the United States of America.
32717049 2020. Cytoskeleton-a crucial key in host cell for coronavirus infection.
32771409 2020. Pathogenesis of SARS-CoV-2 induced cardiac injury from the perspective of the virus.
32818486 2020. Genes encoding ACE2, TMPRSS2 and related proteins mediating SARS-CoV-2 viral entry are upregulated with age in human cardiomyocytes.
32870373 2020. Why do SARS-CoV-2 NSPs rush to the ER?
32826022 2020. Kawasaki-like disease among Italian children in the COVID-19 era.
32768467 2020. Longitudinal Echocardiographic Assessment of Coronary Arteries and Left Ventricular Function following Multisystem Inflammatory Syndrome in Children.
32768466 2020. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2: A Systematic Review.
32756980 2020. Incomplete Kawasaki Disease as Presentation of COVID-19 Infection in an Infant: A Case Report.
32828177 2020. SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome.
32791052 2020. Multisystem inflammatory syndrome associated with COVID-19 in children in Pakistan.
32791050 2020. Coronial autopsies identify the indirect effects of COVID-19.
32813814 2020. Low risk of serological cross-reactivity between dengue and COVID-19.
32872641 2020. Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization.
32835005 2020. Methods for making multiple alignment of genomic sequences for severe acute respiratory syndrome coronavirus 2.
32839745 2020. miRNA target prediction might explain the reduced transmission of SARS-CoV-2 in Jordan, Middle East.
32847471 2020. Vascular underpinning of COVID-19.
32750256 2020. Expression of SARS-CoV-2 receptor ACE2 and the protease TMPRSS2 suggests susceptibility of the human embryo in the first trimester.
32756606 2020. Development and simulation of fully glycosylated molecular models of ACE2-Fc fusion proteins and their interaction with the SARS-CoV-2 spike protein binding domain.
32726325 2020. Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2.
32787702 2020. Anterior Pulmonary Ventilation Abnormalities in COVID-19.
32810737 2020. The cholesterol metabolite 27-hydroxycholesterol inhibits SARS-CoV-2 and is markedly decreased in COVID-19 patients.
32738789 2020. Nox2 activation in Covid-19.
32853309 2020. Sindrome inflamatorio multisistemico asociado a COVID-19 en ninos y adolescentes: un llamado al diagnostico.
32845568 2020. Interleukin-6 in Covid-19: A systematic review and meta-analysis.
32844538 2020. Alpha-1-antitrypsin: A possible host protective factor against Covid-19.
32883951 2020. COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm.
32883949 2020. Profiling and characterization of SARS-CoV-2 mutants' infectivity and antigenicity.
32879307 2020. Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19.
32815352 2020. Multiorgan inflammatorisk syndrom assosiert med sars-CoV-2 hos et barn.
32854725 2020. Characterization of accessory genes in coronavirus genomes.
32755175 2020. CT Manifestations of Coronavirus Disease (COVID-19) Pneumonia and Influenza Virus Pneumonia: A Comparative Study.
32720486 2020. A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications.
32872802 2020. Fractional diffusion on the human proteome as an alternative to the multi-organ damage of SARS-CoV-2.
32755395 2020. MDM2-Mediated Ubiquitination of Angiotensin-Converting Enzyme 2 Contributes to the Development of Pulmonary Arterial Hypertension.
32787714 2020. The Striking Similarities of Multisystem Inflammatory Syndrome in Children and a Myocarditis-like Syndrome in Adults: Overlapping Manifestations of COVID-19.
32885825 2020. Specialized pro-resolving mediator network: an update on production and actions.
32723457 2020. Silent Hypoxia in COVID-19: What is Old is New Again!
32826724 2020. Multisystem Inflammatory Syndrome Associated With Coronavirus Disease in Children: A Multi-centered Study in Belem, Para, Brazil.
32677813 2020. Cytokine Profile in an Adolescent With Pediatric Multisystem Inflammatory Syndrome Temporally Related to COVID-19.
32639461 2020. Pediatric Inflammatory Multisystem Syndrome With Central Nervous System Involvement and Hypocomplementemia Following SARS-COV-2 Infection.
32833376 2020. Mutation dans la proteine Spike de SARS-CoV-2.
32615049 2020. The emerging role and significance of circular RNAs in viral infections and antiviral immune responses: possible implication as theranostic agents.
32788292 2020. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans.
32753553 2020. Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2.
32763915 2020. A molecular pore spans the double membrane of the coronavirus replication organelle.
32675355 2020. The pandemic virus is slowly mutating. But does it matter?
32753554 2020. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans.
32855215 2020. MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses.
32817270 2020. In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges.

32840109 2020. iPSCs-Derived Platform: A Feasible Tool for Probing the Neurotropism of SARS-CoV-2.
32765942 2020. Age-induced NLRP3 Inflammasome Over-activation Increases Lethality of SARS-CoV-2 Pneumonia in Elderly Patients.
32765940 2020. Decreased Naive T-cell Production Leading to Cytokine Storm as Cause of Increased COVID-19 Severity with Comorbidities.
32790652 2020. Three Cases of Pediatric Multisystem Inflammatory Syndrome Associated with COVID-19 Due to SARS-CoV-2.
32876680 2020. Forty Postmortem Examinations in COVID-19 Patients.
32776556 2020. Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical ill COVID-19 patients.
32811513 2020. The current landscape of coronavirus-host protein-protein interactions.
32864628 2020. COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study.
32864626 2020. Delving beneath the surface of hyperinflammation in COVID-19.
32838362 2020. Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.
32778426 2020. Reacciones cruzadas entre factor reumatoide e IgM SARS-CoV-2.
32838292 2020. Viral sepsis is a complication in patients with Novel Corona Virus Disease (COVID-19).
32759017 2020. The importance of cell-mediated immunity in COVID-19 - An opinion.
32758906 2020. Are night shift workers at an increased risk for COVID-19?
32795830 2020. Autoimmunity to ACE2 as a possible cause of tissue inflammation in Covid-19.
32721809 2020. Kawasaki-like disease in children with COVID-19: A hypothesis.
32795834 2020. IL-17A and TNF-alpha as potential biomarkers for acute respiratory distress syndrome and mortality in patients with obesity and COVID-19.
32724296 2020. Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment.
32769902 2020. Macrophage activation syndrome as an unusual presentation of paucisymptomatic severe acute respiratory syndrome coronavirus 2 infection: A case report.
32808941 2020. Hypermetabolism in critically ill patients with COVID-19 and the effects of hypothermia: A case series.
31883098 2020. Histopathologic Evaluation and Scoring of Viral Lung Infection.
31883097 2020. Evaluation of Activation and Inflammatory Activity of Myeloid Cells During Pathogenic Human Coronavirus Infection.
32732237 2020. Genome Sequences of SARS-CoV-2 Strains Detected in Hong Kong.
32732236 2020. Reports of Coding-Complete Genome Sequences of Five 2019 Novel Coronavirus (SARS-CoV-2) Strains Isolated in Bangladesh.
32732235 2020. SARS-CoV-2 Genome Sequence from Morocco, Obtained Using Ion AmpliSeq Technology.
32763945 2020. Genome Sequences of Six SARS-CoV-2 Strains Isolated in Morocco, Obtained Using Oxford Nanopore MinION Technology.
32855259 2020. Four SARS-CoV-2 Genome Sequences from Late April in Stockholm, Sweden, Reveal a Rare Mutation in the Spike Protein.
32791568 2020. Vascular endothelial injury exacerbates coronavirus disease 2019: The role of endothelial glycocalyx protection.
32858978 2020. Compartmentalized Replication of SARS-Cov-2 in Upper vs. Lower Respiratory Tract Assessed by Whole Genome Quasispecies Analysis.
32879413 2020. COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City.
32741970 2020. SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers.
32792598 2020. Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data.
32802902 2020. Genome-wide computational prediction of miRNAs in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) revealed target genes involved in pulmonary vasculature and antiviral innate immunity.
32788344 2020. Serum protein profiling reveals a landscape of inflammation and immune signaling in early-stage COVID-19 infection.
32744436 2020. Single-cell RNA sequencing analysis of human kidney reveals the presence of ACE2 receptor: A potential pathway of COVID-19 infection.
32817460 2020. Levels of the TNF-Related Cytokine LIGHT Increase in Hospitalized COVID-19 Patients with Cytokine Release Syndrome and ARDS.
32873611 2020. Low Baseline Pulmonary Levels of Cytotoxic Lymphocytes as a Predisposing Risk Factor for Severe COVID-19.
32733001 2020. Activation and evasion of type I interferon responses by SARS-CoV-2.
32764693 2020. Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells.
32764665 2020. Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm.
32737462 2020. IgGs drive COVID-19 myeloid hyperinflammation.
32732951 2020. NK cells in COVID-19: protectors or opponents?
32728222 2020. T cell responses in patients with COVID-19.
32728221 2020. Tissue damage from neutrophil-induced oxidative stress in COVID-19.
32873888 2020. Long-lasting SARS-CoV-2-specific T cell memories.
32873886 2020. Immune correlates of SARS-CoV-2 protection.
32839569 2020. Not just antibodies: B cells and T cells mediate immunity to COVID-19.
32826976 2020. CD8(+) T cells remember same bits of SARS-CoV-2.
32826975 2020. Attacking the defence: SARS-CoV-2 can infect immune cells.
32826974 2020. Altered immune cell differentiation in the lungs of patients with critical COVID-19.
32807862 2020. Shared CD8(+) T cell receptors for SARS-CoV-2.
32807861 2020. Spatial resolution of SARS-CoV-2 lung infection.
32782358 2020. The role of IgG Fc receptors in antibody-dependent enhancement.
32782355 2020. Getting to the (germinal) centre of SARS-CoV-2.
32782353 2020. Antibody response to SARS-CoV-2 - sustained after all?
32835124 2020. A multicenter consensus: A role of furin in the endothelial tropism in obese patients with COVID-19 infection.
32855992 2020. A Case of Steroid-Responsive, COVID-19 Immune Reconstitution Inflammatory Syndrome Following the Use of Granulocyte Colony-Stimulating Factor.
32879797 2020. Mutation density changes in SARS-CoV-2 are related to the pandemic stage but to a lesser extent in the dominant strain with mutations in spike and RdRp.
32742818 2020. RdRp mutations are associated with SARS-CoV-2 genome evolution.
32742815 2020. Understanding genomic diversity, pan-genome, and evolution of SARS-CoV-2.
32722596 2020. Immune Pathogenesis of COVID-19 Intoxication: Storm or Silence?
32721181 2020. Immunometabolic Status of COVID-19 Cancer Patients.
32881907 2020. Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight.
32857808 2020. SNPs or RNA modifications? Concerns on mutation-based evolutionary studies of SARS-CoV-2.
32726355 2020. Interplay between SARS-CoV-2 and the type I interferon response.
32845937 2020. Friends or foes? The knowns and unknowns of natural killer cell biology in COVID-19 and other coronaviruses in July 2020.
32822426 2020. COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2.
32797103 2020. Footprint of the host restriction factors APOBEC3 on the genome of human viruses.
32785209 2020. Molecular epidemiology of SARS CoV-2: a review of current data on genetic variability of the virus.
32844302 2020. The Interplay Between Coagulation and Inflammation Pathways in COVID-19-Associated Respiratory Failure: A Narrative Review.
32727465 2020. Association between cytokine profiles and lung injury in COVID-19 pneumonia.
32723327 2020. The pathophysiology of 'happy' hypoxemia in COVID-19.
32880863 2020. Structure of SARS-CoV-2 main protease in the apo state.
32161317 2020. A high ATP concentration enhances the cooperative translocation of the SARS coronavirus helicase nsP13 in the unwinding of duplex RNA.
32848162 2020. Dynamics of the ACE2-SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms.
32843695 2020. Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome.
32820179 2020. Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide.
32814791 2020. Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity.
32680882 2020. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2.
32669297 2020. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.
32694201 2020. Distinct conformational states of SARS-CoV-2 spike protein.
32703906 2020. Structure-based design of prefusion-stabilized SARS-CoV-2 spikes.
32661059 2020. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.
32661058 2020. Structural basis of a shared antibody response to SARS-CoV-2.
32728018 2020. Crystal structure of SARS-CoV-2 nsp10/nsp16 2'-O-methylase and its implication on antiviral drug design.
32712629 2020. COVID-19: immunopathogenesis and Immunotherapeutics.
32868756 2020. Immune characteristics of severe and critical COVID-19 patients.
32843617 2020. Molecular features of IGHV3-53-encoded antibodies elicited by SARS-CoV-2.
32796814 2020. Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals.
32879905 2020. Reduction of ADAMTS13 Levels Predicts Mortality in SARS-CoV-2 Patients.
32684101 2020. Dysfunction of adaptive immunity is related to severity of COVID-19: a retrospective study.
32424954 2020. The hypothetical role of phosphatidic acid in subverting ER membranes during SARS-CoV infection.
32701194 2020. Emergence of European and North American mutant variants of SARS-CoV-2 in South-East Asia.
32863136 2020. Does Cross-neutralization of SARS-CoV-2 Only Relate to High Pathogenic Coronaviruses?
32863134 2020. Modeling Potential Autophagy Pathways in COVID-19 and Sarcoidosis.
32863133 2020. Effect of Low-Pathogenic Human Coronavirus-Specific Antibodies on SARS-CoV-2.
32863132 2020. Is Immunological Memory a Burden in Times of COVID-19?
32720214 2020. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
32705575 2020. Serologic Response to SARS-CoV-2 in COVID-19 Patients with Different Severity.
32822061 2020. Longitudinal Characteristics of T Cell Responses in Asymptomatic SARS-CoV-2 Infection.
31505321 2019. Coronavirus genomic RNA packaging.
32717345 2020. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection.
32730781 2020. Immunometabolism pathways as the basis for innovative anti-viral strategies (INITIATE): A Marie Sklodowska-Curie innovative training network.
32771430 2020. Analysis of codon usage of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) and its adaptability in dog.
32825063 2020. The Sialoside-Binding Pocket of SARS-CoV-2 Spike Glycoprotein Structurally Resembles MERS-CoV.
32824272 2020. A Comparison of Whole Genome Sequencing of SARS-CoV-2 Using Amplicon-Based Sequencing, Random Hexamers, and Bait Capture.
32787398 2020. Coronavirus-19 and malaria: The great mimics.
32734595 2020. Antibodies in serum of convalescent patients following mild COVID-19 do not always prevent virus-receptor binding.
32881583 2020. The Respiratory Drive: An Overlooked Tile of COVID-19 Pathophysiology.
32833500 2020. Injury to the Endothelial Glycocalyx in Critically Ill COVID-19 Patients.
32822239 2020. Bubble Trouble in COVID-19.
32813543 2020. On Happy Hypoxia and on Sadly Ignored "Acute Vascular Distress Syndrome" in COVID-19 Patients.

32761524 2020. Is hypoxemia explained by intracardiac or intrapulmonary shunt in COVID-19-related acute respiratory distress syndrome?
32805179 2020. Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19.
32805177 2020. Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19.
32854247 2020. The Importance of Redox Status in the Frame of Lifestyle Approaches and the Genetics of the Lung Innate Immune Molecules, SP-A1 and SP-A2, on Differential Outcomes of COVID-19 Infection.
32735900 2020. Topoisomerase III-beta is required for efficient replication of positive-sense RNA viruses.
31705922 2020. Non-invasive bioluminescence imaging of HCoV-OC43 infection and therapy in the central nervous system of live mice.
31634494 2020. Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication.
32749662 2020. SARS-CoV-2 nucleocapsid and Nsp3 binding: an in silico study.
32761270 2020. Detection of SARS-CoV-2 by RNAscope((R)) in situ hybridization and immunohistochemistry techniques.
32737584 2020. A palindromic RNA sequence as a common breakpoint contributor to copy-choice recombination in SARS-COV-2.
32719955 2020. The antiviral protein viperin interacts with the viral N protein to inhibit proliferation of porcine epidemic diarrhea virus.
32884212 2020. Comments on "An insertion unique to SARS-CoV-2 exhibits super antigenic character strengthened by recent mutations" by Cheng MH et al.2020.
32831521 2020. Putative Natural History of CoViD-19.
32754004 2020. Expansion of Single Cell Transcriptomics Data of SARS-CoV Infection in Human Bronchial Epithelial Cells to COVID-19.
32728349 2020. Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients.
32882823 2020. Computational and Transcriptome Analyses Revealed Preferential Induction of Chemotaxis and Lipid Synthesis by SARS-CoV-2.
32861070 2020. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19.
32803496 2020. (1)H, (13)C, and (15)N backbone chemical shift assignments of the apo and the ADP-ribose bound forms of the macrodomain of SARS-CoV-2 non-structural protein 3b.
32770392 2020. (1)H, (13)C, and (15)N backbone chemical shift assignments of the nucleic acid-binding domain of SARS-CoV-2 non-structural protein 3e.
32825713 2020. Caveolae and Lipid Rafts in Endothelium: Valuable Organelles for Multiple Functions.
32752270 2020. Viral Ubiquitin and Ubiquitin-Like Deconjugases-Swiss Army Knives for Infection.
32829962 2020. The looming storm: Blood and cytokines in COVID-19.
32803145 2020. Is it infection or rather vascular inflammation? Game-changer insights and recommendations from patterns of multi-organ involvement and affected subgroups in COVID-19.
32750108 2020. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.
32707576 2020. Endothelial barrier integrity in COVID-19-dependent hyperinflammation: does the protective facet of platelet function matter?
32733733 2020. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with 2019 Novel Coronavirus (SARS-CoV-2) Infection.
32723436 2020. COVID-19: disCOVering the role of complement system.
32820801 2020. Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission.
32749472 2020. Suppressed anti-inflammatory heat shock response in high-risk COVID-19 patients: lessons from basic research (inclusive bats), light on conceivable therapies.
32883529 2020. Coronavirus 2019, Microthromboses, and Platelet Activating Factor.
32742654 2020. Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection.
32771962 2020. An in-silico approach to study the possible interactions of miRNA between human and SARS-CoV2.
32859264 2020. Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies.
32854750 2020. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China.
32742881 2020. Pediatric Case of Severe COVID-19 With Shock and Multisystem Inflammation.
32775080 2020. COVID-19 as a Possible Cause of Functional Exhaustion of CD4 and CD8 T-cells and Persistent Cause of Methicillin-Sensitive Staphylococcus aureus Bacteremia.
32864262 2020. A Review of Postmortem Findings in Patients With COVID-19.
32884871 2020. COVID-19 and Hyperinflammatory Syndrome in Children: Kawasaki Disease with Macrophage Activation Syndrome in Disguise?
32852642 2020. Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses.
32767259 2020. Deficiency of Tfh Cells and Germinal Center in Deceased COVID-19 Patients.
32838054 2021. Subcellular hot spots of GPCR signaling promote vascular inflammation.
32784125 2020. Natural killer cell responses to emerging viruses of zoonotic origin.
32866898 2020. ADE and hyperinflammation in SARS-CoV2 infection- comparison with dengue hemorrhagic fever and feline infectious peritonitis.
32873506 2020. Cytokine storm with rapidly elevated interleukin-6 indicates sudden death in patients with critical COVID-19.
32864402 2020. Dataset of mutational analysis, miRNAs targeting SARS-CoV-2 genes and host gene expression in SARS-CoV and SARS-CoV-2 infections.
32861199 2020. Monocyte activation in systemic Covid-19 infection: Assay and rationale.
32818801 2020. SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta.
32815517 2020. 3D virtual pathohistology of lung tissue from Covid-19 patients based on phase contrast X-ray tomography.
32752979 2020. Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients.
32691695 2020. Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells.
32880939 2020. Telomere length, epidemiology and pathogenesis of severe COVID-19.
32869220 2020. COVID-19 and the Antiviral Effect of Saliva.
32816244 2020. Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis.
32803422 2020. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach.
32718910 2020. Extensive coronary artery thrombosis complicating COVID-19 infection and haemophagocytic lymphohistiocytosis.
32733388 2020. Working Hypothesis for Glucose Metabolism and SARS-CoV-2 Replication: Interplay Between the Hexosamine Pathway and Interferon RF5 Triggering Hyperinflammation. Role of BCG Vaccine?
32849840 2020. Genetic Analysis of the Coronavirus SARS-CoV-2 Host Protease TMPRSS2 in Different Populations.
32765596 2020. Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein.
32765592 2020. Epigenetic Regulator miRNA Pattern Differences Among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide Isolates Delineated the Mystery Behind the Epic Pathogenicity and Distinct Clinical Characteristics of Pandemic COVID-19.
32849666 2020. Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?
32849654 2020. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.
32849650 2020. Longer Duration of SARS-CoV-2 Infection in a Case of Mild COVID-19 With Weak Production of the Specific IgM and IgG Antibodies.
32849648 2020. Mucosal-Associated Invariant T Cells as a Possible Target to Suppress Secondary Infections at COVID-19.
32886791 2020. Site-specific characterisation of SARS-CoV-2 spike glycoprotein receptor binding domain.
32883919 2020. Recent developments in COVID-19 therapeutics & current evidence for COVID-19-associated multisystem inflammatory syndrome.
32859866 2020. Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients.
32890939 2020. COVID-19: Brief check through the pathologist's eye (autopsy archive).
32888706 2020. SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings.
32826334 2020. Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates.
32826331 2020. IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome.
32890979 2020. Quantitative phylogenomic evidence reveals a spatially structured SARS-CoV-2 diversity.
32759262 2020. Response to: 'Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5 positive dermatomyositis associated rapidly progressive interstitial lung diseases: a challenge for the future' by Wang et al.
32759260 2020. Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5-positive dermatomyositis-associated rapidly progressive interstitial lung diseases: a challenge for the future.
32866279 2020. Haemoglobin oxygen affinity in patients with severe COVID-19 infection: Still unclear.
32826650 2020. Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface.
32833696 2020. Does Severe Acute Respiratory Syndrome Coronavirus 2 Cause Sepsis?
32749095 2020. MAIT Cells in COVID-19: Heroes, Villains, or Both?
32749094 2020. Novel Coronavirus SARS-CoV-2 Target and Disable Natural Killer Cells: Core Immune Effectors for Fighting the Disease.
32881654 2020. Renin-angiotensin system (RAS) and immune system profile in specific subgroups with COVID-19.
32633334 2020. The hemagglutinin-esterase gene in human coronaviruses SARS-CoV-2, HKU1 and OC43.
32750889 2020. AGTR2, one possible novel key gene for the entry of SARS-CoV-2 into human cells.
32864784 2020. Angiotensin-Converting Enzyme as a new immunologic target for the new SARS-CoV-2.
32762417 2020. Effect of mutation on structure, function and dynamics of receptor binding domain of human SARS-CoV-2 with host cell receptor ACE2: a molecular dynamics simulations study.
32752936 2020. Acute respiratory distress syndrome: a life threatening associated complication of SARS-CoV-2 infection inducing COVID-19.
32746720 2020. Deciphering the protein motion of S1 subunit in SARS-CoV-2 spike glycoprotein through integrated computational methods.
32851910 2020. Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding.
32773643 2020. Genomic variance of Open Reading Frames (ORFs) and Spike protein in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
32860278 2020. Associations between serum amyloid A, interleukin-6, and COVID-19: A cross-sectional study.
32769685 2020. Immunity, inflammation and the vasculature in the COVID-19 era.
32887754 2020. Antibody Responses to SARS-CoV-2: Let's Stick to Known Knowns.
32878912 2020. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
32744884 2020. Letter to the Editor: COVID-19, Mitochondria, and Interferon.
32721252 2020. Eosinophil-Derived Neurotoxin and Respiratory Tract Infection and Inflammation: Implications for COVID-19 Management.
32729633 2020. COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease?
32881026 2020. Fox3(+) CD25(+) CD4(+) T regulatory cells (Tregs) may transform the n-CoV's final destiny to CNS!
32880990 2020. Coronavirus Disease 2019 (COVID-19) is Associated with Low Circulating Plasma Levels of Angiotensin 1 and Angiotensin 1,7.
32726803 2020. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity.
32726801 2020. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.
32726800 2020. Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis.
32805734 2020. Structures and distributions of SARS-CoV-2 spike proteins on intact virions.
32807916 2020. COVID-19 poses a riddle for the immune system.
32826642 2020. A Novel Pediatric Multisystem Inflammatory Syndrome During the COVID-19 Pandemic.
32879033 2020. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
32843441 2020. COVID-19 Inflammatory Syndrome With Clinical Features Resembling Kawasaki Disease.
32812956 2020. Dynamical properties of enzyme-substrate complexes disclose substrate specificity of the SARS-CoV-2 main protease as characterized by the electron density descriptors.
32756685 2020. Intra- and intermolecular atomic-scale interactions in the receptor binding domain of SARS-CoV-2 spike protein: implication for ACE2 receptor binding.
32734714 2020. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
32875598 2020. Lymphopenia an important immunological abnormality in patients with COVID-19: Possible mechanisms.
32826343 2020. Natural killer cell immunotypes related to COVID-19 disease severity.
31538715 2020. Updated phylogenetic analysis of the spike gene and identification of a novel recombinant porcine epidemic diarrhoea virus strain in Taiwan.
32492472 2020. How ISG15 combats viral infection.
32838495 2020. [Recognition of critical coronavirus disease 2019: from the injury of alveolar epithelial cells to vascular endothelial cells].

32738055 2020. Discrepancy between Sp O2 and Sa O2 in patients with COVID-19.
32776522 2020. An analysis of SARS-CoV-2 cell entry genes identifies the intestine and colorectal cancer as susceptible tissues.
32885345 2020. The potential similarities of COVID-19 and autoimmune disease pathogenesis and therapeutic options: new insights approach.
32835036 2020. Quantitative proteomic dataset from oro- and naso-pharyngeal swabs used for COVID-19 diagnosis: Detection of viral proteins and host's biological processes altered by the infection.
32775582 2020. Dataset for homologous proteins in Drosophila melanogaster for SARS-CoV-2/human interactome.
32885781 2020. Pediatric Multisystemic Inflammatory Syndrome Associated With SARS-CoV-2 Infection.
32865490 2020. The Pathology of Severe COVID-19-Related Lung Damage.
32745993 2020. Vascular occlusion by neutrophil extracellular traps in COVID-19.
32736307 2020. The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19).
32857691 2020. Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020.
32730568 2020. Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes.
32860146 2020. Lung and kidney perfusion deficits diagnosed by dual-energy computed tomography in patients with COVID-19-related systemic microangiopathy.
32883678 2020. Confronting the controversy: Interleukin-6 and the COVID-19 cytokine storm syndrome.
32747391 2020. Pathogenesis of COVID-19-induced ARDS: implications for an ageing population.
32849623 2020. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.
32793244 2020. COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella.
32793223 2020. The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System.
32754163 2020. Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies.
32754162 2020. The Potential Effect of Novel Coronavirus SARS-CoV-2 on NK Cells; A Perspective on Potential Therapeutic Interventions.
32754159 2020. Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper.
32733487 2020. Role of Immune Dysregulation in Increased Mortality Among a Specific Subset of COVID-19 Patients and Immune-Enhancement Strategies for Combatting Through Nutritional Supplements.
32719688 2020. Case Report: Systemic Inflammatory Response and Fast Recovery in a Pediatric Patient With COVID-19.
32719687 2020. Cell-Mediated Immune Responses to COVID-19 Infection.
32719686 2020. Establishing a Unified COVID-19 "Immunome": Integrating Coronavirus Pathogenesis and Host Immunopathology.
32849425 2020. Coronavirus Interplay With Lipid Rafts and Autophagy Unveils Promising Therapeutic Targets.
32793182 2020. Geographic and Genomic Distribution of SARS-CoV-2 Mutations.
32719673 2020. In-Depth Bioinformatic Analyses of Nidovirales Including Human SARS-CoV-2, SARS-CoV, MERS-CoV Viruses Suggest Important Roles of Non-canonical Nucleic Acid Structures in Their Lifecycles.
32793108 2020. The Consequences of Coronavirus-Induced Cytokine Storm Are Associated With Neurological Diseases, Which May Be Preventable.
32850560 2020. Quantitative Assessment of Parenchymal Involvement Using 3D Lung Model in Adolescent With Covid-19 Interstitial Pneumonia.
32719757 2020. SARS-COV-2 Infection and Kawasaki Disease: Case Report of a Hitherto Unrecognized Association.
32754041 2020. Pathological Aspects of COVID-19 as a Conformational Disease and the Use of Pharmacological Chaperones as a Potential Therapeutic Strategy.
32848893 2020. The Enigma of Endothelium in COVID-19.
32754056 2020. SARS-CoV-2 Molecular Network Structure.
32850603 2020. Improving Non-specific Immunity to Coronavirus Disease (COVID-19) by the Novelty, Diversity, and Quantity of Antigen.
32719819 2020. Analysis of ACE2 Gene-Encoded Proteins Across Mammalian Species.
32805314 2020. Unravelling host-pathogen interactions: ceRNA network in SARS-CoV-2 infection (COVID-19).
32835214 2020. Time-series analyses of directional sequence changes in SARS-CoV-2 genomes and an efficient search method for candidates for advantageous mutations for growth in human cells.
32708319 2020. Computational Analysis of the Global Effects of Ly6E in the Immune Response to Coronavirus Infection Using Gene Networks.
32867305 2020. COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells.
32858958 2020. Prediction and Analysis of SARS-CoV-2-Targeting MicroRNA in Human Lung Epithelium.
32723359 2020. Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein.
32822756 2020. Missense mutations in SARS-CoV2 genomes from Indian patients.
32739507 2020. From Mutation Signature to Molecular Mechanism in the RNA World: A Case of SARS-CoV-2.
32844125 2020. Integrative analyses of SARS-CoV-2 genomes from different geographical locations reveal unique features potentially consequential to host-virus interaction, pathogenesis and clues for novel therapies.
32844126 2020. Leptin levels in SARS-CoV-2 infection related respiratory failure: A cross-sectional study and a pathophysiological framework on the role of fat tissue.
32835122 2020. Molecular biology of coronaviruses: current knowledge.
32835135 2020. Lung microbiome and coronavirus disease 2019 (COVID-19): Possible link and implications.
32750378 2020. A review of the main histopathological findings in coronavirus disease 2019.
32783921 2020. Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients.
32783920 2020. Distinct Early Serological Signatures Track with SARS-CoV-2 Survival.
32791036 2020. Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses.
32863636 2020. Cytokine Storm in Novel Coronavirus Disease (COVID-19): Expert Management Considerations.
32746940 2020. Abnormal immunity of non-survivors with COVID-19: predictors for mortality.
32801801 2020. Effect of SARS-CoV-2 Infection on the Microbial Composition of Upper Airway.
32801787 2020. Role of Monocytes/Macrophages in Covid-19 Pathogenesis: Implications for Therapy.
32765013 2020. Molecular Basis for Pathogenicity of Human Coronaviruses.
32771700 2020. Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection.
32853823 2020. Intrinsic disorder perspective of an interplay between the renin-angiotensin-aldosterone system and SARS-CoV-2.
32737833 2020. Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases.
32834892 2020. Macrophage activation syndrome and COVID-19.
32834891 2020. Genome evolution of SARS-CoV-2 and its virological characteristics.
32767095 2020. Coronavirus (Covid-19) sepsis: revisiting mitochondrial dysfunction in pathogenesis, aging, inflammation, and mortality.
32844604 2020. Human post-infection serological response to the spike and nucleocapsid proteins of SARS-CoV-2.
32790065 2020. A COVID-19 human viral challenge model. Learning from experience.
32838020 2020. SARS-CoV-2-human protein-protein interaction network.
32792851 2020. Immune Response and COVID-19: A mirror image of Sepsis.
32721529 2020. Isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak.
32771639 2020. Clinical immunity in discharged medical patients with COVID-19.
32771640 2020. Increased Complement Receptor-3 levels in monocytes and granulocytes distinguish COVID-19 patients with pneumonia from those with mild symptoms.
32768699 2020. What can we learn from a COVID-19 lung biopsy?
32758688 2020. The characteristics and predictive role of lymphocyte subsets in COVID-19 patients.
32866640 2020. Comprehensive evolution and molecular characteristics of a large number of SARS-CoV-2 genomes reveal its epidemic trends.
32861823 2020. Multisystem inflammatory syndrome in children (MIS-C): Report of the clinical and epidemiological characteristics of cases in Santiago de Chile during the SARS-CoV-2 pandemic.
32841689 2020. A genetic barcode of SARS-CoV-2 for monitoring global distribution of different clades during the COVID-19 pandemic.
32841688 2020. First report on clinical and radiological features of COVID-19 pneumonitis in a Caucasian population: Factors predicting fibrotic evolution.
32812365 2020. Interest of the cellular population data analysis as an aid in the early diagnosis of SARS-CoV-2 infection.
32883007 2020. Natural Killer Cell Dysfunction and Its Role in COVID-19.
32630064 2020. Vimentin as a Multifaceted Player and Potential Therapeutic Target in Viral Infections.
32867123 2020. Using All-Atom Potentials to Refine RNA Structure Predictions of SARS-CoV-2 Stem Loops.
32767455 2020. Pediatric multisystem inflammatory syndrome temporally associated with SARS-COV-2: Oral manifestations and implications.
32779341 2020. Understanding immunopathological fallout of human coronavirus infections including COVID-19: Will they cross the path of rheumatologists?
32770345 2020. Apoptosis and pericyte loss in alveolar capillaries in COVID-19 infection: choice of markers matters.
32844260 2020. Apoptosis and pericyte loss in alveolar capillaries in COVID-19 infection: choice of markers matters. Author's reply.
32861856 2020. Age-Related Differences in Immunological Responses to SARS-CoV-2.
32742475 2020. Expression of the SAR2-Cov-2 receptor ACE2 reveals the susceptibility of COVID-19 in non-small cell lung cancer.
32835160 2020. The interaction between the endocannabinoid system and the renin angiotensin system and its potential implication for COVID-19 infection.
32867328 2020. Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors.
32873700 2020. Gene of the month: TMPRSS2 (transmembrane serine protease 2).
32722979 2020. Endothelial activation and dysfunction in metabolic syndrome, type 2 diabetes and coronavirus disease 2019.
32884216 2020. Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development.
32880929 2020. Molecular dynamics study with mutation shows that N-terminal domain (NTD) structural re-orientation in NPC1 is required for proper alignment of cholesterol transport.
32735721 2020. Update on the COVID-19-associated inflammatory syndrome in children and adolescents; paediatric inflammatory multisystem syndrome-temporally associated with SARS-CoV-2.
32762140 2020. Circulating endothelial progenitors are increased in COVID-19 patients and correlate with SARS-CoV-2 RNA in severe cases.
32762081 2020. Is the COVID-19 thrombotic catastrophe complement-connected?
32860073 2020. Assessing SARS-CoV-2 RNA levels and lymphocyte/T cell counts in COVID-19 patients revealed initial immune status as a major determinant of disease severity.
32770582 2020. Elucidating the microscopic and computational techniques to study the structure and pathology of SARS-CoVs.
32841626 2020. Sublingual microcirculation in patients with SARS-CoV-2 undergoing veno-venous extracorporeal membrane oxygenation.
32755094 2020. Coronavirus disease 2019 (COVID-19) in critically ill patients: can we re-program the immune system? A primer for intensivists.
32843733 2020. Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID-19.
32817413 2020. Autoimmunity complicating SARS-CoV-2 infection in selective IgA-deficiency.
32794245 2020. A Japanese case of COVID-19: An autopsy report.
32863022 2020. Histopathology of cutaneous COVID-19 lesion: possible SARS-CoV-2 cytopathogenic effect.
32809036 2020. Postmortale Bildgebung der Lunge bei COVID-19-Todesfallen.
32889497 2020. Covid-19 pneumonia and pulmonary vascular disease: A UK Centre perspective.
32845122 2020. Quantum Dot-Conjugated SARS-CoV-2 Spike Pseudo-Virions Enable Tracking of Angiotensin Converting Enzyme 2 Binding and Endocytosis.
32778542 2020. High oligoclonality of immunoglobulins in SARS-CoV2 positive patients.
30943371 2019. SARS coronavirus protein nsp1 disrupts localization of Nup93 from the nuclear pore complex.
32854812 2020. Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in 45 children: a first report from Iran.
32776691 2020. The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID-19.
32723800 2020. Fatal pulmonary fibrosis: a post-COVID-19 autopsy case.
32817204 2020. Histopathological observations in COVID-19: a systematic review.
32734876 2020. [Findings in post-mortem CT and autopsy in a 53-year-old-man with COVID-19].

32833435 2020. Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex.
32806067 2020. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
32821883 2020. SARS-CoV-2 Receptor ACE2 Is Enriched in a Subpopulation of Mouse Tongue Epithelial Cells in Nongustatory Papillae but Not in Taste Buds or Embryonic Oral Epithelium.
32799392 2020. Kawasaki disease or Kawasaki-like disease: influence of SARS-CoV-2 infections in Japan.
32725143 2020. Phosphate metabolism and Respiratory Alkalosis: a forgotten lesson in COVID-19.
32754908 2020. Delayed virus-specific antibody responses associate with COVID-19 mortality.
32851645 2020. Angiotensin-converting enzyme II expression and its implication in the association between COVID-19 and allergic rhinitis.
32743884 2020. Blood Myeloperoxidase-DNA, a biomarker of early response to SARS-CoV-2 infection?
32808976 2020. Humoral Immune Response to SARS-CoV-2.
32755307 2020. SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs.
32878480 2020. Elevated FiO2 increases SARS-CoV-2 co-receptor expression in respiratory tract epithelium.
32755325 2020. The potential role of the carotid body in COVID-19.
31942559 2019. The characteristics of hDPP4 transgenic mice subjected to aerosol MERS coronavirus infection via an animal nose-only exposure device.
32825305 2020. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Exhibits High Predicted Binding Affinity to ACE2 from Lagomorphs (Rabbits and Pikas).
32588590 2020. Coronaviruses fusion with the membrane and entry to the host cell.
32831935 2020. COVID-19: Lessons in laboratory medicine, pathology, and autopsy.
32821902 2020. The Spectrum of Histopathologic Findings in Lungs of Patients with Fatal COVID-19 Infection.
32829876 2020. Mutations in the phosphorylation sites of SARS-CoV-2 encoded nucleocapsid protein and structure model of sequestration by protein 14-3-3.
31594639 2019. An in vivo cell-based assay for investigating the specific interaction between the SARS-CoV N-protein and its viral RNA packaging sequence.
32854762 2020. The receptor binding domain of SARS-CoV-2 spike protein is the result of an ancestral recombination between the bat-CoV RaTG13 and the pangolin-CoV MP789.
32828489 2020. Epigenetic susceptibility to severe respiratory viral infections: pathogenic and therapeutic implications: a narrative review.
32805061 2020. COVID-19 and haemoglobin oxygen affinity: some clarity?
32743639 2020. Application of Bayesian phylogenetic inference modelling for evolutionary genetic analysis and dynamic changes in 2019-nCoV.
32742035 2020. Variant analysis of SARS-CoV-2 genomes.
32856707 2020. Viral dynamics and immune correlates of COVID-19 disease severity.
32844958 2020. Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome.
32837710 2020. Structural insights into the mechanism of RNA recognition by the N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoprotein.
32765822 2020. Genus-specific pattern of intrinsically disordered central regions in the nucleocapsid protein of coronaviruses.
32787909 2020. Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients.
32778136 2020. A physiological approach to understand the role of respiratory effort in the progression of lung injury in SARS-CoV-2 infection.
32880654 2020. The Collision of Meta-Inflammation and SARS-CoV-2 Pandemic Infection.
32880957 2020. Variation and multilevel selection of SARS-CoV-2.
32890763 2020. Evolutionary dynamics of the SARS-CoV-2 ORF8 accessory gene.
32889094 2020. Inferring the genetic variability in Indian SARS-CoV-2 genomes using consensus of multiple sequence alignment techniques.
32890666 2020. Echocardiographic Findings in Pediatric Multisystem Inflammatory Syndrome Associated with COVID-19 in the United States.
32725137 2020. Role of the early secretory pathway in SARS-CoV-2 infection.
32759312 2020. Immunoinformatic approach to assess SARS-CoV-2 protein S epitopes recognised by the most frequent MHC-I alleles in the Brazilian population.
32759311 2020. Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2).
32848014 2020. Histopathological features of multiorgan percutaneous tissue core biopsy in patients with COVID-19.
32761894 2020. COVID-19 and immunological regulations - from basic and translational aspects to clinical implications.
32678431 2020. Neutrophils and COVID-19: Nots, NETs, and knots.
32754556 2020. Is there antibody-dependent enhancement in SARS Coronavirus 2?
32787459 2020. Epstein-Barr Virus Versus Novel Coronavirus-Induced Hemophagocytic Lymphohistocytosis: The Uncharted Waters.
32790406 2020. Does SARS-CoV-2 Bind to Human ACE2 More Strongly Than Does SARS-CoV?
32787330 2020. Dynamic Asymmetry Exposes 2019-nCoV Prefusion Spike.
32787225 2020. Structure of Furin Protease Binding to SARS-CoV-2 Spike Glycoprotein and Implications for Potential Targets and Virulence.
32867854 2020. Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1.
32746922 2020. A consideration of publication-derived immune-related associations in Coronavirus and related lung damaging diseases.
31776274 2020. Nucleocapsid Protein Recruitment to Replication-Transcription Complexes Plays a Crucial Role in Coronaviral Life Cycle.
31911390 2020. Analysis of preferred codon usage in the coronavirus N genes and their implications for genome evolution and vaccine design.
32796155 2020. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
32838080 2020. SARS-CoV-2 Virions or Ubiquitous Cell Structures? Actual Dilemma in COVID-19 Era.
32822564 2020. Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study.
32818434 2020. COVID-19 and multisystem inflammatory syndrome in children and adolescents.
32844161 2020. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study.
32739876 2020. Autopsies of COVID-19 deceased? Absolutely!
32823907 2020. Molecular Epidemiology Analysis of SARS-CoV-2 Strains Circulating in Romania during the First Months of the Pandemic.
32735885 2020. The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
32735883 2020. Molecular profiling of immune cell-enriched Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) interacting protein USP13.
32768580 2020. Structural analysis of ACE2 variant N720D demonstrates a higher binding affinity to TMPRSS2.
32871183 2020. Immunocytometric analysis of COVID patients: A contribution to personalized therapy?
32835700 2020. Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies.
32822087 2020. Gut Microbiome Imbalance and Neuroinflammation: Impact of COVID-19 on Parkinson's Disease.
32878932 2020. A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture.
32878931 2020. Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity.
32461278 2020. Respiratory Syncytial Virus-Induced Oxidative Stress Leads to an Increase in Labile Zinc Pools in Lung Epithelial Cells.
32874019 2020. Coronavirus herd immunity optimizer (CHIO).
32825438 2020. SARS-CoV-2 ORF8 and SARS-CoV ORF8ab: Genomic Divergence and Functional Convergence.
32785274 2020. Structural insight into the role of novel SARS-CoV-2 E protein: A potential target for vaccine development and other therapeutic strategies.
32780783 2020. Global cataloguing of variations in untranslated regions of viral genome and prediction of key host RNA binding protein-microRNA interactions modulating genome stability in SARS-CoV-2.
32780218 2020. A human circulating immune cell landscape in aging and COVID-19.
32822073 2020. Comparing the binding properties of peptides mimicking the Envelope protein of SARS-CoV and SARS-CoV-2 to the PDZ domain of the tight junction-associated PALS1 protein.
32777054 2020. Vascular inflammation and endothelial injury in SARS-CoV-2 infection: The overlooked regulatory cascades implicated by the ACE2 gene cluster.
32876096 2021. CLINICAL-EPIDEMIOLOGICAL RELATION BETWEEN SARS-COV-2 AND KAWASAKI DISEASE: AN INTEGRATIVE LITERATURE.
32876282 2020. MULTISYSTEM INFLAMMATORY SYNDROME IN A CHILD ASSOCIATED WITH CORONAVIRUS DISEASE 19 IN THE BRAZILIAN AMAZON: FATAL OUTCOME IN AN INFANT.
32611651 2020. Is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic.
32699064 2020. Viral subversion of nonsense-mediated mRNA decay.
32747912 2020. Histopathological findings in the advanced natural evolution of the SARS-CoV-2 infection.
32838198 2020. Lung Barrier Function in COVID-19?
32642005 2020. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
32839288 2020. Histopathological findings in fatal COVID-19 severe acute respiratory syndrome: preliminary experience from a series of 10 Spanish patients.
32851697 2020. Single-cell RNA expression profiling of ACE2 and TMPRSS2 in the human trophectoderm and placenta.
32798244 2020. Anatomical and timely assessment of protein expression of angiotensin-converting enzyme 2, SARS-CoV-2 specific receptor, in fetal and placental tissues: new insight for perinatal counseling.
32551795 2020. Coronaviruses.
32732586 2020. Histopathologic and Autopsy Findings in Patients Diagnosed With Coronavirus Disease 2019 (COVID 19): What we know So Far Based on Correlation With Clinical, Morphologic and Pathobiological Aspects.
32366572 2020. The Biology of Pulmonary Coronavirus Infection Underscores Host-Directed Therapies as an Option.
32826274 2020. Response to: 'Exaggerated neutrophil extracellular trap formation in Kawasaki disease: a key phenomenon behind the outbreak in western countries?' by Yamashita et al.
32529459 2020. Genome-wide analysis of long noncoding RNA profiles in Vero cells infected with porcine epidemic diarrhea virus.
32730589 2020. Persistent minimal sequences of SARS-CoV-2.
32818261 2020. Structural basis of SARS-CoV-2 spike protein induced by ACE2.
32805023 2020. Mechanistic insights into SARS-CoV-2 epidemic via revealing the features of SARS-CoV-2 coding proteins and host responses upon its infection.
32877502 2020. Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition.
32737031 2020. Cellular immune responses to covid-19.
32871617 2020. The implications of COVID-19 infection on the endothelium: A metabolic vascular perspective.
32628899 2020. Coronaviruses and Integrin alphavbeta3: Does Thyroid Hormone Modify the Relationship?
32749914 2020. Resolution of coronavirus disease 2019 (COVID-19).
32878546 2020. Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses.
32845733 2020. Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19.
32841579 2020. Cytokines and COVID-19: friends or foes?
32753027 2020. Role of key point Mutations in Receptor Binding Domain of SARS-CoV-2 Spike Glycoprotein.
32738851 2020. Can a Healthy Lung Keep the COVID-19 Away?
32889794 2020. SARS-CoV-2 infection, oxidative stress and male reproductive hormones: can testicular-adrenal crosstalk be ruled-out?
32013309 2020. Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy.
32744052 2020. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
32828084 2020. Conformational transition of SARS-CoV-2 spike glycoprotein between its closed and open states.
32886755 2020. Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients.
32841329 2020. Underlying Vulnerabilities to the Cytokine Storm and Adverse COVID-19 Outcomes in the Aging Immune System.
32731783 2020. Novel coronavirus infection and Kawasaki disease.
32846427 2020. Sex differences in immune responses that underlie COVID-19 disease outcomes.
32776761 2020. Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): providing resuscitative care.
32882717 2020. Pulmonary Megakaryocytes in Coronavirus Disease 2019 (COVID-19): Roles in Thrombi and Fibrosis.
32882716 2020. Perspectives on Platelet Heterogeneity and Host Immune Response in Coronavirus Disease 2019 (COVID-19).

32766671 2020. Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19.
32735892 2020. Network perturbation analysis in human bronchial epithelial cells following SARS-CoV2 infection.
32838215 2020. An Impaired Natriuretic Peptide Hormone System May Play a Role in COVID-19 Severity in Vulnerable Populations.
32779891 2020. Sympathetic activation: a potential link between comorbidities and COVID-19.
32790936 2020. Nicotine and the nicotinic cholinergic system in COVID-19.
32738184 2020. Tumor markers as an entry for SARS-CoV-2 infection?
32760733 2020. Multisystem Inflammatory Syndrome With Complete Kawasaki Disease Features Associated With SARS-CoV-2 Infection in a Young Adult. A Case Report.
32866507 2020. Fever and diarrhea as the only symptoms of Multisystem Inflammatory Syndrome in Children (MIS-C).
32769230 2020. Epidemiological and Clinical Profile of Pediatric Inflammatory Multisystem Syndrome - Temporally Associated with SARS-CoV-2 (PIMS-TS) in Indian Children.
32441271 2020. Novel Coronavirus Mimicking Kawasaki Disease in an Infant.
32788432 2020. Multisystem Inflammatory Syndrome in Children With COVID-19 in Mumbai, India.
32738607 2020. The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike.
32812719 2020. The Hyper-Inflammatory Response in Adults with Severe COVID-19 Pneumonia Differs from the Cytokine Storm of Hemophagocytic Syndrome.
32763970 2020. Impaired NLRP3 inflammasome activation/pyroptosis leads to robust inflammatory cell death via caspase-8/RIPK3 during coronavirus infection.
32713862 2020. RNAi suppressor: The hidden weapon of SARS-CoV.
32840072 2020. [The mechanism and treatment strategies of SARS-CoV-2 mediated inflammatory response].
32859733 2020. Functional respiratory imaging identifies redistribution of pulmonary blood flow in patients with COVID-19.
32852402 2020. Histopatological Findings in the Explant Lungs of a Patient With COVID-19 Treated With Bilateral Orthotopic Lung Transplant.
32762171 2020. [Comparative analysis of structural characteristics and epitopes in S proteins between SARS-CoV-2 and SARS-CoV].
32762165 2020. [Replication and transmission mechanisms of highly pathogenic human coronavirus].

32725143 2020. Phosphate metabolism and Respiratory Alkalosis: a forgotten lesson in COVID-19.
32726150 2020. Cardiac Endotheliitis and Multisystem Inflammatory Syndrome After COVID-19.
32735900 2020. Topoisomerase III-beta is required for efficient replication of positive-sense RNA viruses.
32737584 2020. A palindromic RNA sequence as a common breakpoint contributor to copy-choice recombination in SARS-COV-2.
32754004 2020. Expansion of Single Cell Transcriptomics Data of SARS-CoV Infection in Human Bronchial Epithelial Cells to COVID-19.
32728349 2020. Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients.
32745829 2020. Orientation of immobilized antigens on common surfaces by a simple computational model: Exposition of SARS-CoV-2 Spike protein RBD epitopes.
32721790 2020. Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics.
32743639 2020. Application of Bayesian phylogenetic inference modelling for evolutionary genetic analysis and dynamic changes in 2019-nCoV.
32707576 2020. Endothelial barrier integrity in COVID-19-dependent hyperinflammation: does the protective facet of platelet function matter?
32728199 2020. SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70.
32725381 2020. Interaction of HSPA5 (Grp78, BIP) with negatively charged phospholipid membranes via oligomerization involving the N-terminal end domain.
32722449 2020. A Message from the Human Placenta: Structural and Immunomodulatory Defense against SARS-CoV-2.
32770235 2020. Cerebrospinal fluid features in SARS-CoV-2 RT-PCR positive patients.
32745196 2020. Longitudinal dynamics of the neutralizing antibody response to SARS-CoV-2 infection.
32742654 2020. Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection.
32771962 2020. An in-silico approach to study the possible interactions of miRNA between human and SARS-CoV2.
32742881 2020. Pediatric Case of Severe COVID-19 With Shock and Multisystem Inflammation.
32775080 2020. COVID-19 as a Possible Cause of Functional Exhaustion of CD4 and CD8 T-cells and Persistent Cause of Methicillin-Sensitive Staphylococcus aureus Bacteremia.
32767259 2020. Deficiency of Tfh Cells and Germinal Center in Deceased COVID-19 Patients.
32745993 2020. Vascular occlusion by neutrophil extracellular traps in COVID-19.
32749957 2020. SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease.
32752979 2020. Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients.
32691695 2020. Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells.
32730568 2020. Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes.
32735892 2020. Network perturbation analysis in human bronchial epithelial cells following SARS-CoV2 infection.
32738184 2020. Tumor markers as an entry for SARS-CoV-2 infection?
32741461 2020. Endometrial susceptibility to SARS CoV-2: explained by gene expression across the menstrual cycle?
32765596 2020. Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein.
32765592 2020. Epigenetic Regulator miRNA Pattern Differences Among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide Isolates Delineated the Mystery Behind the Epic Pathogenicity and Distinct Clinical Characteristics of Pandemic COVID-19.
32754162 2020. The Potential Effect of Novel Coronavirus SARS-CoV-2 on NK Cells; A Perspective on Potential Therapeutic Interventions.
32754159 2020. Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper.
32733448 2020. Role of Autophagy in Lung Inflammation.
32719688 2020. Case Report: Systemic Inflammatory Response and Fast Recovery in a Pediatric Patient With COVID-19.
32719687 2020. Cell-Mediated Immune Responses to COVID-19 Infection.
32719686 2020. Establishing a Unified COVID-19 "Immunome": Integrating Coronavirus Pathogenesis and Host Immunopathology.
32723359 2020. Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein.
32739507 2020. From Mutation Signature to Molecular Mechanism in the RNA World: A Case of SARS-CoV-2.
32737833 2020. Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases.
32720978 2020. The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications.
32721529 2020. Isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak.
32738607 2020. The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike.
32730233 2020. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2.
32730226 2020. Is multisystem inflammatory syndrome in children on the Kawasaki syndrome spectrum?
32739486 2020. Characterising differential antibody response is integral to future SARS-CoV-2 serostudies.
32726448 2020. IFITM3 related to COVID-19.
32726417 2020. Differences in antibody kinetics and functionality between severe and mild SARS-CoV-2 infections.
32738141 2020. Immunoserologic detection and diagnostic relevance of cross-reactive auto-antibodies in COVID-19 patients.
32735721 2020. Update on the COVID-19-associated inflammatory syndrome in children and adolescents; paediatric inflammatory multisystem syndrome-temporally associated with SARS-CoV-2.
32735785 2020. Lung fibrosis: an undervalued finding in COVID-19 pathological series.
32739471 2020. The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach.
32735885 2020. The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
32735883 2020. Molecular profiling of immune cell-enriched Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) interacting protein USP13.
32732237 2020. Genome Sequences of SARS-CoV-2 Strains Detected in Hong Kong.
32732236 2020. Reports of Coding-Complete Genome Sequences of Five 2019 Novel Coronavirus (SARS-CoV-2) Strains Isolated in Bangladesh.
32732235 2020. SARS-CoV-2 Genome Sequence from Morocco, Obtained Using Ion AmpliSeq Technology.
32744436 2020. Single-cell RNA sequencing analysis of human kidney reveals the presence of ACE2 receptor: A potential pathway of COVID-19 infection.
32733001 2020. Activation and evasion of type I interferon responses by SARS-CoV-2.
32737462 2020. IgGs drive COVID-19 myeloid hyperinflammation.
32732951 2020. NK cells in COVID-19: protectors or opponents?
32728222 2020. T cell responses in patients with COVID-19.
32728221 2020. Tissue damage from neutrophil-induced oxidative stress in COVID-19.
32724189 2020. Rising to the challenge of COVID-19.
32722596 2020. Immune Pathogenesis of COVID-19 Intoxication: Storm or Silence?
32721181 2020. Immunometabolic Status of COVID-19 Cancer Patients.
32780783 2020. Global cataloguing of variations in untranslated regions of viral genome and prediction of key host RNA binding protein-microRNA interactions modulating genome stability in SARS-CoV-2.
32726325 2020. Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2.
32726355 2020. Interplay between SARS-CoV-2 and the type I interferon response.
32738789 2020. Nox2 activation in Covid-19.
32727465 2020. Association between cytokine profiles and lung injury in COVID-19 pneumonia.
32723327 2020. The pathophysiology of 'happy' hypoxemia in COVID-19.
32703906 2020. Structure-based design of prefusion-stabilized SARS-CoV-2 spikes.
32661059 2020. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.
32728018 2020. Crystal structure of SARS-CoV-2 nsp10/nsp16 2'-O-methylase and its implication on antiviral drug design.
32712629 2020. COVID-19: immunopathogenesis and Immunotherapeutics.
32720214 2020. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
32705575 2020. Serologic Response to SARS-CoV-2 in COVID-19 Patients with Different Severity.
32717345 2020. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection.
32730781 2020. Immunometabolism pathways as the basis for innovative anti-viral strategies (INITIATE): A Marie Sklodowska-Curie innovative training network.
32730780 2020. 100 days of solitude: The spring of COVID-19 through the eyes of 15 young virologists of the INITIATE program.
32732586 2020. Histopathologic and Autopsy Findings in Patients Diagnosed With Coronavirus Disease 2019 (COVID 19): What we know So Far Based on Correlation With Clinical, Morphologic and Pathobiological Aspects.
32734595 2020. Antibodies in serum of convalescent patients following mild COVID-19 do not always prevent virus-receptor binding.
32726474 2020. SARS-CoV-2 receptor ACE2 protein expression in serum is significantly associated with age.
32675499 2020. Tracheobronchial Slough, a Potential Pathology in Endotracheal Tube Obstruction in Patients With Coronavirus Disease 2019 (COVID-19) in the Intensive Care Setting.
32730589 2020. Persistent minimal sequences of SARS-CoV-2.
32737031 2020. Cellular immune responses to covid-19.
32735457 2020. The vascular nature of COVID-19.
32697499 2020. Dealing With the CARDS of COVID-19.
32749095 2020. MAIT Cells in COVID-19: Heroes, Villains, or Both?
32749094 2020. Novel Coronavirus SARS-CoV-2 Target and Disable Natural Killer Cells: Core Immune Effectors for Fighting the Disease.
32628899 2020. Coronaviruses and Integrin alphavbeta3: Does Thyroid Hormone Modify the Relationship?
32654788 2020. Histological characterization of placenta in COVID19 pregnant women.
32773420 2020. Transcriptome & viral growth analysis of SARS-CoV-2-infected Vero CCL-81 cells.
32727719 2020. Postmortem Kidney Pathology Findings in Patients with COVID-19.
32723800 2020. Fatal pulmonary fibrosis: a post-COVID-19 autopsy case.
32744884 2020. COVID-19, Mitochondria, and Interferon.
32721252 2020. Eosinophil-Derived Neurotoxin and Respiratory Tract Infection and Inflammation: Implications for COVID 19 Management.
32731783 2020. Novel coronavirus infection and Kawasaki disease.
32770807 2020. Kawasaki disease fact check: Myths, misconceptions and mysteries.
32740530 2020. COVID-19-Associated Multisystem Inflammatory Syndrome in Children Presenting as Acute Pancreatitis.
32739908 2020. COVID-19, neutrophil extracellular traps and vascular complications in obstetric practice.
32726507 2020. Hypoxia - an overlooked trigger for thrombosis in COVID-19 and other critically ill patients.
32730555 2020. Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases.
32725017 2020. Quantitative determination of mechanical stability in the novel coronavirus spike protein.
32724171 2020. Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic.
32737467 2020. A thermostable, closed SARS-CoV-2 spike protein trimer.
32726803 2020. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity.
32726801 2020. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.
32677813 2020. Cytokine Profile in an Adolescent With Pediatric Multisystem Inflammatory Syndrome Temporally Related to COVID-19.
32639461 2020. Pediatric Inflammatory Multisystem Syndrome With Central Nervous System Involvement and Hypocomplementemia Following SARS-COV-2 Infection.
32734714 2020. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
32753554 2020. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans.

32747721 2020. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19.
32773102 2020. Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression.
32773100 2020. NK cells: A double edge sword against SARS-CoV-2.
32706115 2020. Relative lymphocytosis in COVID-19 - a ray of hope.
32754908 2020. Delayed virus-specific antibody responses associate with COVID-19 mortality.
32755307 2020. SARS-CoV-2 may regulate cellular responses through depletion of specific host miRNAs.
32755325 2020. The potential role of the Carotid Body in COVID-19.
32761524 2020. Is hypoxemia explained by intracardiac or intrapulmonary shunt in COVID-19-related acute respiratory distress syndrome?
32759839 2020. Is the Host Viral Response and the Immunogenicity of Vaccines Altered in Pregnancy?
32749662 2020. SARS-CoV-2 nucleocapsid and Nsp3 binding: an in silico study.
32762083 2020. Neuropathologic features of four autopsied COVID-19 patients.
32778874 2020. Pathogenetic profiling of COVID-19 and SARS-like viruses.
32742035 2020. Variant analysis of SARS-CoV-2 genomes.
32733733 2020. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with 2019 Novel Coronavirus (SARS-CoV-2) Infection.
32730807 2020. The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity.
32759967 2020. Dysregulated adaptive immune response contributes to severe COVID-19.
32753756 2020. SARS-CoV-2 infects human neural progenitor cells and brain organoids.
32754823 2020. Human molecular chaperones share with SARS-CoV-2 antigenic epitopes potentially capable of eliciting autoimmunity against endothelial cells: possible role of molecular mimicry in COVID-19.
32611087 2020. Topological analysis of SARS CoV-2 main protease.
32690231 2020. The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy.
32753517 2020. Cytokine storm release syndrome and the prospects for immunotherapy with COVID-19, part 3: The role of GM-CSF.
32758273 2020. Management of epigenomic networks entailed in coronavirus infections and COVID-19.
32749472 2020. Suppressed anti-inflammatory heat shock response in high-risk COVID-19 patients: lessons from basic research (inclusive bats), light on conceivable therapies.
32765822 2020. Genus-specific pattern of intrinsically disordered central regions in the nucleocapsid protein of coronaviruses.
32775582 2020. Dataset for homologous proteins in Drosophila melanogaster for SARS-CoV-2/human interactome.
32752129 2020. Effect of Coronavirus Disease 2019 in Pulmonary Circulation. The Particular Scenario of Precapillary Pulmonary Hypertension.
32766671 2020. Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19.
32779891 2020. Sympathetic activation: a potential link between comorbidities and COVID-19.
32760733 2020. Multisystem Inflammatory Syndrome With Complete Kawasaki Disease Features Associated With SARS-CoV-2 Infection in a Young Adult. A Case Report.
32719673 2020. In-Depth Bioinformatic Analyses of Nidovirales Including Human SARS-CoV-2, SARS-CoV, MERS-CoV Viruses Suggest Important Roles of Non-canonical Nucleic Acid Structures in Their Lifecycles.
32719672 2020. Severe Acute Respiratory Syndrome Coronavirus 2: From Gene Structure to Pathogenic Mechanisms and Potential Therapy.
32719757 2020. SARS-COV-2 Infection and Kawasaki Disease: Case Report of a Hitherto Unrecognized Association.
32765270 2020. The Folate Concentration and/or Folic Acid Metabolites in Plasma as Factor for COVID-19 Infection.
32754041 2020. Pathological Aspects of COVID-19 as a Conformational Disease and the Use of Pharmacological Chaperones as a Potential Therapeutic Strategy.
32754056 2020. SARS-CoV-2 Molecular Network Structure.
32754569 2020. Clinical Characteristics and Eosinophils in Young SARS-CoV-2-Positive Chinese Travelers Returning to Shanghai.
32769230 2020. Epidemiological and Clinical Profile of Pediatric Inflammatory Multisystem Syndrome - Temporally Associated with SARS-CoV-2 (PIMS-TS) in Indian Children.
32746940 2020. Abnormal immunity of non-survivors with COVID-19: predictors for mortality.
32765013 2020. Molecular Basis for Pathogenicity of Human Coronaviruses.
32771700 2020. Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection.
32767095 2020. Coronavirus (Covid-19) sepsis: revisiting mitochondrial dysfunction in pathogenesis, aging, inflammation, and mortality.
32760213 2020. Bioinformatic Analysis of Correlation between Immune Infiltration and COVID-19 in Cancer Patients.
32771640 2020. Increased Complement Receptor-3 levels in monocytes and granulocytes distinguish COVID-19 patients with pneumonia from those with mild symptoms.
32768699 2020. What can we learn from a COVID-19 lung biopsy?
32763446 2020. Patterns of viral clearance in the natural course of asymptomatic COVID-19: Comparison with symptomatic non-severe COVID-19.
32767018 2020. Complete post-mortem data in a fatal case of COVID-19: clinical, radiological and pathological correlations.
32767455 2020. Pediatric multisystem inflammatory syndrome temporally associated with SARS-COV-2: Oral manifestations and implications.
32779341 2020. Understanding immunopathological fallout of human coronavirus infections including COVID-19: Will they cross the path of rheumatologists?
32770345 2020. Apoptosis and pericyte loss in alveolar capillaries in COVID-19 infection: choice of markers matters.
32756323 2020. Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic.
32759312 2020. Immunoinformatic approach to assess SARS-CoV-2 protein S epitopes recognised by the most frequent MHC-I alleles in the Brazilian population.
32763812 2020. The D614G substitution in the S gene and clinical information for patients with COVID-19 detected in Hong Kong.
32777762 2020. Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19.
32779780 2020. Atomistic simulation reveals structural mechanisms underlying D614G spike glycoprotein-enhanced fitness in SARS-COV-2.
32678431 2020. Neutrophils and COVID-19: Nots, NETs, and knots.
32779742 2020. A child with a severe multisystem inflammatory syndrome following an asymptomatic COVID-19 infection: A novel management for a new disease?
32761905 2020. Comment on Hu et al: The cytokine storm and COVID-19.
32779784 2020. Mutational spectra of SARS-CoV-2 orf1ab polyprotein and signature mutations in the United States of America.
32776556 2020. Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical ill COVID-19 Patients.
32762140 2020. Circulating endothelial progenitors are increased in COVID-19 patients and correlate with SARS-CoV-2 RNA in severe cases.
32756980 2020. Incomplete Kawasaki Disease as Presentation of COVID-19 Infection in an Infant: A Case Report.
32733785 2020. Characterization of changes in global gene expression in the hearts and kidneys of transgenic mice overexpressing human angiotensin-converting enzyme 2.
32768580 2020. Structural analysis of ACE2 variant N720D demonstrates a higher binding affinity to TMPRSS2.
32724296 2020. Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment.
32755094 2020. Coronavirus disease 2019 (COVID-19) in critically ill patients: can we re-program the immune system? A primer for intensivists.
32778817 2020. A paradox of social distancing for SARS-CoV-2: loneliness and heightened immunological risk.
32764693 2020. Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells.
32764665 2020. Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm.
32780218 2020. A human circulating immune cell landscape in aging and COVID-19.
32743565 2020. Severe SARS-CoV-2 infection in humans is defined by a shift in the serum lipidome resulting in dysregulation of eicosanoid immune mediators.
32611651 2020. Is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic.
32680882 2020. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2.
32669297 2020. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.
32661058 2020. Structural basis of a shared antibody response to SARS-CoV-2.
32771430 2020. Analysis of codon usage of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) and its adaptability in dog.
32722574 2020. In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection.
32732269 2020. COVID-19 and Involvement of the Corpus Callosum: Potential Effect of the Cytokine Storm?
32755212 2020. Imaging Findings in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19
32755507 2020. Rewiring the Immune Response in COVID-19.
32778542 2020. High oligoclonality of immunoglobulins in SARS-CoV2 positive patients.
32720486 2020. A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications.
32779445 2020. Profiling of Initial Available SARS-CoV-2 Sequences from Iranian Related COVID-19 Patients.
32772742 2020. Non-chemical signatures of biological materials: Radio signals from Covid19?
32750889 2020. AGTR2, one possible novel key gene for the entry of SARS-CoV-2 into human cells.
32773417 2020. Quasispecies analysis of the SARS-CoV-2 from representative clinical samples: A preliminary analysis.
32753027 2020. Role of key point Mutations in Receptor Binding Domain of SARS-CoV-2 Spike Glycoprotein.
32776691 2020. The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID-19.
32744052 2020. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
32773643 2020. Genomic variance of Open Reading Frames (ORFs) and Spike protein in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
32723457 2020. Silent Hypoxia in COVID-19: What is Old is New Again!
32723446 2020. A Case of 45-Year Man Who Succumbed to Coronavirus Disease 2019 (COVID-19).
32769685 2020. Immunity, inflammation and the vasculature in the COVID-19 era.
32729633 2020. COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease?
32780968 2020. Four months into the COVID-19 pandemic, Sweden's prized herd immunity is nowhere in sight.
32631657 2020. Molecular chronicles of cytokine burst in patients with coronavirus disease 2019 (COVID-19) with cardiovascular diseases.
32778886 2020. Multi-System Inflammatory Syndrome in a Child Mimicking Kawasaki Disease.
32780125 2020. Regulatory T Cells Tested in Patients With COVID-19 ARDS.
32758881 2020. SARS-CoV-2 and the sympathetic immune response: Dampening inflammation with antihypertensive drugs (Clonidine and Propranolol).
32762609 2020. A Novel Hypothesis for Original Antigenic Sin in the Severe Disease of SARS-CoV-2 Infection.
32747830 2020. Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection.
32753755 2020. Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation.
32776761 2020. Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): providing resuscitative care.
32756685 2020. Intra- and intermolecular atomic-scale interactions in the receptor binding domain of SARS-CoV-2 spike protein: implication for ACE2 receptor binding.
32748124 2020. Endo-Lysosomal Cation Channels and Infectious Diseases.
32732280 2020. Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy.
32631885 2020. Rewilding immunology.
32694201 2020. Distinct conformational states of SARS-CoV-2 spike protein.
32675364 2020. Aging immunity may exacerbate COVID-19.
32675355 2020. The pandemic virus is slowly mutating. But does it matter?
32762171 2020. [Comparative analysis of structural characteristics and epitopes in S proteins between SARS-CoV-2 and SARS-CoV].
32762165 2020. [Replication and transmission mechanisms of highly pathogenic human coronavirus].

32765942 2020. Age-induced NLRP3 Inflammasome Over-activation Increases Lethality of SARS-CoV-2 Pneumonia in Elderly Patients.
32765940 2020. Decreased Naive T-cell Production Leading to Cytokine Storm as Cause of Increased COVID-19 Severity with Comorbidities.
32656827 2020. Letter: ACE2, Rho kinase inhibition and the potential role of vitamin D against COVID-19.
32750108 2020. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.
32763951 2020. A Comprehensive, Flexible Collection of SARS-CoV-2 Coding Regions.
32750378 2020. A review of the main histopathological findings in the Coronavirus Disease 2019 (COVID-19).
32681497 2020. COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy.
32713862 2020. RNAi suppressor: The hidden weapon of SARS-CoV.
32742475 2020. Expression of the SAR2-Cov-2 receptor ACE2 reveals the susceptibility of COVID-19 in non-small cell lung cancer.
32761894 2020. COVID-19 and immunological regulations - from basic and translational aspects to clinical implications.
32773261 2020. SARS-CoV 2 and the pathobiology of the respiratory control mechanisms in the brainstem.
32727811 2020. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
32736274 2020. Structural stability of the SARS-CoV-2 main protease: Can metal ions affect function?
32768467 2020. Longitudinal Echocardiographic Assessment of Coronary Arteries and Left Ventricular Function Following Multisystem Inflammatory Syndrome in Children (MIS-C).
32768466 2020. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2: A Systematic Review.
32746922 2020. A consideration of publication-derived immune-related associations in Coronavirus and related lung damaging diseases.
32759577 2020. Role of cytotoxic T lymphocytes and interferon-gamma in coronavirus infection: lessons from murine coronavirus infections in mice.
32778426 2020. Reacciones cruzadas entre factor reumatoide e IgM SARS-CoV-2.
32759016 2020. Estrogen shields women from COVID-19 complications by reducing ER stress.
32758906 2020. Are night shift workers at an increased risk for COVID-19?
32759006 2020. Low Incidence and Mortality from SARS-CoV-2 in Southern Europe. Proposal of a hypothesis for Arthropod borne Herd immunity.
32759008 2020. Fenofibrate increases the amount of sulfatide which seems beneficial against Covid-19.
32759007 2020. Prostaglandin D2 as a mediator of lymphopenia and a therapeutic target in COVID-19 disease.
32758903 2020. Mevalonate pathway, selenoproteins, redox balance, immune system, Covid-19: Reasoning about connections.
32758901 2020. Acute respiratory distress syndrome from Covid-19: A perfect storm from free radicals? Proposal for a new treatment.
32721809 2020. Kawasaki-like disease in children with COVID-19: A hypothesis.
32721808 2020. Prior infection with intestinal coronaviruses moderates symptom severity and mortality in patients with COVID-19: A hypothesis and preliminary evidence.
32769902 2020. Macrophage activation syndrome as an unusual presentation of paucisymptomatic severe acute respiratory syndrome coronavirus 2 infection: A case report.
32741970 2020. SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers.
32723797 2020. Comparative Genomic Analysis of Rapidly Evolving SARS-CoV-2 Reveals Mosaic Pattern of Phylogeographical Distribution.
32750256 2020. Expression of SARS-CoV-2 receptor ACE2 and the protease TMPRSS2 suggests susceptibility of the human embryo in the first trimester.
32742818 2020. RdRp mutations are associated with SARS-CoV-2 genome evolution.
32742815 2020. Understanding genomic diversity, pan-genome, and evolution of SARS-CoV-2.
32684101 2020. Dysfunction of adaptive immunity is related to severity of COVID-19: a retrospective study.
32769398 2020. Shedding Light on COVID-19: ADAM17 the Missing Link?
32759264 2020. Correspondence on: 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort' by Pouletty et al.
32759261 2020. Response to: 'Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort' by Pouletty et al' by Pino et al.
32633334 2020. The hemagglutinin-esterase gene in human coronaviruses SARS-CoV-2, HKU1 and OC43.
32746720 2020. Deciphering the protein motion of S1 subunit in SARS-CoV-2 spike glycoprotein through integrated computational methods.
32725137 2020. Role of the early secretory pathway in SARS-CoV-2 infection.

012

head
32669777 2020. Microthrombotic Complications of COVID-19 Are Likely Due to Embolism of Circulating Endothelial Derived Ultralarge von Willebrand Factor (eULVWF) Decorated-Platelet Strings.
32670298 2020. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.
32671009 2020. Vitamin D Deficiency and Air Pollution Exacerbate COVID-19 Through Suppression of Antiviral Peptide LL37.
C7255426 ?. Overcoming nonstructural protein 15-nidoviral uridylate-specific endoribonuclease (nsp15/NendoU) activity of SARS-CoV-2.
32658591 ?. The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer.
C7236793 ?. Prediction and analysis of key protein structures of 2019-nCoV.
C7341045 2020. Phylogenomic proximity and comparative proteomic analysis of SARS-CoV-2.
C7323676 ?. Coronavirus disease 2019 (COVID-19): cytokine storms hyper-inflammatory phenotypes and acute respiratory distress syndrome.
C7264919 ?. Amino acid variation analysis of surface spike glycoprotein at 614 in SARS-CoV-2 strains.
32668194 ?. Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease.
32659347 2020. Genome-wide analysis of Indian SARS-CoV-2 genomes for the identification of genetic mutation and SNP.
C7308782 2020. Identification and classification of differentially expressed genes reveal potential molecular signature associated with SARS-CoV-2 infection in lung adenocarcinomal cells.
32683296 2020. Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A systematic review.
32669955 2020. A comprehensive investigation of the mRNA and protein level of ACE2 the putative receptor of SARS-CoV-2 in human tissues and blood cells.
C7274027 ?. The potential for antibody-dependent enhancement of SARS-CoV-2 infection: Translational implications for vaccine development.
32659712 2020. First results of a national external quality assessment scheme for the detection of SARS-CoV-2 genome sequences.
32707511 2020. SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons.
32674001 2020. Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis a case series.
32661206 2020. Assessment of risk conferred by coding and regulatory variations of TMPRSS2 and CD26 in susceptibility to SARS-CoV-2 infection in human.
C7358169 ?. Lung ACE2 and ADAM17 in pulmonary arterial hypertension: Implications for COVID-19?
C7332243 ?. Activation of cytotoxic T cell population and inversion of CD4:CD8 ratio as manifestations of cellular immune response in SARS-COV-2 infection.
C7323226 ?. Cancer Prevales on Covid?19: To Maintain a High Quality Standard Concerning Diagnosis and Oncological Care Even During a Pandemic.
C7351386 ?. Implications of SARS-CoV-2 genetic diversity and mutations on pathogenicity of the COVID-19 and biomedical interventions.
C7311326 2020. Coronavirus disease 2019?related Kawasaki-like disease in an adult: A case report.
C7314447 ?. Dynamic Regulation of SARS-CoV-2 Binding and Cell Entry Mechanisms in Remodeled Human Ventricular Myocardium.
C7296312 ?. Children at risk: multisystem inflammatory syndrome and COVID-19.
C7316659 ?. Localization of Cell Receptor-Related Genes of SARS-CoV-2 in the Kidney through Single-Cell Transcriptome Analysis.
C7275990 ?. COVID-19?Related Glomerulopathy: A Report of 2 Cases of Collapsing Focal Segmental Glomerulosclerosis.
32659211 2020. An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19.
C7292579 2020. Genotyping SARS-CoV-2 through an interactive web application.
C7266609 2020. An integrated national scale SARS-CoV-2 genomic surveillance network.
C7351415 ?. Severe refractory Kawasaki disease in seven infants in the COVID-19 era.
C7259908 2020. Coronavirus is the trigger but the immune response is deadly.
C7234786 2020. Detection of IgM and IgG antibodies against SARS-CoV-2 in patients with autoimmune diseases.
32680625 2020. Glucose-6-Phosphate Dehydrogenase Deficiency and COVID-19 Infection.
C7256601 ?. In Reply?The ?Perfect Cytokine Storm? of COVID-19.
C7256539 2020. Sex Hormones and Novel Corona Virus Infectious Disease (COVID-19).
C7256537 ?. THE ?PERFECT CYTOKINE STORM? OF COVID-19.
32721799 2020. SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression.
32679425 2020. The hypothesis that SARS-CoV-2 affects male reproductive ability by regulating autophagy.
32679426 2020. The «moonlighting protein» able to explain the Th1 immune lockdown in severe COVID-19?.
32673940 2020. EMMPRIN/BASIGIN as a biological modulator of oral cancer and COVID-19 interaction: Novel propositions.
32679424 2020. Natural protection of ocular surface from viral infections ? A hypothesis.
32688183 2020. Corrigendum to ?COVID-19-related Complications and Decompression Illness Share Main Features. Could the SARS-CoV2-related complications rely on blood foaming?? [Med Hypothesis 144 (2020) 109918].
C7326438 2020. Cross-immunity between respiratory coronaviruses may limit COVID-19 fatalities.
C7322475 2020. COVID-19: NAD+ deficiency may predispose the aged obese and type2 diabetics to mortality through its effect on SIRT1 activity.
C7313490 2020. Understanding Covid and the associated post-infectious hyper-inflammatory state (PIMS-TS) in children.
C7313483 2020. Unique fibrinogen-binding motifs in the nucleocapsid phosphoprotein of SARS CoV-2: Potential implications in host-pathogen interactions.
32670517 2020. Kawasaki Disease as the Immune-Mediated Echo of a Viral Infection.
32670592 2020. Mild SARS-CoV-2 infections in children might be based on evolutionary biology and linked with host reactive oxidative stress and antioxidant capabilities.
C7334952 2020. Pathologic features of COVID-19: A concise review.
32703502 2020. Autopsy of patients with COVID-19: A balance of fear and curiosity.
C7346848 2020. Lessons learned from the mechanisms of posttraumatic inflammation extrapolated to the inflammatory response in COVID-19: a review.
C7328593 2020. Behavioral immune system linked to responses to the threat of COVID-19.
C7329651 ?. Severe cardiac dysfunction in a patient with multisystem inflammatory syndrome in children associated with COVID-19: Retrospective diagnosis of a puzzling presentation. A case report.
C7244417 ?. COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; a Western New York approach.
32713710 ?. Neuropsychiatric Symptoms in an Adolescent Boy With Multisystem Inflammatory Syndrome in Children.
C7335763 ?. Histopathologische Befunde bei therapierter und nichttherapierter SARS-CoV-2-Infektion ? Bericht über 3 Autopsien.
C7335629 ?. Der erste COVID-19-Hotspot in einer Hamburger Senioreneinrichtung: Präventionskonzept Letalität und Obduktionsbefunde.
C7247437 ?. Evidence for systematic autopsies in COVID-19 positive deceased: Case report of the first German investigated COVID-19 death.
C7311357 2020. Expression profiling meta-analysis of ACE2 and TMPRSS2 the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells and identification of putative modulators.
32702724 ?. Age-dependent assessment of genes involved in cellular senescence telomere and mitochondrial pathways in human lung tissue of smokers COPD and IPF: Associations with SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 axis .
32702726 ?. SARS-CoV2 drives JAK1/2-dependent local and systemic complement hyper-activation .
32702716 ?. Can Hyperperfusion of Nonaerated Lung Explain COVID-19 Hypoxia? .
32702718 ?. E-cigarette-Induced Pulmonary Inflammation and Dysregulated Repair are Mediated by nAChR ?7 Receptor: Role of nAChR ?7 in ACE2 Covid-19 receptor regulation.
32702714 ?. Interactome of SARS-CoV-2 / nCoV19 modulated host proteins with computationally predicted PPIs.
32702737 ?. B cell clonal expansion and convergent antibody responses to SARS-CoV-2.
32702728 ?. A potential role for AHR in SARS-CoV-2 pathology.
C7347481 2020. Hemophagocytic syndrome and COVID-19.
C7328624 2020. Sars-CoV-2 et Kawasaki rapprochement ? risque.
C7297549 ?. Kawasaki Disease and Invasive Pneumococcal Infection.
32680648 ?. Using Serology with Models to Clarify the Trajectory of the SARS-CoV-2 Emerging Outbreak. head
C7340772 ?. Prototype of a Smart Microfluidic Platform for the Evaluation of SARS-Cov-2 Pathogenesis Along with Estimation of the Effectiveness of Potential Drug Candidates and Antigen?Antibody Interactions in Convalescent Plasma Therapy.
C7358563 2020. Unleashing the mysterious link between COVID-19 and a famous childhood vasculitis: Kawasaki disease.
C7320653 ?. Fractal signature of coronaviruses related to severe acute respiratory syndrome.
C7318729 2020. Gemeinschaftlich in Krisenzeiten: NMR-Strukturbiologie gegen COVID-19.
C7297671 2020. Covid-19: An urgent need for a psychoneuroendocrine perspective.
C7344205 2020. Crystal Structure of the Main Protease of Human Coronavirus NL63.
C7225694 2020. COVID-19 y estudios microbiológicos post mortem.
C7211634 2020. Autopsias en casos sospechosos de SARS-CoV-2.
C7211618 2020. Gestión de los cadáveres durante la pandemia por COVID-19 en España.
C7334659 2020. Devilishly radical NETwork in COVID-19: Oxidative stress neutrophil extracellular traps (NETs) and T cell suppression.
C7292949 2020. NK cells: A double edge sword against SARS-CoV-2.
C7315969 ?. COVID-19 and preeclampsia with severe features at 34-weeks gestation.
32668317 ?. COVID-19?Related Collapsing Glomerulopathy in a Kidney Transplant Recipient.
32659225 ?. The role of a cytokine storm in severe COVID-19 disease in pregnancy.
32659620 2020. Cytologic and molecular correlates of SARS-CoV-2 infection of the nasopharynx.
C7314264 ?. Human neutralizing antibodies to SARS-CoV-2: views and perspectives from Professor Linqi Zhang at Tsinghua University.
32718664 ?. Afectación endotelial por COVID-19 en criobiopsia pulmonar.
32682575 ?. Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review.
C7323440 ?. Children s (and autoimmune patients) morbidity (and mortality) from Covid?19 is similar to the general population: immunologic rationale.
C7305885 2020. SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine.
32703419 2020. Proteasome activator PA28?-dependent degradation of coronavirus disease (COVID-19) nucleocapsid protein.
C7356136 2020. Transcription Factor Nrf2 as a Potential Therapeutic Target for Prevention of Cytokine Storm in COVID-19 Patients.
32601146 2020. Special dermatological presentation of paediatric multisystem inflammatory syndrome related to COVID-19: erythema multiforme.
32665075 ?. Oral ulceration as presenting feature of paediatric inflammatory multisystem syndrome associated with COVID-19.
C7308744 2020. Antipsychotic-induced immune dysfunction: A consideration for COVID-19 risk.
32673567 ?. Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.
32697970 ?. Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear.
32697968 ?. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.
C7091918 ?. COVID-19 infection: the perspectives on immune responses.
32735849 ?. Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2.
32668215 2020. Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection.
C7276302 2020. Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients.
32673562 2020. RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus.
32673668 2020. Insights into pediatric multi-system inflammatory syndrome and COVID-19.
32673711 2020. mTORC inhibitor Sirolimus deprograms monocytes in ?cytokine storm? in SARS-CoV2 secondary hemophagocytic lymphohistiocytosis- like syndrome.
32659373 2020. Long-term infection of SARS-CoV-2 changed the body s immune status.
C7245680 ?. Hyperinflammation with COVID-19: The key to patient deterioration????.
C7354860 2020. Citrullinated histone H3 a marker of extracellular trap formation is increased in blood of stable asthma patients.
32696004 2020. Consideration of Severe Coronavirus Disease 2019 As Viral Sepsis and Potential Use of Immune Checkpoint Inhibitors.
32711241 2020. Coronavirus infection and immune system: An insight of COVID-19 in cancer patients.
C7287426 ?. On the evolutionary epidemiology of SARS-CoV-2.
C7328575 ?. A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization.
C7354376 ?. Monitoring antibody response following SARS-CoV-2 infection: Diagnostic efficiency of four automated immunoassays.
32711184 2020. The importance of cycle threshold values in interpreting molecular tests for SARS-CoV-2.
C7335417 ?. Assessment of samples pooling for SARS-CoV-2 molecular testing for screening of asymptomatic persons in Tunisia.
32673978 2020. How many are we missing with ID NOW COVID-19 assay using direct nasopharyngeal swabs? Findings from a mid-sized academic hospital clinical microbiology laboratory.
32731192 2020. COVID-19: Understanding the science of antibody testing and lessons from the HIV epidemic.
C7316051 2020. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series.
C7305505 2020. Tocilizumab for treatment of patients with severe COVID?19: A retrospective cohort study.
C7245291 ?. EL CUIDADO HUMANIZADO EN LA MUERTE POR COVID-19: A PROPÓSITO DE UN CASO.
C7357538 ?. Particulate matter (PM10) enhances RNA virus infection through modulation of innate immune responses?.
C7358302 ?. A Study on Herd Immunity of COVID-19 in South Korea: Using a Stochastic Economic-Epidemiological Model.
32665942 2020. Rapid Radiological Worsening and Cytokine Storm Syndrome in COVID-19 Pneumonia.
C7267447 2020. An address to the European immunology community concerning the Coronavirus pandemic.
C7318732 2020. Can India develop herd immunity against COVID-19?
C7262083 ?. SARS?CoV?2 an evolutionary perspective of interaction with human ACE2 reveals undiscovered amino acids necessary for complex stability.
C7337683 ?. Lions Tigers and Kittens too: ACE2 and susceptibility to CoVID-19.
C7337764 ?. COVID-19 and Evolutionary Medicine.
C7324322 2020. Endometrial susceptibility to SARS CoV-2: explained by gene expression across the menstrual cycle?

32656452 2020. Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor.
32631771 2020. COVID-19 associated Kawasaki-like multisystem inflammatory disease in an adult.
32598981 2020. Infections and Collapsing Glomerulopathy.
32564928 2020. Host immune responses to influenza infection and vaccines: Lessons learned for all viral pandemic challenges.
32653819 2020. The autopsy at the time of SARS-CoV-2: Protocol and lessons.
32571869 2020. Kawasaki disease or Kawasaki syndrome?
32489438 2020. Spectrum of histopathological findings in coronavirus disease-19, Middle East respiratory syndrome and severe acute respiratory syndrome.
32565134 2020. The influence of interferon-lambda on restricting Middle East Respiratory Syndrome Coronavirus replication in the respiratory epithelium.
32533513 2020. Cytosolic DNA sensing through cGAS and STING is inactivated by gene mutations in pangolins.
32405132 2020. Targeting the Linear Ubiquitin Assembly Complex to Modulate the Host Response and Improve Influenza A Virus Induced Lung Injury.
32653765 2020. Immunosenescence exacerbates the COVID-19.
32611485 2020. Molecular Alterations Prompted by SARS-CoV-2 Infection: Induction of Hyaluronan, Glycosaminoglycan and Mucopolysaccharide Metabolism.
32651741 2020. Gene expression pattern differences in primary human pulmonary epithelial cells infected with MERS-CoV or SARS-CoV-2.
32559654 2020. Hypoxia induced up-regulation of tissue factor is mediated through extracellular RNA activated Toll-like receptor 3-activated protein 1 signalling.
32646445 2020. Isolation and characterization of WUPyV in polarized human airway epithelial cells.
32618551 2020. Covid-19 and Kawasaki syndrome.
32645325 2020. The Global Phosphorylation Landscape of SARS-CoV-2 Infection.
32645326 2020. Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies.
32649876 2020. Human Virus Transcriptional Regulators.
32623480 2020. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.
32623546 2020. Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus.
32632255 2020. Pulmonary alveolar regeneration in adult COVID-19 patients.
32612199 2020. Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients.
32622823 2020. Systemic Capillary Leak Syndrome Secondary to Coronavirus Disease 2019.
32622819 2020. Two Immunocompromised Patients With Diffuse Alveolar Hemorrhage as a Complication of Severe Coronavirus Disease 2019.
32118646 2020. Voice from China: nomenclature of the novel coronavirus and related diseases.
32118645 2020. Single-cell RNA sequencing data suggest a role for angiotensin-converting enzyme 2 in kidney impairment in patients infected with 2019-novel coronavirus.
32653658 2020. Disappearance of antibodies to SARS-CoV-2 in a Covid-19 patient after recovery.
32533338 2020. A 9-year-old girl with Kawasaki disease and pulmonary nodules.
32418043 2020. Experience with Cidofovir as an adjunctive therapy in a patient of adenovirus-induced macrophage activation syndrome in systemic arthritis.
32513224 2020. Serum and fecal profiles of aromatic microbial metabolites reflect gut microbiota disruption in critically ill patients: a prospective observational pilot study.
32541570 2020. Bronchiolitis and Potential Pathophysiological Implications in Coronavirus Disease 2019 ARDS Patients With Near-Normal Respiratory Compliance.
32642354 2020. Do COVID-19 and SARS Gene Complexities and Variations Help Overcome the Knowledge Gap?
32428465 2020. Pandemics and the great evolutionary mismatch.
32563779 2020. Protective and pathogenic roles for mast cells during viral infections.
32484440 2020. Shear stress activates ADAM10 sheddase to regulate Notch1 via the Piezo1 force sensor in endothelial cells.
32617121 2020. Myocardial and Microvascular Injury Due to Coronavirus Disease 2019.
24935083 2015. Clinical features, genetics, and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in Korea: report of a nationwide survey from Korea Histiocytosis Working Party.
23452147 2013. Autoprocessing mechanism of severe acute respiratory syndrome coronavirus 3C-like protease (SARS-CoV 3CLpro) from its polyproteins.
32641214 2020. SARS-CoV-2 infection risk assessment in the endometrium: viral infection-related gene expression across the menstrual cycle.
32637365 2020. Participation of the IL-10RB Related Cytokines, IL-22 and IFN-lambda in Defense of the Airway Mucosal Barrier.
32655580 2020. Human Sialome and Coronavirus Disease-2019 (COVID-19) Pandemic: An Understated Correlation?
32655579 2020. Intoxication With Endogenous Angiotensin II: A COVID-19 Hypothesis.
32612617 2020. The COVID-19 Cytokine Storm; What We Know So Far.
32582219 2020. IL-22 Plays a Critical Role in Maintaining Epithelial Integrity During Pulmonary Infection.
32574256 2020. Pangolins Lack IFIH1/MDA5, a Cytoplasmic RNA Sensor That Initiates Innate Immune Defense Upon Coronavirus Infection.
32626680 2020. Leucocyte Subsets Effectively Predict the Clinical Outcome of Patients With COVID-19 Pneumonia: A Retrospective Case-Control Study.
32392463 2020. Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection.
32294404 2020. Something Else to Stress about: Perinatal Stress Attenuates CD8(+) T Cell Activity in Adults.
32500198 2020. Corona deaths in Hamburg, Germany.
32626922 2020. A dissection of SARSCoV2 with clinical implications (Review).
32466119 2020. Lipid-Protein and Protein-Protein Interactions in the Pulmonary Surfactant System and Their Role in Lung Homeostasis.
32365944 2020. SARS Unique Domain (SUD) of Severe Acute Respiratory Syndrome Coronavirus Induces NLRP3 Inflammasome-Dependent CXCL10-Mediated Pulmonary Inflammation.
32340172 2020. Glycyrrhizin Inhibits PEDV Infection and Proinflammatory Cytokine Secretion via the HMGB1/TLR4-MAPK p38 Pathway.
32488343 2020. Coronavirus disease 2019 as a particular sepsis: a 2-week follow-up of standard immunological parameters in critically ill patients.
32385629 2020. From the quarantine diary of an emergency physician: the coronavirus and the dysautonomic storm.
17340620 2007. Angiotensin converting enzyme 2 is primarily epithelial and is developmentally regulated in the mouse lung.
28063205 2017. Pathogenetic determinants in Kawasaki disease: the haematological point of view.
30146782 2019. Modulation of the immune response by Middle East respiratory syndrome coronavirus.
32648027 2020. Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.
32623351 2020. Identification of multiple large deletions in ORF7a resulting in in-frame gene fusions in clinical SARS-CoV-2 isolates.
16752365 2006. Coronavirus phylogeny based on 2D graphical representation of DNA sequence.
32006540 2020. Genetic diversity and potential recombination between ferret coronaviruses from European and American lineages.
32142930 2020. Insights into the cross-species evolution of 2019 novel coronavirus.
26287378 2016. Viral etiology, clinical and laboratory features of adult hemophagocytic lymphohistiocytosis.
24760654 2014. Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease.
32585239 2020. Multisystem Inflammatory Syndrome in Children and Kawasaki Disease: Two Different Illnesses with Overlapping Clinical Features.
32441751 2020. Pediatric Coronavirus Disease-2019-Associated Multisystem Inflammatory Syndrome.
32582339 2020. Variation of 2019 novel coronavirus complete genomes recorded in the 1(st) month of outbreak: Implication for mutation.
32188728 2020. Structure-Guided Mutagenesis Alters Deubiquitinating Activity and Attenuates Pathogenesis of a Murine Coronavirus.
26269185 2015. Severe Acute Respiratory Syndrome (SARS) Coronavirus ORF8 Protein Is Acquired from SARS-Related Coronavirus from Greater Horseshoe Bats through Recombination.
24478444 2014. Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity.
16940539 2006. Modulation of the unfolded protein response by the severe acute respiratory syndrome coronavirus spike protein.
32432657 2020. Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults.
32437764 2020. Visualization of putative coronavirus in kidney.
32505464 2020. Am I a coronavirus?
32653518 2020. Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges.
32498008 2020. Is the gingival sulcus a potential niche for SARS-Corona virus-2?
32652428 2020. Coronavirus disease 2019 (COVID 19) and Malaria: Have anti glycoprotein antibodies a role?
32634734 2020. Hypoxemia in COVID-19 patients: An hypothesis.
32653475 2020. Does the hygiene hypothesis apply to COVID-19 susceptibility?
32656314 2020. COVID-19-A theory of autoimmunity to ACE-2.
25077179 2014. Kawasaki disease patients homozygous for the rs12252-C variant of interferon-induced transmembrane protein-3 are significantly more likely to develop coronary artery lesions.
32598829 2020. Childhood Multisystem Inflammatory Syndrome - A New Challenge in the Pandemic.
32461612 2020. Vulnerabilities in coronavirus glycan shields despite extensive glycosylation.
32555182 2020. Cryo-EM structures of HKU2 and SADS-CoV spike glycoproteins provide insights into coronavirus evolution.
32651568 2020. T cell renaissance in COVID-19.
32591759 2020. Caught by NETs.
32591758 2020. Transient IgA, steady IgG?
32533112 2020. Neutralizing antibodies in convalescent patients.
32533130 2020. Epigenetic and epitranscriptomic regulation of viral replication.
32561857 2020. Coronavirus replication factories.
32287794 2020. Wuhan-like virus discovered seven years ago.
31863580 2020. A nucleobase-binding pocket in a viral RNA-dependent RNA polymerase contributes to elongation complex stability.
30070073 2018. Is an infectious trigger always required for primary hemophagocytic lymphohistiocytosis? Lessons from in utero and neonatal disease.
28950425 2018. Pulmonary presentation of Kawasaki disease-A diagnostic challenge.
22022266 2011. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex.
32620366 2020. COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor.
32611518 2020. COVID-19: Role of neutrophil extracellular traps in acute lung injury.
32650970 2020. Autopsy findings from the first known death from Severe Acute Respiratory Syndrome SARS-CoV-2 in Spain.
32650969 2020. The first COVID-19 autopsy in Spain performed during the early stages of the pandemic.
32434680 2020. AID in Antibody Diversification: There and Back Again.
32651761 2020. Infectivity, virulence, pathogenicity, host-pathogen interactions of SARS and SARS-CoV-2 in experimental animals: a systematic review.
28738245 2017. Two-amino acids change in the nsp4 of SARS coronavirus abolishes viral replication.
18045721 2008. SARS coronavirus accessory proteins.
32456011 2020. The Role of Extracellular Vesicles as Allies of HIV, HCV and SARS Viruses.
32331321 2020. Broadly Neutralizing Bovine Antibodies: Highly Effective New Tools against Evasive Pathogens?

32656452 2020. Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor.
32712145 2020. Multisystem inflammatory syndrome with particular cutaneous lesions related to COVID 19 in a young adult.
32659225 2020. The role of a cytokine storm in severe COVID-19 disease in pregnancy.
32701539 2020. HLA-DR Deficiency and Immunosuppression-Related End-Organ Failure in SARS-CoV2 Infection.
32659620 2020. Cytologic and molecular correlates of SARS-CoV-2 infection of the nasopharynx.
32653819 2020. The autopsy at the time of SARS-CoV-2: Protocol and lessons.
32676824 2020. Respiratory mechanics and gas exchanges in the early course of COVID-19 ARDS: a hypothesis-generating study.
32708525 2020. From Anti-SARS-CoV-2 Immune Responses to COVID-19 via Molecular Mimicry.
32669265 2020. Discovery of M Protease inhibitors encoded by SARS-CoV-2.
32708430 2020. Genetic Polymorphisms Complicate COVID-19 Therapy: Pivotal Role of HO-1 in Cytokine Storm.
32653765 2020. Immunosenescence exacerbates the COVID-19.
32651741 2020. Gene expression pattern differences in primary human pulmonary epithelial cells infected with MERS-CoV or SARS-CoV-2.
32717432 2020. Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee.
32685484 2020. Identification of COVID-19 Infection-Related Human Genes Based on a Random Walk Model in a Virus-Human Protein Interaction Network.
32664932 2020. Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?
32664879 2020. New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis.
32665075 2020. Oral ulceration as presenting feature of paediatric inflammatory multisystem syndrome associated with COVID-19.
32708264 2020. Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19.
32645325 2020. The Global Phosphorylation Landscape of SARS-CoV-2 Infection.
32697970 2020. Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear.
32697968 2020. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.
32673567 2020. Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.
32690996 2020. COVID-19 infection: mitohormetic concept of immune response.
32697943 2020. Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1alpha/Glycolysis-Dependent Axis.
32612152 2020. Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19.
32623480 2020. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.
32712910 2020. Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses.
32623546 2020. Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus.
32668215 2020. Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection.
32632255 2020. Pulmonary alveolar regeneration in adult COVID-19 patients.
32612199 2020. Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients.
32673562 2020. RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus.
32619549 2020. Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection.
32660065 2020. COVID-19, Renin-Angiotensin System and Endothelial Dysfunction.
32635598 2020. Canonical and Noncanonical Autophagy as Potential Targets for COVID-19.
32707842 2020. Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73(-) Phenotype Identifies Polyfunctional Cytotoxic Lymphocytes.
32622823 2020. Systemic Capillary Leak Syndrome Secondary to Coronavirus Disease 2019.
32707182 2020. Novel Temperature Trajectory Subphenotypes in COVID-19.
32622819 2020. Two Immunocompromised Patients With Diffuse Alveolar Hemorrhage as a Complication of Severe Coronavirus Disease 2019.
32630212 2020. Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management.
32700055 2020. The extended autonomic system, dyshomeostasis, and COVID-19.
32671502 2020. Is 'happy hypoxia' in COVID-19 a disorder of autonomic interoception? A hypothesis.
32661775 2020. Testing cardiovascular autonomic function in the COVID-19 era: lessons from Bologna's Autonomic Unit.
32673668 2020. Insights into pediatric multi-system inflammatory syndrome and COVID-19.
32683814 2020. Can we get a clue for the etiology of Kawasaki disease in the COVID-19 pandemic?
32664709 2020. Immunopathogenesis of COVID-19 and early immunomodulators.
32712394 2020. Letter to the Editor: Lessons from COVID-19, ACE2 and intestinal inflammation - could a virus trigger chronic intestinal inflammation?
32659373 2020. Long-term infection of SARS-CoV-2 changed the body's immune status.
32653662 2020. Viral shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2.
32653658 2020. Disappearance of antibodies to SARS-CoV-2 in a Covid-19 patient after recovery.
32717416 2020. Evolution of viral quasispecies during SARS-CoV-2 infection.
32711057 2020. Viable SARS-CoV-2 in various specimens from COVID-19 patients.
32688067 2020. Body temperature and host species preferences of SARS-CoV-2.
32658736 2020. Bioinformatics studies on a function of the SARS-CoV-2 spike glycoprotein as the binding of host sialic acid glycans.
32709253 2020. Response to "Body temperature correlates with mortality in COVID-19 patients".
32698857 2020. Could the severity of COVID-19 be increased by low gastric acidity?
32690058 2020. Detection of IgG antibody during the follow-up in patients with COVID-19 infection.
32711241 2020. Coronavirus infection and immune system: An insight of COVID-19 in cancer patients.
32685628 2020. Haematological and immunological data of Chinese children infected with coronavirus disease 2019.
32707212 2020. Lymphocyte subsets with the lowest decline at baselineand the slow lowest rise during recovery in COVID-19 critical illnesspatients with diabetes mellitus.
32665025 2020. The spectrum of pathological findings in coronavirus disease (COVID-19) and the pathogenesis of SARS-CoV-2.
32699547 2020. Kawasaki disease in siblings and a review of drug treatment.
32711256 2020. Spatial and temporal dynamics of SARS-CoV-2 in COVID-19 patients: A systematic review and meta-analysis.
32711254 2020. Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity.
32707445 2020. Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections.
32717182 2020. Lessons for COVID-19 Immunity from Other Coronavirus Infections.
32712315 2020. Decoding the proteome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for cell-penetrating peptides involved in pathogenesis or applicable as drug delivery vectors.
32707288 2020. Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19.
32668462 2020. COVID-19: An Immunopathologic Assault.
32709193 2020. Lung Injury in COVID-19-An Emerging Hypothesis.
32673476 2020. Anosmia in COVID-19: A Bumpy Road to Establishing a Cellular Mechanism.
32672403 2020. microRNAs as new possible actors in gender disparities of Covid-19 pandemic.
32662161 2020. Covid-19, ACE2, and the kidney.
32681166 2020. SARS-CoV-2 Infection-Associated Hemophagocytic Lymphohistiocytosis.
32666092 2020. SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity.
32662111 2020. COVID-19 and Treg/Th17 imbalance: Potential relationship to pregnancy outcomes.
32706609 2020. Inducible Epithelial Resistance Against Coronavirus Pneumonia in Mice.
32663409 2020. Single-cell RNA Expression Profiling of ACE2, The Receptor of SARS-CoV-2.
32662396 2020. Temporal Change of SARS-CoV-2 in Clinical Specimens of COVID-19 Pneumonia Patients.
32705809 2020. American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyperinflammation in COVID-19. Version 1.
32716641 2020. Coronavirus Optimization Algorithm: A Bioinspired Metaheuristic Based on the COVID-19 Propagation Model.
32686774 2020. Multiple sclerosis and COVID-19.
32654296 2020. A Tale of (Glycogen Synthase Kinase) Three: Lithium, The Kidney and Coronavirus Disease 19.
32679621 2020. Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients.
32678953 2020. Clinical characteristics, management and outcome of Covid-19-associated immune thrombocytopenia. A French multicenter series.
32678950 2020. Single-cell oxygen saturation imaging shows that gas exchange by red blood cells is not impaired in COVID-19 patients.
32663362 2020. ACE2, the Receptor that Enables the Infection by SARS-CoV-2: Biochemistry, Structure, Allostery and Evaluation of the Potential Development of ACE2 Modulators.
32654514 2020. Cardiac Arrest Risk During Acute Infections: Systemic Inflammation Directly Prolongs QTc Interval via Cytokine-mediated Effects on Potassium Channel Expression.
32689809 2020. Unexpected Features of Cardiac Pathology in COVID-19 Infection.
32706417 2020. Characteristics and roles of SARS-CoV-2 specific antibodies in patients with different severities of COVID-19.
32717055 2020. Diagnosing SARS-CoV-2 Related Multisystem Inflammatory Syndrome in Children (MIS-C): Focus on the Gastrointestinal Tract and the Myocardium.
32710613 2020. Multi-Inflammatory Syndrome in Children related to SARS-CoV-2 in Spain.
32672790 2020. Excess soluble fms-like tyrosine kinase 1 correlates with endothelial dysfunction and organ failure in critically ill COVID-19 patients.
32667973 2020. SARS-CoV-2 infects and damages the mature and immature olfactory sensory neurons of hamsters.
32663256 2020. Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity.
32694169 2020. Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?
32713339 2020. Viral Evolution will Automatically Resolve COVID-19 Pandemic.
32660402 2020. NPC1 as a Modulator of Disease Severity and Viral Entry of Sars-CoV-2.
32657802 2020. Severe acute respiratory syndrome coronavirus 2, original antigenic sin, and antibody-dependent enhancement: menage a trois.
32675718 2020. Reflections on rheumatological aspects of COVID-19.
32654350 2020. Decrease of non-classical and intermediate monocyte subsets in severe acute SARS-CoV-2 infection.
32662099 2020. Therapeutic dilemma in the repression of severe acute respiratory syndrome coronavirus-2 proteome.
32657473 2020. TWIRLS, a knowledge-mining technology, suggests a possible mechanism for the pathological changes in the human host after coronavirus infection via ACE2.
32652001 2020. Endocrine significance of SARS-CoV-2's reliance on ACE2.
32686577 2020. Epigenetic mechanisms regulating COVID-19 infection.
32710612 2020. Endomyocardial biopsy findings in Kawasaki-like disease associated with SARS-CoV-2.
32643968 2020. Does SARS-CoV-2 infection cause sperm DNA fragmentation? Possible link with oxidative stress.
32706090 2020. CXCL10 an important chemokine associated with cytokine storm in COVID-19 infected patients.
32692465 2020. COVID-19, Cilia, and Smell.
32692408 2020. Third Trimester Placentas of SARS-CoV-2-Positive Women: Histomorphology, including Viral Immunohistochemistry and in Situ Hybridization.
32678695 2020. Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development.
32689852 2020. Immune Responses to the Novel Coronavirus-2: Friend or Foe?

32662421 2020. Does the human placenta express the canonical cell entry mediators for SARS-CoV-2?
32665942 2020. Rapid Radiological Worsening and Cytokine Storm Syndrome in COVID-19 Pneumonia.
32675207 2020. Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects.
32675206 2020. Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue.
32703822 2020. Abnormal carbon monoxide diffusion capacity in COVID-19 patients at time of hospital discharge.
32714336 2020. Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19.
32676080 2020. "Small" Intestinal Immunopathology Plays a "Big" Role in Lethal Cytokine Release Syndrome, and Its Modulation by Interferon-gamma, IL-17A, and a Janus Kinase Inhibitor.
32670298 2020. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.
32695025 2020. Regulatory Cross Talk Between SARS-CoV-2 Receptor Binding and Replication Machinery in the Human Host.
32676039 2020. COVID-19 Sepsis and Microcirculation Dysfunction.
32658591 2020. The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer.
32682765 2020. Lipotoxicity and cytokine storm in severe acute pancreatitis and COVID-19.
32668194 2020. Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease.
32659267 2020. Intermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: Crosstalk among calorie restriction, autophagy and immune response.
32683337 2020. Pediatric Inflammatory Multisystem Syndrome Temporally Associated With COVID-19.
32683336 2020. Hyperinflammatory Syndrome in Children Associated with COVID-19: Need for Awareness.
32659347 2020. Genome-wide analysis of Indian SARS-CoV-2 genomes for the identification of genetic mutation and SNP.
32708334 2020. Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes.
32668803 2020. COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks.
32664543 2020. Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation.
32681297 2020. Pulmonary immune responses against SARS-CoV-2 infection: harmful or not?
32666177 2020. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based antihypertensive therapies-reply.
32695405 2020. COVID-19 and cryo-EM.
32675285 2020. Intracellular autoactivation of TMPRSS11A, an airway epithelial transmembrane serine protease.
32701511 2020. Distinct clinical and immunological features of SARS-COV-2-induced multisystem inflammatory syndrome in children.
32708872 2020. Neutralizing Antibody Production in Asymptomatic and Mild COVID-19 Patients, in Comparison with Pneumonic COVID-19 Patients.
32674356 2020. Kurarinone Inhibits HCoV-OC43 Infection by Impairing the Virus-Induced Autophagic Flux in MRC-5 Human Lung Cells.
32690544 2020. Genetic variations in the human severe acute respiratory syndrome coronavirus receptor ACE2 and serine protease TMPRSS2.
32707511 2020. SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons.
32674001 2020. Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis, a case series.
32652214 2020. Factors affecting stability and infectivity of SARS-CoV-2.
32699345 2020. SARS-CoV-2 genomic variations associated with mortality rate of COVID-19.
32675312 2020. ACE2 and TMPRSS2 expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19.
32652168 2020. Oscillation of SARS CoV-2 RNA load in a cohort of children and adolescents with neuro-psychiatric disorders resident in a nursing home of Lombardy Region (Italy).
32718895 2020. Immune response in COVID-19: A review.
32707537 2020. Hazards of the cytokine storm and cytokine-targeted therapy in COVID-19 patients: A Review.
32627759 2020. An Overview of the Genetic Variations of the SARS-CoV-2 Genomes Isolated in Southeast Asian Countries.
32710986 2020. Mutations Strengthened SARS-CoV-2 Infectivity.
32717229 2020. Epidemiological trends in Kawasaki disease during COVID-19 in Singapore.
32661139 2020. Broad and differential animal ACE2 receptor usage by SARS-CoV-2.
32706339 2020. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis.
32687484 2020. Severe immunosuppression and not a cytokine storm characterize COVID-19 infections.
32659211 2020. An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19.
32682491 2020. Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series.
32653054 2020. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study.
32653518 2020. Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges.
32693241 2020. Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation.
32687918 2020. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.
32703818 2020. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells.
32694143 2020. Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2.
32679426 2020. The <> able to explain the Th1 immune lockdown in severe COVID-19.
32679424 2020. Natural protection of ocular surface from viral infections - A hypothesis.
32673940 2020. EMMPRIN/BASIGIN as a biological modulator of oral cancer and COVID-19 interaction: Novel propositions.
32683222 2020. The immunomodulatory effects of exercise against COVID-19.
32679425 2020. The hypothesis that SARS-CoV-2 affects male reproductive ability by regulating autophagy.
32664116 2020. Late histological findings in symptomatic COVID-19 patients: A case report.
32670525 2020. Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure.
32670517 2020. Kawasaki Disease as the Immune-Mediated Echo of a Viral Infection.
32653475 2020. Does the hygiene hypothesis apply to COVID-19 susceptibility?
32710269 2020. Preliminary Analysis of B- and T-Cell Responses to SARS-CoV-2.
32709887 2020. Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin.
32709886 2020. Structural basis of RNA cap modification by SARS-CoV-2.
32708840 2020. Genetic Diversity Among SARS-CoV2 Strains in South America may Impact Performance of Molecular Detection.
32672799 2020. Eosinopenia and COVID-19.
32680910 2020. Kidney Biopsy Findings in Patients with COVID-19.
32675304 2020. Histopathologic and Ultrastructural Findings in Postmortem Kidney Biopsy Material in 12 Patients with AKI and COVID-19.
32669323 2020. Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19.
32660970 2020. COVID-19-Associated Kidney Injury: A Case Series of Kidney Biopsy Findings.
32651224 2020. Caution in Identifying Coronaviruses by Electron Microscopy.
32700513 2020. Clock genes may drive seasonal variation in SARS-CoV-2 infectivity: are we due for a second wave of COVID-19 in the fall?
32660959 2020. Is FURIN gene expression in salivary glands related to SARS-CoV-2 infectivity through saliva?
32667280 2020. A putative new SARS-CoV protein, 3c, encoded in an ORF overlapping ORF3a.
32699160 2020. COVID-19: Complement, Coagulation, and Collateral Damage.
32696489 2020. Cytokine storm syndrome in coronavirus disease 2019: A narrative review.
32716059 2020. Response to Comment on "Genetic Variants and Source of Introduction of SARS-CoV-2 in South America".
32710647 2020. Antibody responses to SARS-CoV-2 in healthy individuals returning to Shenzhen.
32706425 2020. The dynamic changes of serum IgM and IgG against SARS-CoV-2 in patients with COVID-19.
32706420 2020. Qualitative assessment of SARS-CoV-2-specific antibody avidity by lateral flow immunochromatographic IgG/IgM antibody assay.
32706410 2020. SARS-CoV-2 Causes Kawasaki like Disease in children; Cases reported in Pakistan.
32706407 2020. SARS-Cov-2 infection causes pulmonary shunt by vasodilatation.
32681651 2020. COVID-19: What type of cytokine storm are we dealing with?
32699095 2020. Evolutionary arms race between virus and host drives genetic diversity in bat SARS related coronavirus spike genes.
32679087 2020. COVID-19: from rapid genome sequencing to fast decisions.
32654359 2020. Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations.
32687176 2020. Evidence for strong mutation bias towards, and selection against, U content in SARS-CoV-2: implications for vaccine design.
32706959 2020. Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.
32706954 2020. Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.
32678534 2020. Pulmonary Vascular Pathology in Covid-19. Reply.
32678533 2020. Pulmonary Vascular Pathology in Covid-19.
32678532 2020. Pulmonary Vascular Pathology in Covid-19.
32678531 2020. Pulmonary Vascular Pathology in Covid-19.
32719485 2020. Sampling the host response to SARS-CoV-2 in hospitals under siege.
32661393 2020. Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19.
32704094 2020. LY6E impairs coronavirus fusion and confers immune control of viral disease.
32669681 2020. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology.
32717743 2020. Longitudinal analyses reveal immunological misfiring in severe COVID-19.
32668444 2020. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.
32659783 2020. A perspective on potential antibody-dependent enhancement of SARS-CoV-2.
32661414 2020. A race to determine what drives COVID-19 severity.
32684080 2020. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
32659199 2020. COVID-19 Pulmonary and Olfactory Dysfunctions: Is the Chemokine CXCL10 the Common Denominator?
32654247 2020. Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein.
32672025 2020. Immunite cellulaire contre SARS-CoV-2 : substrat de l'immunite croisee entre coronavirus saisonniers et SARS-CoV-2 ?
32686248 2020. Novel coronavirus SARS-CoV-2 (Covid-19) dynamics inside the human body.
32671966 2020. Why the elderly appear to be more severely affected by COVID-19: The potential role of immunosenescence and CMV.
32656939 2020. Lessons from dermatology about inflammatory responses in Covid-19.
32668509 2020. Variabilidad genetica y epigenetica, y la pandemia de Covid-19.
32697854 2020. Interferon: the invisible link between COVID-19 and BCGitis female protection?
32697367 2020. inverted question markAre Superantigens the Cause of Cytokine Storm and viral sepsis in Severe COVID-19? Observations and hypothesis.
32680954 2020. SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection.
32669287 2020. Comprehensive mapping of immune perturbations associated with severe COVID-19.
32651212 2020. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19.

32679910 2020. SARS-CoV-2 Virologic and Immunologic Correlates in Patients with Olfactory and Taste Disorders.
32678072 2020. Detection and Genetic Characterization of Community-Based SARS-CoV-2 Infections - New York City, March 2020.
32694615 2020. Comments to: A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression.
32715628 2020. Can ACE2 expression explain SARS-CoV-2 infection of the respiratory epithelia in COVID-19?
32715618 2020. The protein expression profile of ACE2 in human tissues.
32669467 2020. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
32694127 2020. COVID-19 and the Gut Microbiome: More than a Gut Feeling.
32681106 2020. Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein.
32665645 2020. SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses.
32686754 2020. Antibody responses to SARS-CoV-2 short-lived.
32686753 2020. Virus dissociated from inflammation in fatal COVID-19.
32651570 2020. CRISPRing for host genes regulating SARS-CoV-2.
32651569 2020. SARS-CoV-2 on the neural battleground.
32651568 2020. T cell renaissance in COVID-19.
32690876 2020. Can COVID-19 strike twice?
32699357 2020. COVID-19 management in light of the circadian clock.
32668692 2020. Mutational Frequencies of SARS-CoV-2 Genome during the Beginning Months of the Outbreak in USA.
32691391 2020. Chromosome X riddle in SARS-CoV-2 (COVID-19) - related lung pathology.
32665786 2020. Lessons learned from the mechanisms of posttraumatic inflammation extrapolated to the inflammatory response in COVID-19: a review.
32685291 2020. Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and their implications on its protein structure.
32659343 2020. Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): A preliminary report.
32671793 2020. Single-cell analysis reveals bronchoalveolar epithelial dysfunction in COVID-19 patients.
32651900 2020. SARS-CoV-2 and Male Infertility: Possible Multifaceted Pathology.
32611518 2020. COVID-19: Role of neutrophil extracellular traps in acute lung injury.
32704472 2020. Hemophagocytic syndrome and COVID-19.
32664949 2020. SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis.
32704018 2020. Human SARS-CoV-2 has evolved to reduce CG dinucleotide in its open reading frames.
32691370 2020. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45(-) Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome.
32702413 2020. Multisystem Inflammatory Syndrome in Children: Is There a Linkage to Kawasaki Disease?
32653566 2020. Understanding The Complex Relationship Between Androgens and SARS-CoV2.
32679691 2020. Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes.
32666230 2020. Germany's first COVID-19 deceased: a 59-year-old man presenting with diffuse alveolar damage due to SARS-CoV-2 infection.
32699972 2020. Mild Cytokine Elevation, Moderate CD4(+) T Cell Response and Abundant Antibody Production in Children with COVID-19.
32687861 2020. Phylogenetic and phylodynamic analyses of SARS-CoV-2.
32674515 2020. Validation of Variant Assembly Using HAPHPIPE with Next-Generation Sequence Data from Viruses.
32614178 2020. Pulmonary Edema in COVID19-A Neural Hypothesis.
32638079 2020. Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-19.
32628642 2020. Serum IgM against SARS-CoV-2 correlates with in-hospital mortality in severe/critical patients with COVID-19 in Wuhan, China.
32650004 2020. Eicosanoids: the Overlooked Storm in COVID-19?
32628931 2020. ASSOCIATION OF INITIAL VIRAL LOAD IN SARS-CoV-2 PATIENTS WITH OUTCOME AND SYMPTOMS.
32639866 2020. DISEQUILIBRIUM BETWEEN THE CLASSIC RENIN-ANGIOTENSIN SYSTEM AND ITS OPPOSING ARM IN SARS-COV-2 RELATED LUNG INJURY.
32622243 2020. Delving deep into the structural aspects of a furin cleavage site inserted into the spike protein of SARS-CoV-2: A structural biophysical perspective.
32611313 2020. Identification of a druggable binding pocket in the spike protein reveals a key site for existing drugs potentially capable of combating Covid-19 infectivity.
32629042 2020. Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters.
32646930 2020. Cytokine release syndrome and the prospects for immunotherapy with COVID-19. Part 2: The role of interleukin 1.
32645391 2020. Correlation between cytokines and coagulation-related parameters in patients with coronavirus disease 2019 admitted to ICU.
32646523 2020. Adrenomedullin in COVID-19 induced endotheliitis.
32643351 2020. Successful sequencing of the first SARS-CoV-2 genomes from Croatian patients.
32640417 2020. Neuroinvasive potential of a primary respiratory pathogen SARS- CoV2: Summarizing the evidences.
32610564 2020. COVID-19 as a Vascular Disease: Lesson Learned from Imaging and Blood Biomarkers.
32646736 2020. Patients with COVID-19 present with low plasma citrulline concentrations that associate with systemic inflammation and gastrointestinal symptoms.
32650275 2020. Reappearance of effector T cells is associated with recovery from COVID-19.
32629393 2020. Illuminating COVID-19 lung disease through autopsy studies.
32632419 2020. Eosinopenia and COVID-19 patients: So specific ?
32633718 2020. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.
32614767 2020. Main Routes of Entry and Genomic Diversity of SARS-CoV-2, Uganda.
32618497 2020. High neutralizing antibody titer in intensive care unit patients with COVID-19.
32620946 2020. Coronary artery dilatation in a child with hyperinflammatory syndrome with SARS-CoV-2-positive serology.
32615182 2020. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19.
32634438 2020. Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus.
32631841 2020. JAK inhibitors in COVID-19: need for vigilance regarding increased inherent thrombotic risk.
32631838 2020. Rapid onset honeycombing fibrosis in spontaneously breathing patient with Covid-19.
32631836 2020. Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care?
32646049 2020. Mutation Patterns of Human SARS-CoV-2 and Bat RaTG13 Coronavirus Genomes Are Strongly Biased Towards C>U Transitions, Indicating Rapid Evolution in Their Hosts.
32646047 2020. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.
32645523 2020. Comparative genomic signature representations of the emerging COVID-19 coronavirus and other coronaviruses: High identity and possible recombination between Bat and Pangolin coronaviruses.
32640274 2020. SARS-CoV2 envelope protein: Non-synonymous mutations and its consequences.
32641873 2020. Inflammation, Immunity and Immunogenetics in COVID-19: A Narrative Review.
32621172 2020. Multisystem Inflammatory Syndrome in Children in COVID-19 Pandemic.
32615316 2020. Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission.
32622082 2020. Ancestral origin, antigenic resemblance and epidemiological insights of novel coronavirus (SARS-CoV-2): Global burden and Bangladesh perspective.
32638151 2020. A viral infection explanation for Kawasaki disease in general and for COVID-19 virus-related Kawasaki disease symptoms.
32634585 2020. Dynamic changes of peripheral blood lymphocytes subsets in adult patients with COVID-19.
32613447 2020. SARS-CoV-2-related deaths in routine forensic autopsy practice: histopathological patterns.
32630032 2020. Body Composition Findings by Computed Tomography in SARS-CoV-2 Patients: Increased Risk of Muscle Wasting in Obesity.
32629995 2020. Putative Roles for Peptidylarginine Deiminases in COVID-19.
32645951 2020. Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting.
32640747 2020. Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications.
32621017 2020. SARS-COV-2 and eye immunity: the lesson was learned but we are not done yet. Brainstorming on possible pathophysiology inspired by ocular models.
32642784 2020. Serum antibody response in critically ill patients with COVID-19.
32624257 2020. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
32615258 2020. Lack of complications in patients with eosinophilic gastrointestinal diseases during SARS-CoV-2 outbreak.
32639084 2020. Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19/SARS-CoV-2.
32634129 2020. Kinetics of viral load and antibody response in relation to COVID-19 severity.
32610587 2020. Does SARS-CoV-2 Trigger Stress-InducedAutoimmunity by Molecular Mimicry? A Hypothesis.
32635302 2020. Atherosclerosis as Pathogenetic Substrate for Sars-Cov2 Cytokine Storm.
32645361 2020. Inflammasome Activation and Pyroptosis in Lymphopenic COVID-19 Liver Patients.
32615199 2020. SARS-CoV-2 detection, viral load and infectivity over the course of an infection.
32622905 2020. Longitudinal anti-SARS-CoV-2 antibody profile and neutralization activity of a COVID-19 patient.
32614392 2020. Clinical characteristics and factors associated with long-term viral excretion in patients with SARS-CoV-2 infection: a single center 28-day study.
32647285 2020. Detection of SARS-CoV-2 in formalin-fixed paraffin-embedded tissue sections using commercially available reagents.
32645344 2020. Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination.
32645661 2020. Is the presence of lung injury in COVID-19 an independent risk factor for secondary lung cancer?
32645660 2020. Is macrophages heterogeneity important in determining COVID-19 lethality?
32650197 2020. Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole.
32645659 2020. Epithelial cilia is the first line of defence against Coronavirus; addressing the observed age-gradient in the COVID-19 infection.
32646911 2020. Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Early Manifestations of COVID-19 in Israel.
32646908 2020. Coding-Complete Genome Sequence of SARS-CoV-2 Isolate from Bangladesh by Sanger Sequencing.
32641700 2020. Immunological and inflammatory profiles in mild and severe cases of COVID-19.
32641705 2020. Single cell transcriptome revealed SARS-CoV-2 entry genes enriched in colon tissues and associated with coronavirus infection and cytokine production.
32648040 2020. Unlocking the lockdown of science and demystifying COVID-19: how autopsies contribute to our understanding of a deadly pandemic.
32642842 2020. Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists.
32627524 2020. Considerations around the SARS-CoV-2 Spike Protein with particular attention to COVID-19 brain infection and neurological symptoms.
32650002 2020. ASSOCIATION OF INITIAL VIRAL LOAD IN SARS-CoV-2 PATIENTS WITH OUTCOME AND SYMPTOMS.
32631071 2020. COVID-ARDS Clarified: A Vascular Endotype?
32649217 2020. RV Infections in Asthmatics Increase ACE2 Expression and Cytokine Pathways Implicated in COVID-19.
32608999 2020. COVID-19 Severity Correlates with Weaker T Cell Immunity, Hypercytokinemia and Lung Epithelium Injury.
32628534 2020. Clinical Validity of Serum Antibodies to SARS-CoV-2: A Case-Control Study.
32633104 2020. Covid-19 related IgA vasculitis.
32636189 2020. Covid-19: Herd immunity is "unethical and unachievable," say experts after report of 5% seroprevalence in Spain.
32643798 2020. Tackling COVID-19 infection through complement-targeted immunotherapy.
32640169 2020. Potential impact of SARS-CoV-2 infection on the thymus.
32641195 2020. Reply to the letter concerning Kawasaki Disease and Covid-19.
32638018 2020. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
32636454 2020. Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques.
32639942 2020. Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study.
32639941 2020. The early antibody response to SARS-Cov-2 infection.
32638022 2020. Direct evidence of active SARS-CoV-2 replication in the intestine.
32645713 2020. Microbiota and Covid-19. Which came first, the chicken or the egg?
32645228 2020. Angiotensin II Receptors - Impact for COVID-19 Severity.
32631463 2020. COVID-19: Yin and Yang and Herd Immunity.
32645207 2020. Basic Immunology may lead to translational therapeutic rationale:: SARS-CoV-2 and Rheumatic Diseases.
32635753 2020. Pathology and pathogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
32614086 2020. Insights into pathogenesis of fatal COVID-19 pneumonia from histopathology with immunohistochemical and viral RNA studies.
32629518 2020. Inflammatory Cell Infiltration of Adrenals in COVID-19.
32643416 2020. SARS-CoV-2 Receptor ACE2 is upregulated in Colonic Organoids from Hypertensive Rats.
32615317 2020. Gene signatures of SARS-CoV/SARS-CoV-2-infected ferret lungs in short- and long-term models.
32624498 2020. COVID 19 vaccination lessons from Japanese anti-HPV vaccination lobby.
32643586 2020. On the potential role of exosomes in the COVID-19 reinfection/reactivation opportunity.
32639183 2020. The Inter-alpha-Trypsin Inhibitor Family: Versatile Molecules in Biology and Pathology.
32640487 2020. BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy.
32644266 2020. Immune responses and pathogenesis in persistently PCR-positive patients with SARS-CoV-2 infection.
32644223 2020. Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19.
32639581 2020. Changes in RT-PCR test results and symptoms during the menstrual cycle of female individuals infected with SARS-CoV-2: Report of two cases.
32633840 2020. The variability of the serological response to SARS corona virus-2: Potential resolution of ambiguity through determination of avidity (functional affinity).
32633815 2020. An update on the origin of SARS-CoV-2: Despite closest identity, bat (RaTG13) and pangolin derived coronaviruses varied in the critical binding site and O-linked glycan residues.
32642770 2020. Proteome-wide Data Analysis Reveals Tissue-specific Network Associated with SARS-CoV-2 Infection.
32640066 2020. Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: First case from Iran.
32641486 2020. Genomic Analysis of Early SARS-CoV-2 Variants Introduced in Mexico.
32622377 2020. Kawasaki disease in the COVID-19 era: a distinct clinical phenotype?
32611256 2020. Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection.
32640127 2020. Case 23-2020: A 76-Year-Old Woman Who Died from Covid-19.
32641847 2020. A COVID-19 model.
32647358 2020. Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling.
32647346 2020. SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects.
32616673 2020. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.
32638509 2020. The interface between coronaviruses and host cell RNA biology: Novel potential insights for future therapeutic intervention.

32611670 2020. Angiotensin-converting enzyme 2, a SARS-CoV-2 receptor, is upregulated by interleukin-6 via STAT3 signaling in synovial tissues.
32627126 2020. COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?
32641482 2020. LY6E Restricts the Entry of Human Coronaviruses, Including the Currently Pandemic SARS-CoV-2.
32622376 2020. Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis.
32619412 2020. Endothelial cells orchestrate COVID-19 coagulopathy.
32619411 2020. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.
32616514 2020. Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework.
32629204 2020. A hypothesis on the role of the human immune system in covid-19.
32622045 2020. Integrated Approaches to Reveal Mechanisms by which RNA Viruses Reprogram the Cellular Environment.
32616647 2020. Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Causing a COVID-19 Case in Morocco.
32616644 2020. Genome Sequencing of a Severe Acute Respiratory Syndrome Coronavirus 2 Isolate Obtained from a South African Patient with Coronavirus Disease 2019.
32620916 2020. Histiocytic hyperplasia with hemophagocytosis and acute alveolar damage in COVID-19 infection.
32632085 2020. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia.
32612128 2020. High-altitude populations need special considerations for COVID-19.
32636479 2020. Pre-existing immunity to SARS-CoV-2: the knowns and unknowns.
32636475 2020. SARS-CoV-2-specific T cells without antibodies.
32629960 2020. Evidence for SARS-CoV-2 Infection of Animal Hosts.
32640525 2020. Molecular Aspects of COVID-19 Differential Pathogenesis.
32627515 2020. Dysregulation of the immune system as a driver of the critical course of the novel coronavirus disease 2019.
32638966 2020. Immunological aspects of coronavirus disease during pregnancy: an integrative review.
32621057 2020. The use of SARS-CoV-2-related coronaviruses from bats and pangolins to polarize mutations in SARS-Cov-2.
32616709 2020. Mapping the T cell response to COVID-19.
32619819 2020. S2 Subunit of SARS-nCoV-2 Interacts with Tumor Suppressor Protein p53 and BRCA: an In Silico Study.
32615987 2020. Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitis.